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vPrefácio
O trabalho apresentado nesta dissertação resulta unicamente da minha atividade de in-
vestigação e não inclui contribuições de outrem, excepto quando explicitamente refe-
renciado no texto.
O corpo destes resultados será submetido para publicação numa revista científica inter-
nacional:
Roque CM, Wong HW, and Holt CE. Cancer-associated Tctp Regulates Axon Pathfin-
ding by Promoting Mitochondrial Homeostasis.
Certifico ainda que toda e qualquer secção aqui incluída, e que venha a constar dessa 
publicação, foi redigida somente por mim.
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Sumário
Com os seus cerca de 86 mil milhões de neurónios [1], o cérebro humano é constituído 
por uma rede intrincada de processos axonais e dendríticos complexamente interliga-
dos, e que, como um todo coerente, nos permite reconhecer sinais com origem no meio 
externo e responder de forma consciente sobre este. A formação de ligações precisas 
entre as diversas áreas do sistema nervoso assume, portanto, um papel fundamental no 
garante das suas funções.
Numa primeira fase, os programas de conectividade neuronal desenvolvem-se 
no decurso da embriogénese. Em concreto, após a formação e subsequente migração 
do neurónio, este estende um axónio que se expande de modo estereotipado até à vizi-
nhança do seu alvo pós-sináptico. Os mecanismos de navegação axonal dependem de 
uma sequência de marcos moleculares distribuídos pelo sistema nervoso embrionário, 
os quais são integrados ao nível do cone de crescimento, uma estrutura ameboide com 
capacidades sensoriais e motoras, existente no extremo distal do axónio. Ao longo das 
últimas três décadas, um vasto leque de estudos foi permitindo perceber que o cone de 
crescimento é dotado de um certo grau de autonomia funcional [2], facto claramente 
ilustrado pela capacidade inalterada revelada por axónios embrionários seccionados – 
isto é, separados dos seus corpos celulares – para se orientarem corretamente in vivo 
[3]. Sabe-se hoje que esta flexibilidade de atuação advém, em parte, da regulação local 
do proteoma axonal promovida pelos sinais moleculares presentes no meio extrace-
lular embrionário. A tradução local de novas proteínas despoletada por estes factores 
permite, por exemplo, alterações rápidas ao nível do citoesqueleto [4-6] e da expressão 
de receptores na membrana celular do cone de crescimento [7], assim como potenciar 
mecanismos de manutenção axonal e mitocondrial [8-10]. É, no entanto, o carácter 
transversal do transcriptoma axonal – o número de espécies de ARNm localizados no 
compartimento axonal situa-se na ordem dos milhares [11-15] – que porventura nos dá 
verdadeiramente conta da importância funcional deste processo celular.
Nos estudos laboratoriais conducentes a esta tese, foi estudada a participação 
da Tctp (do acrónimo inglês, translationally controlled tumor protein) nos processos de 
conectividade neuronal, usando como modelo a projeção retinotectal da rã-de-unhas-
xiv
-africana (Xenopus laevis). A Tctp é uma proteína conservada filogeneticamente [16], 
relevante ao nível de processos de sobrevivência [17] e de crescimento celular [18, 19], 
e bem caracterizada em particular no âmbito da oncogénese [20]. A motivação inicial 
para estudar a Tctp neste contexto surgiu da identificação do ARNm que codifica a Tctp 
entre os mais abundantemente expressos no compartimento axonal de diversas popula-
ções neuronais [11-14], incluindo em células ganglionares da retina, indicando que esta 
proteína detém um papel local relevante, mas por explorar, no campo da neurobiologia.
A minha contribuição original mais significativa para o conhecimento prende-
-se com a identificação do envolvimento da Tctp na regulação do desenvolvimento 
axonal através da sua função de suporte à homeostasia mitocondrial. Especificamente, 
a depleção da Tctp durante a embriogénese resulta em projeções retinotectais que não 
granjeiam alcançar a zona-alvo no mesencéfalo aquando do estádio de desenvolvimen-
to normal. Os axónios deficitários em Tctp apresentam uma disfunção e menor densi-
dade mitocondrial, bem como dinâmicas de transporte mitocondrial alteradas; contudo, 
tais manifestações não se traduzem em decréscimos globais da biogénese ou da massa 
destes organelos, pelo que se infere um fenótipo com repercussões predominantemente 
axonais. Documento ainda a interação intra-axonal da Tctp com duas oncoproteínas 
anti-apoptóticas da família Bcl-2 – a Mcl1 (do acrónimo inglês, myeloid cell leukemia 
1) e a Bcl-XL (Bcl-2-like protein 1) – e aumentos nos níveis de expressão da P53 e da 
forma ativada da Caspase-3 no cone de crescimento de axónios desprovidos da Tctp.
Estes resultados indicam que a Tctp regula o desenvolvimento axonal pela sua 
ação nos mecanismos de homeostasia celular. O meu estudo sugere, portanto, que à 
Tctp cabe uma função de fundamental relevância nos mecanismos de formação dos 
circuitos neuronais em vertebrados.
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Summary
With 86 billion neurons in the human brain [1], the ordered array of neuronal pathways 
is an exceptionally complex web of accurately connected axonal and dendritic process-
es, ultimately allowing us to perceive the world and respond consciously to it. Precise 
wiring of the nervous system is therefore the cornerstone of its intricate functions.
Neuronal connectivity begins to take shape during embryonic development, 
when post-migratory newborn neurons send out a single threadlike axon that extends in 
a highly directed manner to the vicinity of its appropriate target region. Axon pathfind-
ing relies on molecular ‘guideposts’ presented in the embryonic landscape and integrat-
ed by the growth cone, an amoeboid, sensory structure at the tip of developing axons 
first identified by the legendary Ramón y Cajal [21]. Studies in the past three decades 
have revealed that a certain degree of functional autonomy is endowed upon this cel-
lular outpost [2], perhaps best exemplified by the demonstration that axons separated 
from their cell bodies can still navigate correctly in vivo [3]. It is now evident that this 
flexibility partly arises from the local regulation of the axonal proteome in response to 
extracellular cues. The local translation of new proteins elicited by these factors allows 
for rapid alterations in cytoskeleton dynamics [4-6], guidance receptor expression [7], 
substrate adhesion [22], as well as promoting axonal and mitochondrial maintenance 
[8-10]. The recent appreciation of the complexity of the axonal transcriptome, with 
thousands of mRNAs identified [11-15], clearly illustrates the functional significance 
of this homeostatic mechanism.
Here, I pioneered the study of translationally controlled tumor protein (Tctp) 
in the context of neural connectivity using the Xenopus laevis (African clawed frog) 
retinotectal projection as an in vivo model system. Tctp is an evolutionary conserved 
pro-survival protein implicated in cell growth [16-19] and particularly well-studied in 
cancer pathogenesis [20], where its expression is often found upregulated and correlates 
with indicative markers of aggressive disease [23-25]. Significantly, across diverse neu-
ronal populations, including retinal ganglion cells, the tpt1 transcript, which encodes 
for Tctp, is ranked among the most enriched in the axonal compartment [11-14], sug-
gestive of an unexplored relevant role in neurobiology. 
My most significant original contribution to knowledge is the identification of 
Tctp as a cell-autonomous checkpoint for axon development through its support of mi-
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tochondrial homeostasis. Specifically, Tctp deficiency during embryogenesis results in 
shorter retinotectal projections that fail to reach their target at the appropriate devel-
opmental window. Tctp-depleted axons exhibit mitochondrial dysfunction, decreased 
mitochondrial density and defects in mitochondrial dynamics, but Tctp knockdown em-
bryos have intact mitochondrial biogenesis and mass, arguing for a phenotype with pre-
dominantly axonal repercussions. Furthermore, I document that axonal Tctp interacts 
with Bcl-2 pro-survival oncoproteins myeloid cell leukemia 1 (Mcl1) and Bcl-2-like 
protein 1 (Bcl-XL), and that Caspase-3 activation and increased P53 levels are found in 
growth cones depleted of Tctp.
Overall, the data I have collected over the course of my research indicate that 
Tctp regulates axon development by impacting on the homeostatic mechanisms of the 
neuron. My findings thus suggest a novel and fundamental role for Tctp in vertebrate 
neural circuitry formation.
xvii
Note on Gene Nomenclature
For overall clarity and consistency, Xenopus gene nomenclature guidelines were used 
throughout this dissertation [26].
Note that the tumor protein, translationally-controlled 1 (tpt1) gene, is transcribed into 
tpt1 mRNA, which encodes for Tctp protein.

1A – Axon Development
The arrangement of retinal neurons in the brain reflects that of the light-sensitive cells 
in the retina and, ultimately, the visual world. The computing power such organization 
commands is staggering: in each eye we have approximately 126 million photorecep-
tors, connecting to 540 million visual cortex cells [27]. In between, processing of in-
formation in the visual system begins at the very first synapse, to the extent that when 
leaving the eye, each electric signal relays not a point of light but a pattern of light. 
In lower vertebrates, independent of the birthplace in the retina, retinal ganglion cell 
(RGC) axons extend towards the optic nerve head, where they collect to exit the eye 
and form the optic nerve. Once past the midline optic chiasma in the ventral dienceph-
alon, retinal ganglion cell axons turn dorsally and grow to the optic tectum, their most 
prominent synaptic target in the midbrain, where they terminate and arborize in a topo-
graphic array that, in essence, copies the spatial map on the retina into the brain (Figure 
1.1). Likewise, several other stereotyped trajectories of axonal growth are concurrently 
established in the embryonic brain; so, how do axons succeed in finding their way?
a Binocular vision requires that information from both eyes converge on the same areas of the brain. At 
the optic chiasm, axons from specific regions of the retina, project either contralaterally or ipsilaterally, 
enabling those neurons that share visual space to converge on the same brain hemisphere. By contrast, 
fish and birds do not extend ipsilateral projections for they do not have binocular vision.
1. Introduction
2A.1 Principles of Axon Guidance
Historically, the neuroscience field debated two explanatory hypotheses regarding the 
wiring of the nervous system. The ‘resonance theory’ explained the developmental pat-
terning of the central nerve tracts on a purely mechanical basis, by schemes of initially 
non-selective growth that, based on the validity of the connection formed, were later 
maintained or eliminated [29, 30]. A second framework proposed that selective chem-
ical or electrical forces guided neuronal connections and found initial support in the 
experiments of John Langley in the late ninetieth century [31]. The extensive studies 
of Roger Sperry on how regenerating frog retinal ganglion cell axonsa are arranged 
when re-innervating their target categorically proved the latter hypothesis [32-34]. In 
a Unlike their mammalian counterparts, central axons regenerate well in lower vertebrates, thus their 
utilization in such experiments.
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Figure 1.1 – Overview of the visual system. (A) Hand-drawn representation of the mammalian retinal 
structure by Santiago Ramón y Cajal. (B) Global organization of the visual system. Note that the optic 
tectum in lower vertebrates is the anatomic equivalent of the superior colliculus in mammals. In higher 
mammals (e.g. in cats and humans) the dorsal lateral geniculate (LGN) in the thalamus is instead the 
main target in the diencephalon. From Sanes and Zipursky (2010) [28]. (C) Xenopus laevis transverse 
section showing a single retinal ganglion cell with its axon growing through the optic pathway en route 
to the optic tectum. Adapted, courtesy of Christine Holt.
3his most dramatic experiment, Sperry rotated the eye 180º on its dorsoventral axis after 
severing the optic nerve and noted that it lead to the animal having inverted vision; 
that is, the axons were originating from reversed positions in the eye yet managing to 
find their appropriate synaptic connections in the brain. He concluded that “the cells 
and fibers of the brain and cord must carry some kind of individual identification tags, 
presumably cytochemical in nature, by which they are distinguished one from another 
almost, in many regions, to the level of the single neuron” [34], a molecular view of 
the structuring of the nervous system which remains largely unchallenged to date [35].
Indeed, observations in vivo of developing axonal projections have revealed 
that their growth is highly directed, with axons navigating along a prescribed trajectory 
en route to their respective synaptic targets and making very few errors of navigation 
in the process [36-39]. Growing axons encounter successive spatial signals – guidance 
cues – with each section of the trajectory governed by distinct attractive or repulsive 
guidance mechanisms [40]; id est, axon trajectories are seemingly divided into shorter 
segments [41-43], thus reducing the effort of navigating towards a distant target – in 
the order of centimetres in some instances, or a thousand-fold the diameter of the cell 
body – to the simpler task of reaching consecutive intermediate points.
What are the mechanisms that govern the stereotyped axon growth in each seg-
ment of their trajectory? Classically, four evolutionary conserved families of signaling 
molecules that function as instructive guidance cues are described for their widespread 
roles in axon guidance: netrins, semaphorins, slits and ephrins (Figure 1.2) [44]. Two 
additional classes of molecules with roles in axon guidance and originally character-
ized in other settings have been more recently recognized: morphogens (members of 
the Wnt, Hedgehog, and Bone Morphogenic Protein families), and various molecules 
classified primarily as growth factors [44]. Importantly, the actions of these cues are 
not mutually exclusive, but rather coordinately act to ensure an unerring navigation. 
For example, commissural axons, a particularly well-studied and illustrative guidance 
paradigm, are attracted to the ventral midline by members of the Netrin family [43], the 
morphogen Sonic Hedgehog (Shh) [45] and the prototypic angiogenic factor Vegf [46], 
all exerting complementary effects; synchronously, roof plate cells in the dorsal midline 
secrete bone morphogenic proteins (BMPs) which act as chemorepellents and provide 
a decisive forward push on their ventral journey [47]. Thus, the involvement of various 
instructive signals even along a short trajectory considerably diminishes the likelihood 
of guidance errors and promotes the necessary fidelity in the establishment of neuronal 
connections (Figure 1.3). 
4Figure 1.2 – Families of axon guidance molecules. Schematic representation of the four ‘canonical’ 
ligand/receptor families of signaling proteins involved in axon guidance. Netrins comprise a family of 
extracellular proteins related to laminin and are the vertebrate homologues of the Unc-6 protein identified 
in Caenorhabditis elegans. In vertebrates, the Netrin family is formed by three secreted (Netrin-1, Ne-
trin-3 and Netrin-4) and two glycosylphosphatidylinositol (GPI)-linked membrane proteins (Netrin-G1 
and Netrin-G2). From worms to vertebrates, secreted Netrins can function as attractive cues to some 
axons and repulsive to others, depending on the complement of receptors present and cellular context. 
Netrin-1 attraction is mediated by receptors of the deleted in colorectal cancer (Dcc) family, which are 
members of the immunoglobulin superfamily of cell adhesion molecules. By contrast, Netrin-mediat-
ed repulsion is dependent on the combinatorial actions of Dcc and Unc-5 receptors, which belong to 
the immunoglobulin gene superfamily. More recently, the highly conserved Down syndrome cell ad-
hesion molecule (Dscam) has been characterized as a Netrin-1 receptor, mediating attractive guidance 
to commissural axons in collaboration with Dcc [48, 49]. Semaphorins constitute a family of secreted, 
transmembrane and GPI-anchored proteins that were originally identified as repulsive axon guidance 
cues. Semaphorin input is signalled predominantly through members of the Plexin family, though many 
secreted semaphorins, including the first vertebrate semaphorin to be identified (Semaphorin 3A), do not 
bind these receptors directly but instead neuropilins, which act as semaphorin co-receptors. Downstream 
of receptor activation, signaling pathways activated by semaphorins promote the local disassembly of the 
cytoskeleton and substrate adhesion contacts, counteracting axon outgrowth and/or inducing repulsive 
guidance responses [49, 50]. Slits are large secreted glycoproteins identified in the late 90s as axonal 
repellents and mediators of axon branching. The actions of Slit proteins are primarily intermediated by 
receptors of the Roundabout (Robo) family, which, like Dcc, are part of the immunoglobulin superfami-
ly. Ephrin ligands are cell surface signaling molecules that function exclusively as short-range guidance 
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5Figure 1.3 – The concerted action of multiple guidance cues upholds fidelity in axon guidance 
mechanisms. The development of commissural axons in the spinal cord is accurately directed by a 
combination of repellent (denoted by the red colour and minus sign) and attractive (green and plus sign) 
factors in the spinal cord to achieve. BMPs - bone morphogenic proteins; Shh - sonic hedgehog; Vegf 
- vascular endothelial growth factor. See text for details. Adapted from Fundamental Neuroscience, 3th 
Edition [348].
cues, binding Eph receptors and producing bidirectional output signals at points of contact between cells. 
Class A ephrins are anchored to the cell surface via GPI-linkages, whereas class B ephrins are transmem-
brane proteins and, as a general rule, interact with EphA and EphB receptors, respectively. Eph receptors 
constitute the largest family of receptor tyrosine kinases [49, 51]. All the receptors described herein have 
single-pass transmembrane domains.
Upon crossing the midline, commissural axons are faced with a rostral-to-cau-
dal decreasing gradient of Wnt molecules in the spinal cord instructing an anterior turn 
in the direction of the brain. Similarly, caudally projecting corticospinal tract axons are 
guided by Wnts along the longitudinal axis (Figure 1.3), illustrating another funda-
mental aspect of guidance mechanisms: different axons may have contrary responses 
to the same cuea[52, 53]. In turn, if the intermediate target is understood as attractive, 
how can axons move onwards to the following segment of the pathway? Ingeniously, 
axonal growth cones are capable of altering their responsiveness to guidance factors to 
such an extent that a territory initially sensed as permissive is subsequently perceived 
as repulsive. In the case of commissural axons, in addition to secreting Netrin-1, the 
floor plate cells also produce repellents of the Slit family [54, 55] (Figure 1.3). These 
axons can cross the midline unaffected by the repulsive cue because they are initially 
insensitive to it. However, upon passing the midline, they become responsive to the 
Slit gradient due to an increase in the expression and function of its receptors [56] and, 
a Although incompletely defined, the divergent responses to Wnt gradients partially reflect the expres-
sion of distinct surface receptors.
6concomitantly, to a loss of responsiveness to Netrin-1 [57]. Thus, just as important as 
the mechanisms that accurately guide axons through the pathway, are the coordinate 
switches from attraction to repulsion that ensure their progression past the intermediate 
targets.
In addition to chemical signals, growth cones are instructed by cell-cell and 
cell-matrix physical adhesions that provide not only an effective roadmap for navigation 
but also an essential platform for growth cone motility [58]. In the context of growth 
cone steering, adhesive molecules can be encountered upon contact with neighbouring 
cells (cell-cell adhesion) or, indirectly, through the binding to components of the sur-
rounding extracellular matrix (cell-matrix adhesion). These contacts can be mediated 
by members of the integrin, cadherin and, most prominently, immunoglobin (IgG) su-
perfamilies (Figure 1.4) [58, 59]. Though much of the initial work on neural connec-
tivity was dedicated to identifying factors that mediate adhesion to substrates, many 
cell adhesion molecules with neuronal expression were shown to promote surprisingly 
subtle axon guidance defects upon biochemical or genetic loss-of-function. Nonethe-
less, experiments with fly fasII mutantsa provided a breakthrough understanding of how 
the selective expression of adhesion receptors can shape neural connectivity; specifi-
cally, despite still projecting in roughly correct trajectories, ultrastructural analysis of 
fasII mutants embryos showed defasciculation phenotypes along the longitudinal tracts 
where Fasciclin II is selectively expressed [60]. Furthermore, selective cell adhesion 
events underlie another major feature in the wiring of the nervous system: the stepwise 
nature of the process [61]. Notably, whereas the very first axons advance when the em-
bryonic brain is still relatively small and ‘uncomplicated’, most later-born neurons face 
an expanding and increasingly complex environment. Fittingly, as the brain matures, 
pioneer tracts can serve as scaffolds for many of the later developing axons for at least 
some parts of their trajectory [62-64]. Such scheme, in which successive waves of ax-
ons extend to their targets along preexisting tracts, much simplifies the elaboration of 
the complex three-dimensional neuritic web of the brain.
A.2 The Dynamic Growth Cone
A colourful analogy pictures the growth cone on its journey as both ‘vehicle’ and ‘nav-
igator’ [58]. And indeed, guidance cues are instructive signaling molecules that modu-
late whether the growth cone turns, extends or retracts in pursue of a new direction; id 
a fasII, encodes for the neural cell adhesion molecule Fasciclin II, which is the fly orthologue of proto-
typic NCAM in vertebrates. 
7Figure 1.4 – Overview of major cell-cell and cell-matrix adhesive interactions regulating axon 
guidance. In the process of axon pathfinding, adhesive contacts are primarily mediated by cell adhesion 
molecules (CAMs), namely cadherins, integrins, and members of the immunoglobulin (Ig) superfamily 
of cell adhesion molecules (IgCAMs). Cadherins are calcium-binding adhesive molecules that mostly 
function in homophilic cross-bridges. Differently, integrins participate in cell-matrix, as well as cell-cell 
interactions (not depicted here). Integrin heterodimers are composed of various combinations of α and β 
subunits, which generate multiple affinity profiles. The immunoglobulin superfamily is comprised of ei-
ther transmembrane or GPI-anchored proteins, with extracellular Ig-like domains and fibronectin type III 
repeats. Some IgCAMs can associate in homophilic contacts, while others interact through heterophilic 
cross-bridges. Of note, the cytosolic domains of some CAMs can engage with adapter proteins that act as 
direct or indirect (through downstream signaling cascades) linkers to the cytoskeleton.  [65, 66]. Image 
sourced from Development of the Nervous System, 3th Edition [349].
est, guidance signals, one way or another, must impinge on the dynamics of the growth 
cone motility machinery. Thus, as important as understanding the molecular environ-
ment the growth cone navigates, is to know how these spatial cues are integrated and 
how they shape its responses.
 To this end, learning the structure of the growth cone is critical to decipher the 
nature of its plastic and protrusive behaviours. Although functionally indissociable, the 
distribution of the actin and microtubule cytoskeletons in the growth cone define two 
distinct compartments: the central domain, enclosing tightly bundled microtubules in 
addition to various organelles (e.g., mitochondria), and the peripheral domain, com-
posed of a dense meshwork of branched actin networks supporting lamellipodia-like 
veils and long, polarized actin fibrils highlighting several transient filopodia that inces-
santly scout the environment [58]. At the interface between these two domains lies the 
transition zone, an actomyosin contractile arc that regulates both actin and microtubule 
cytoskeletons (Figure 1.5) [67, 68].
8As with migratory cells, the forward-crawling motion of a growth cone is de-
pendent on its cytoskeleton, and particularly the dynamic properties of actin. The ‘actin 
motor’ is propelled by a continuous myosin-based rearward flux of filamentous (F)-ac-
tin from the leading edge of the growth towards its central domain (termed ‘actin retro-
grade flow’) in combination with F-actin treadmilling, which involves the constant re-
cycling of depolymerized actin monomers from the transition zone to the leading edge, 
where they re-polymerize. Without productive adhesive contacts, the actin retrograde 
flow rapidly equalizes polymerization-depolymerization rates and no net contribution 
to forward movement is made. However, when filopodia encounter an adhesive sub-
strate, a molecular complex that functions as a clutch is formed between the receptors 
and the actin cytoskeleton that, in essence, tethers the F-actin fibrils and attenuates 
retrograde flow [58, 69]. Simultaneously, F-actin polymerization at the leading edge 
continuesa, pushing the peripheral domain forward and, as a result, protrusion of the 
growth cone occurs.
a Or is even stimulated, as the signaling cascades initiated by some guidance cues can lead to the activa-
tion of Rho GTPases and downstream effectors that promote actin polymerization.
Figure 1.5 – The growth cone ‘vehicle’. As Ramón y Cajal famously described it, the growth cone is 
“(...) endowed with exquisite chemical sensitivity, rapid amoeboid movements, and a certain motive 
force (...)” [3]. The growth cone is a dynamic structure acted upon by spatial cues in the environment 
which bias the behaviour of its cytoskeleton machinery. C domain - central domain; T zone - transition 
zone; P domain - peripheral domain. See text for details. From Lowery and Van Vactor (2009) [58].
9In parallel, adhesion events selectively shape the dynamics of the microtubule 
cytoskeleton, particularly, at their onseta, the population of individual microtubule 
polymers that actively explore the peripheral domain [70, 71]. Specifically, it has been 
demonstrated that these highly dynamic microtubules explore filopodia along F-actin 
bundles and are necessary as scaffolding platforms for the localized accumulation of 
key signaling components of the navigation machinery at strongly attached filopodia 
[72, 73]. Hence, a productive attachment of a filopodium onto a permissive substrate 
or cell induces a localized increase in actin polymerization that is ‘encouraged’ further 
by invading microtubules. In this way, filopodia act both as distal guidance sensors and 
‘points of attachment’ to the substrate, continuously searching the molecular environ-
ment and generating the required tension for growth cone progression [74]. 
Spatial bias can also be introduced into the system by guidance cues. Indeed, 
many chemotropic factors ultimately converge on signaling cascades (e.g. Rho fami-
ly GTPases) that modulate actin dynamics, and their differential activation across the 
growth cone compartment can lead to localized changes in the rate of actin polym-
erization or depolymerization [75, 76]. Graded distributions of ‘positive’, attractive 
cues can invoke an asymmetric increase in actin polymerization rates that promotes 
protrusion preferentially in the direction of the attractive gradient; conversely, repulsive 
signals decrease polymerization or increase catastrophe events on the nearside, favor-
ing protrusion away from the ‘source’ [58]. Some guidance cues have also been shown 
to regulate microtubule dynamics, particularly by modulating the activity of proteins 
associated with the plus-end of microtubules [59, 77, 78]. 
A.3 Asymmetric Endocytosis and Exocytosis in the Growth Cone
Though distal membrane stores were identified four decades ago [79, 80], only recently 
has regulated plasma membrane trafficking at the tip of developing axons emerged as a 
major contributing aspect to chemotropic growth cone decisions alongside the cooper-
ative interaction between cytoskeleton and adhesion machineries [81-84]. Nonetheless, 
it is now increasingly evident that asymmetric membrane trafficking across the growth 
cone plasma membrane – in the form of endocytosis and exocytosis – arises at the onset 
of guidance cue responses. 
Kamiguchi and colleagues provided the first demonstration that polarized ves-
icle dynamics mediates chemotactic responses in growth cones, by showing that a 
a In a later phase of the steering mechanism, bundled microtubules in the central domain extend into the 
area of new growth and effectively commit the growth cone as a whole in a new direction.
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gradient of chemoattractants stimulates the centrifugal transport of vesicle-associated 
membrane protein 2 (Vamp2)-positive exocytic vesicles along microtubules towards 
the gradient side of the growth cone. It was also shown that this type of exocytosis op-
erates exclusively in attractive turning responses and does not mediate axon outgrowth 
[81]. Conversely, the same group later reported that a repulsive chemotactic gradient 
promotes the asymmetric removal of growth cone plasma membrane on the side facing 
the stimulus via clathrin-mediated endocytosis, and that this event is required and suf-
ficient for repulsive turning [82]. Taken together, these findings support the notion that 
a polarized disturbance of membrane trafficking across the growth cone is sufficient to 
promote a directional turning response towards the side undergoing more exocytosis or, 
alternatively, less endocytosis [85].
Given that differential membrane trafficking temporally precedes any detect-
able cytoskeletal rearrangements, it appears likely that membrane remodeling imparts 
a decisive contribution to initiate turning responses [59, 85], although, to the best of 
my knowledge, only two studies have addressed this issue directly in the context of 
asymmetric stimulation [83, 84], a[86, 87]. Most notably, Hines et al. demonstrated that 
a repulsive myelin-associated glycoprotein (Mag) gradient provokes a polarized clath-
rin-mediated endocytic response and, concurrently, a localized remodeling of cell ad-
hesion components, including the loss of β1-integrin receptors on the side of the growth 
cone experiencing the negative stimulus [83]. Thus, asymmetric membrane trafficking 
can allow the growth cone to rapidly adjust its adhesiveness across its axis – an essen-
tial step to commence a chemotactic turning response, as I have described above. 
A.4 The Optic Pathway
The optic pathway (Figure 1.6), comprised of the axons of retinal ganglion cells – the 
sole output neurons of the retina – joins the retina to the optic tectum/superior collic-
ulus, and has served as a particular suitable model to study the mechanisms of axon 
guidance, for it entails diverse molecular environments through which retinal growth 
cones must precisely navigate b[3, 34, 88-91].
a Outside the ‘asymmetric’ paradigm, it is well established the involvement of the endocytic and exocyt-
ic pathways in the modulation of signaling nodes in the growth cone. For example, endocytosis of Dcc 
and Neuropilin 1 receptors upon collapse-inducing Netrin 1 and Semaphorin 3A stimulation, selectively 
adjusts their surface availability and desensitizes the growth cone transiently to its environment. 
b In particular, the Xenopus laevis retinotectal tract offers a number of attractive reasons for its continued 
utilization in studies addressing the mechanisms of axon guidance. First, X. laevis embryos develop ex-
ternally and can be obtained throughout the year by in vitro fertilization. They require minimal daily care 
to maintain and grow rapidly, allowing the researcher to run successive experiments in a matter of days. 
Protocols for culturing X. laevis eye explants are well established and retinal neurons develop in vitro at 
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Figure 1.6 – Diagram of the embryonic Xenopus laevis retinotectal pathway. Lateral (A) and trans-
verse (B) views of the optic pathway. Inside the neural retina, retinal ganglion cell axons extend radially 
along the retinal surface towards the optic nerve head/optic disk, where they collect to exit the eye and 
form the optic nerve. Once past the midline optic chiasm in the ventral diencephalon, retinal ganglion 
cell axons turn dorsally. Subsequently, in the mid-optic tract, retinal ganglion cell axons turn caudally 
to reach the optic tectum (pioneer axons complete their stereotypic journey as early as stage 37/38). 
For anatomical clarity, the retinotectal projection in (B) is divided into nine discrete regions. The doted 
circumference in (A) denotes the opposite retina (in respect to the viewpoint of the illustration), from 
where the depicted axon projection originates. OT- optic tract; scale bar: 50 μm. The illustration in (B) 
was redrawn from Holt (1989) [92].
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room temperature without requiring growth factors, thus permitting the functional exploration of individ-
ual guidance cues without extra factors in the culture media. Plus, a myriad of techniques are available to 
the experimenter to effectively manipulate gene expression in a targeted fashion and follow live growing 
axons in vivo, making the X. laevis visual system a stellar, all-round model to study axon guidance.
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The journey of retinal ganglion cell axons starts in the retina, extending radial-
ly along the optic fiber layer (OFL) before converging at the optic disc and extending 
through the optic nerve head (ONH) to exit the eye. Upon completing differentiation, 
extracellular matrix (ECM) components of the basal lamina provide the necessary stim-
uli to polarize the emergence of retinal ganglion cell axons on the basal pole of their cell 
bodies [93]. Subsequently, as retinal ganglion cell axons extend towards the optic disc, 
their growth is confined to the optic fiber layer in the inner surface of the retina. This 
is achieved by the actions of negative signals inhibiting awry navigation into the outer 
layers of the retina and the embryonic lens, acting in concert with attractive cues pro-
moting growth centrally [94-96]; in particular, a high central–low peripheral wave of 
the morphogen Sonic Hedgehog is involved in regulating the directed growth of retinal 
ganglion cell axons towards the optic disc [97], whereas repulsive gradients of Slit2 and 
the proteoglycan chondroitin sulfate (Cspg) are present at higher levels peripherally 
[98, 99]. Next, the growth cones of retinal axons are guided into the optic nerve head by 
Netrin-1 [100], which here functions ‘locally’, unlike its modus operandi in the spinal 
cord, where it acts as a long-range diffusible cue to guide commissural axons towards 
the ventral midline [101].
After exiting the eye, the optic nerve steers through the embryonic optic stalk 
and enter the brain at the optic chiasm in the ventral diencephalon, where retinal gan-
glion cell axons either cross the midline and extend to the contralateral hemisphere 
or, alternatively, remain ipsilateral. In Xenopus tadpoles, all retinal ganglion cell ax-
ons grow contralaterally at the optic chiasm before metamorphosis [102]a. As retinal 
growth cones approach the chiasm, Slits and Sonic Hedgehog, which are expressed in 
the ventral-most diencephalic region, function as inhibitory cues to retinal ganglion cell 
axons, effectively establishing the coordinates of the optic chiasm in the midline neuro-
axis [95]. At the chiasm, Sonic Hedgehog works as an inhibitor of retinal ganglion cell 
axon extension, in opposition to its attractive role inside the retina. In fact, it has been 
shown in vitro that Sonic Hedgehog elicits contrary responses in retinal ganglion cell 
growth cones depending on the concentration used in the assay [97]. Hence, different 
levels of Sonic Hedgehog expression in the retina and chiasm may partly explain the 
a Xenopus laevis tadpoles – id est, pre-metamorphic animals – were used throughout the laboratory 
research I conducted.
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differential behaviors exhibited by retinal ganglion cell axons in respect to the same 
cue [95], as has been demonstrated in other instances [103, 104]. Once at the chiasm, 
distinct subpopulations of retinal ganglion cell axons respond oppositely to Ephrin-Bs 
expressed by radial glia, as initial studies in Xenopus indicated [102]. The mechanism 
was later elucidated in mouse: Ephrin-B2-mediated repulsion is determined by the ex-
pression of EphB1 protein in the growth cone of ipsilaterally projecting retinal ganglion 
cells emerging from the temporoventral crescent. Conversely, contralaterally project-
ing axons emanating from the dorsal and ventral regions of the retina do not express 
EphB1, and are therefore insusceptible to the repulsive influence of Ephrin-B2 [105].
Once in the optic tract, retinal axons are restrained to a path adjacent to the tel-
encephalon as they extend dorsally through the diencephalon. Initial axon progression 
from the optic chiasm is dependent on Growth associated protein (Gap)-43 function to 
overcome the inhibitory regional environment [106, 107]. Similarly to other discrete 
segments of the optic pathway, retinal ganglion cell growth cones are guided within the 
optic tract by inhibitory Cspg and Slit cues, which prevent aberrant intrusions into the 
telencephalon and inappropriate domains of the diencephalon [108-112]. As for a mo-
lecular mechanism, initial biochemical studies in Xenopus found evidence implicating 
N-cadherin in the ordered formation of the optic tract [113], which was followed a few 
years later by the demonstration that N-cadherin-mediated cell adhesion is inactivated 
downstream of repulsive Slit signals [114]. Furthermore, Slit 2 has been shown to pro-
mote the rapid, protein-synthesis dependent upregulation of the actin-depolymerizing 
protein Cofilin in retinal growth cones, suggesting also a role for local translation in the 
path-restraining effects operated by Slits [115]. Subsequently, repellent Semaphorin 3A 
and Slit signals at the mid-optic tract impose a caudal turn in the direction of the optic 
tectum, and effectively demarcate the last section of optic tract [22, 116]. In specific, 
the Holt laboratory has shown recently that NF-protocadherin local synthesis evoked 
by Semaphorin 3A in retinal growth cones facilitates the accurate navigation at the 
mid-optic tract caudal turn, which suggests that an effective cross-talk exists between 
the two signaling systems and help to shape the formation of the optic pathway [22].
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As they near the target area, retinal ganglion cell axons begin to defasciculate 
from the compact bundle of the optic tract. Finally, in addition to the signals discussed 
in the next section, entry into the target region is partly defined by the transition from 
an environment highly rich in fibroblast growth factor, the optic tract, which promotes 
axonal growth, to a territory where very little of it is present, the optic tectum [117].
A.5 Axon Guidance at the Optic Tectum
From the optic tract, retinal ganglion cell axons enter the optic tectum/superior collic-
ulus anteriorly; here, retinal axons significantly slow down as they extend along the 
anterior-posterior axis of the optic tectum/superior colliculus, and their growth cones 
become more complex and eventually begin to branch [3, 118]. However, important 
interspecies differences arise at this stage: the initial development of retinotectal topog-
raphy in frog and fish is a much more precise process than in chicks or rodents, the other 
two major vertebrate models that have been utilized to study such mechanisms. Indeed, 
in the former duo, retinal ganglion cell axons extend to, or just about to, a defined 
territory within the tectum and afterwards arborize from the back of the growth cone; 
differently, in mouse and chick, axons initially grow well past their specific targets, in-
stead establishing contacts through interstitial branches formed along the axon shaft at 
the anterior-posterior location of their correct termination zone [119].
As I have briefly introduced before, the retinotectal projection, like other senso-
ry systems of the body, is organized topographically; that is, retinal ganglion cells with 
neighboring points of origin within the retina maintain neighboring relationships in 
the target field. Ultimately, it is this correct neuroanatomical representation that allows 
us to perceive the visual space as a contiguous, coherent whole. In lower vertebrates, 
the temporo-nasal axis of the retina is represented along the anterior-posterior axis of 
the optic tectum, whereas the ventro-dorsal retinal axis maps along the dorso-ventral 
axis [102]. A similar arrangement is observed in mammals: the temporo-nasal retina 
projects along the anterior-posterior axis of the superior colliculus, and ventro-dorsal 
regions along its lateral-medial axis. Consequently, the two-dimensional map of the 
visual world on the optic tectum/superior colliculus is effectively maintained, albeit 
inverted, in respect to that on the retina. As Sperry deduced from his experiments, each 
point in the optic tectum/superior colliculus seems to have a unique molecular ‘post 
code’ defined by gradients of topographic guidance molecules orthogonally distributed; 
in turn, these ‘molecular coordinates’ are matched by unique profiles of guidance recep-
tors on the surface of each retinal ganglion cell axon. Hence, both innervating neurons 
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and their targets are chemically specified in a complementary fashion to promote appro-
priate synaptic contacts [119].
 Though the exact complement of ligands and receptors may differ between spe-
cies, the extent of anterior-posterior mapping is largely determined by repulsive inter-
actions between Ephrin-A ligands expressed on the optic tectum/superior colliculus 
and EphA-expressing retinal axons. In particular, quantitative differences, rather than 
qualitative, account for the astonishing fidelity of the system: EphAs have a graded 
high-temporal to low-nasal expression pattern in the retina, matched by a overall low-
to-high complementary gradient of Ephrin-As distributed along the anterior-posterior 
axis of the optic tectum/superior colliculusa. Simply put, temporal axons are repulsed 
by relative lower concentrations of Ephrin-As because they express higher EphAs lev-
els. Consequently, their progression is halted along the anterior-posterior axis at ‘more 
anterior’ positions, and how much so is determined by the actual amount of EphAs 
each individual growth cone expresses. On the other hand, nasal retinal ganglion cell 
axons, which express lower levels of EphAs, solely become repulsed by relative higher 
– therefore more posterior – concentrations of Ephrin-As [119, 120].
Mechanisms contributing to topographic mapping along the optic tectum/supe-
rior colliculus dorso-ventral/lateral-medial axis are more incompletely defined. Effec-
tively, dorso-ventral/lateral-medial order begins to be established within the optic tract 
itself as retinal ganglion cell axons defasciculate, a process known as pre-target sorting 
[121, 122]. Then, similarly to anterior-posterior topographic mechanisms, graded dis-
tributions of EphB/Ephrin-B help to further refine dorso-ventral/lateral-medial map-
ping in the optic tectum/superior colliculus. Specificically, both EphBs and Ephrin-Bs 
are expressed in the retina, albeit in opposite gradients: Ephrin-Bs have a high dorsal 
to low ventral expression pattern, while EphBs have an overall low-to-high distribution 
along the dorso-ventral retinal axis. Although in vivo loss- and gain-of-function studies 
clearly support the notion that EphB/Ephrin-B signaling is important for dorso-ven-
tral/lateral-medial mapping [123, 124], neither EphBs nor Ephrin-Bs are expressed as 
a discernible dorso-ventral/lateral-medial gradient in the tectum/superior colliculus, 
impairing definite conclusions about their mode of action [119, 120]. Nonetheless, as 
with the nasotemporal representation, other molecules have been shown to participate 
in dorso-ventral/lateral-medial topographic decisions, including Wnts, which have a 
graded expression pattern in the chick optic tectum and mouse superior colliculus [119, 
a Note that Eph/Ephrin dyads are bidirectional cell surface signaling molecules and, by their very nature, 
do not function as long-range diffusible guidance molecules, but as contact-dependent signals.
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120]. Therefore, like elsewhere in the nervous system, multiple cues acting in concert 
are necessary to establish a truly accurate neuroanatomical representation of the visual 
world.
A.6 Mitochondria, Axon Maintenance and Survival
Since, as a general rule, neuronal cells cannot be replaced throughout the individual’s 
lifetime [125], the upkeep of functional neural circuits must necessarily rely on effec-
tive axonal protective mechanisms. Classical conjectures supported the view that the 
process of axonal degeneration ensued from deficient sustenance from the cell body 
(e.g. as a result of cell body death) [126]. However, it is now well established that the 
axonal degenerative cascade can be actively promoted by in situ death pathways, and, 
similarly, is counteracted by locally acting and, to some extent, axon-specific pro-sur-
vival mechanisms [126]. Moreover, adequate metabolic provision – and hence mito-
chondria, where much of the interplay between pro-degenerative and protective factors 
occurs [126, 127] – is pivotal to axon integrity and function, as the demand for energy, 
metabolites and calcium buffering is particularly elevated at axons terminals (e.g. to 
support synaptic transmission) [128]. Indeed, many mitochondrial dysfunctions trigger 
neurodegenerative disorders with prominent axonal phenotypesa[129-131], suggest-
ing that axons are particularly vulnerable to mitochondrial compromise. A growing 
axon is all the more dependent on adequate mitochondrial operation, as it requires the 
continuous provision of energy for its expansion in the developing brain. It follows 
that neurons, with their elongated and complex morphologies, must tightly operate, as 
well as preserve, a damage-prone mitochondrial network to maintain functionality and 
integrity.           
 During the development of the nervous system, the refinement of neural cir-
cuits results from the selective preservation and elimination of axons: target areas are 
initially innervated by an exuberant number of processes, which is followed by the 
pruning of inapt connections and maintenance of the valid ones [126]. The original 
postulate of the “neurotrophic hypothesis” explained this phenomenon on the basis of 
target field-derived signals and their limited availability [132]. It is now known that, 
in addition to neurotrophic growth factors, neuronal activity also potentiates the main-
tenance of functional connections partly through its promotion of mitochondria-acting 
a The integral role of mitochondria in axonal physiology is truly appreciated when one considers the 
substantial list of neurodegenerative diseases associated with mitochondrial defects including Alzhei-
mer’s, Parkinson’s and Huntington’s disease, but also retinal ganglion cell-specific pathologies, such as 
dominant optic atrophy and Leber’s hereditary optic neuropathy.
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axon survival pathways [126]. Of particular note, the axon survival-promoting effects 
triggered by neurotrophin stimulation is abolished when axonal protein synthesis is 
inhibited, suggesting that, at least to some extent, this neuroprotective signaling mode 
relies on locally synthesized factors to bring about its neuroprotective effects [133]. Id 
est, the preservation of neural circuits depends on a finely tuned network of axon-local-
ized protective factors [11, 126, 133].
18
19
B – Axonal mRNA Localization and 
Local Protein Synthesis
The synapse underlies one the neuron’s most striking features: the axon-dendrite duali-
ty, with the inherent cellular and molecular polarization of the nerve cell it encompasses 
[134]. Necessarily asymmetric in function, these two compartments receive an inde-
pendent assortment of organelles, membrane components and molecules from the cell 
body [135]. Subcellular RNA localization has emerged as a particularly prevalent and 
cost-efficient mechanism of outsourcing genomic information in these highly polarized 
cells, where the site of transcription can be far removed from the final destination of the 
protein [2, 136]. Specific transcripts can be precisely localized to subcellular compart-
ments using the ‘address’ information harboured in their untranslated regions (UTRs), 
which function as cis-acting platforms for regulatory RNA-binding proteins (RBPs) 
and small non-coding RNAs [136, 137]. Subsequently, local, ‘on-site’ synthesis confers 
both spatial and temporal precision, as the new protein is present only where and when 
a biological demand for it exists [138]. It is this mRNA-based mechanism that, for ex-
ample, allows the growth cone to enjoy a certain degree of functional autonomy in its 
guidance process [2]. Still, it was not until the recent appreciation of the complexity of 
the axonal transcriptome – several independent genome-wide screens have identified 
thousands of mRNAs localizing in the axonal compartment of embryonic and adult 
neuronal cells [11-15] – that the functional significance of this cellular mechanism was 
really fully grasped. It is thus not surprising that deregulated RNA localization and 
translation are at the core of many neurodevelopment and neurodegenerative diseases 
[139-142].
B.1 Regulation of Axonal mRNA Translation
Protein synthesis inhibition in severed axons can hinder the ability of the growth cone 
to respond in vitro to a plethora of extrinsic – attractive or repulsive – guidance factors 
[2]. These guidance signals promote rapid alterations of the local proteome by modulat-
ing the activation of the mechanistic target of rapamycin (mTOR) pathway, which, as a 
master regulator of mRNA translation, acts as a global rheostat to the process of protein 
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synthesis [2], a[143], b[144, 145]. 
However, whereas attractive cues like Netrin-1 or brain-derived neurotrophic 
factor (Bdnf) induce β-actin synthesis to build up the growth cone cytoskeleton [4, 5], 
repellent factors such as Slit 2b and Semaphorin 3A elicit de novo synthesis of proteins 
that promote cytoskeletal disassembly (e.g. RhoA and Cofilin) [6, 115], implying that 
different protein synthesis-inducing signals regulate the translation of distinct groups 
of transcripts. But since the mTOR pathway controls the translational output at a global 
level, how does one account for such fine regulation of the growth cone proteome?
The main strategy utilized to achieve translational specificity is centred on 
trans-acting factors – such as RNA-binding proteins and microRNAs (miRNAs) – 
which associate with specific mRNAs to regulate their axonal transport, stability and 
translation [137]. For example, the zipcode-binding protein 1 (Zbp1), a well-charac-
terized RNA-binding protein, has affinity for a conserved 54-nucleotide long motif 
– termed the zipcode – located in the 3’UTR of the actb (β-actin) mRNA; on encoun-
tering Bdnf, a signaling cascade is triggered within the growth cone compartment re-
sulting in Src-dependent phosphorylation of Zbp and translational derepression of actb 
mRNA [146, 147]. Drawing on these and other reports [2], current models speculate 
that different trans-acting factors, each associating with a unique cohort of mRNAs, are 
independently regulated by distinct guidance cues, thus allowing for the translation of 
specific sets of transcripts [148] (Figure 1.7).
B.2 Scope of the Axonal Transcriptome
The prevailing view at the turn of the century was that axons did not synthesize proteins 
[2, 149]. This notion has since been overwhelmingly dismissed, as evidence linking local 
mRNA translation to many aspects of axonal biology accumulated. It is now known that 
axonal mRNA translation regulates not only growth cone guidance decisions [5-7, 22, 
144], where its involvement was originally studied, but also axon elongation [150, 151], 
a mTORC1 exerts its actions through the phosphorylation of ribosomal protein S6 kinase 1 (p70S6K1/2) 
and eukaryotic translation initiation factor 4E binding protein 1 (eIF4E-BP1), which associate with mR-
NAs and control translation initiation and the overall progression of the translation mechanism.
b The ubiquitin proteasome system (UPS) also plays a central role in regulating the axonal proteome in 
response to some guidance signals. For example, the chemotropic response elicited by Netrin-1 results 
from the coordinate regulation of the local proteome by protein synthesis and degradation mechanisms.
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Figure 1.7 – Axonal mRNA localization and local protein synthesis: an overview. (A) Subcel-
lular targeting of specific mRNAs depends on the recognition of ‘localization-coding’ cis-acting 
elements by nuclear and cytoplasmic trans-acting factors (TAFs), which collectively associate as 
part of higher-order messenger ribonucleoprotein (mRNP) complexes [130]. Most of the cis-acting 
axon-targeting elements that have been identified are situated in the 3’UTR of the mRNA, and are 
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synapse formation [2], axon maintenance [9, 11, 152], and nerve injury and axon regen-
eration responses [153-156], among other processes [2].
Significantly, the diversity of neurobiological functions associated with local 
protein synthesis underlines another crucial aspect of axonal RNA localization: the dy-
namic nature of the local transcriptome. Indeed, even within the same population, com-
parative profiling of two different developmental stages has revealed that axons contain 
‘age’-specific mRNA pools. For example, mRNAs encoding for branching-promoting 
cytoskeletal proteins and synaptic vesicle proteins, which intuition suggests to be ir-
relevant during the pathfinding stages, are only found enriched in the transcriptome of 
target-arrived axons [2, 12]. 
Nevertheless, it is noteworthy that all the axonal populations analysed to date 
appear to have a common core of transcripts, such as those encoding for mitochondrial 
proteins, ribosomal proteins and other factors involved in the protein synthesis process, 
components of the cytoskeleton, as well as proteins related to signal transduction [2], 
suggesting their encoded proteins are implicated in the maintenance of constitutive ax-
onal functions. Moreover, several of these independent genome-wide screens have also 
found cancer-linked transcripts to be well represented in axonal mRNA populations 
[11-13], denoting potential shared mechanisms in developmental processes and cancer 
pathogenesis. Accordingly, the tpt1a transcript, which encodes for translationally con-
trolled tumor protein (Tctp), is ranked among the most enriched in the axonal compart-
ment across diverse embryonic and adult neuronal populationsb[11, 13, 14], including 
a Gene name: tumor protein, translationally-controlled 1.
b In the study performed by Gumy et al., which used rat embryonic sensory neurons, tpt1 mRNA ranks 
as the 31th most enriched in the axonal compartment [13]; in Taylor et al. analysis, using rat naïve cortical 
axons aged to maturity in culture, tpt1 mRNA appears in the 11th position [14]; in the sequential analysis 
of gene expression (SAGE) screen conducted by Antonella Riccio’s group in rat perinatal sympathetic 
neurons, the tpt1 transcript placed as the 5th most abundant message [11].
‘decoded’ by various TAFs operating synchronously [129, 130]. Commonly, distally targeted messages 
have longer 3’UTRs than their soma-localizing counterparts, and unique ‘address’ information is pres-
ent in these additional segments [11]. 3’UTR diversity mainly arises from differential 3’-end process-
ing mechanisms such as alternative polyadenylation [262]. Some mRNAs are known to share similar 
cis-acting motifs and to be regulated by a common set of TAFs, a property that allows functionally 
related cohorts of transcripts to be conjointly translated with temporal and spatial precision [2, 130]. (B) 
Upon recruiting additional adapter proteins (not depicted), mRNPs are ‘shipped’ along cytoskeletal tracts 
by motor-based active transport mechanisms towards their subcellular destination in the axonal com-
partment. Notably, mRNAs are maintained in a translationally dormant state during the assembly and 
transport phases [2, 130]. (C and D) By modulating the activation of mTOR signaling and, in parallel, 
eliciting changes in the binding affinity of specific TAFs, various local stimuli, including guidance cues, 
can bring about concerted alterations in gene expression programs [2, 130]. Panel ‘D’ taken from Jung, 
Yoon, and Holt (2012) [2].
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Xenopus laevis retinal ganglion cells [12], raising the possibility of an important, and 
still entirely unexplored, subcellular function.
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C – The Translationally Controlled Tumor Protein
Tctp is a small, multifunctional, evolutionarily conserved protein implicated in cell 
growth [18, 19] and tumorigenesis [23-25, 157]. Initially discovered in 1982 as an 
abundant mRNA in untranslated, partially suppressed messenger ribonucleoprotein 
(mRNP) complexes in mouse sarcoma ascites cells [158], it was further characterized 
as a protein whose rate of synthesis is greatly enhanced in growing versus non-growing 
Ehrlich ascites tumour cells [159, 160]. Tctp has been identified in a multitude of tissues 
[24, 161] and is involved in cellular functions as diverse as DNA damage and allergy 
responses (incidentally, it is also known as Histamine-releasing factora) [162, 163]. As 
its high degree of sequence conservation suggests, Tctp plays an essential, but still not 
fully realized, role in development, as loss of tpt1 expression in mice results in embry-
onic lethality [17, 164].
C.1 Gene and mRNA Structure
The human tpt1 gene is arranged in six exons intercalated by five introns, in addition 
to a relatively well-characterized upstream promoter region. Exon 1 spans the entire 
5’UTR and the first 9 codons of the coding sequence, and exon 6 encompasses in its 
entirety the 3’UTR of the mRNAs. To the best of my knowledge, an identical exon/
intron organization is present in higher vertebrates and mammals. Likewise, in Xenopus 
laevis, the tpt1 gene structure follows the same arrangement [165]. 
The human tpt1 promoter contains two highly conserved cAMP response ele-
ment (CRE) sites, suggesting that tpt1 is under transcriptional control by cAMP signal-
ing [166]. Moreover, Amson et al. and Chen et al. have both identified a P53-responsive 
element in the promoter region of tpt1, albeit with ambiguous downstream outcomes. 
Indeed, Amson et al. reported that P53 represses tpt1 expression [24], whereas Chen et 
al. described it as an inducer of tpt1 transcription [167]. Significantly, mammalian ge-
nomes retain a large number (up to 15 in humans) of processed tpt1 pseudogenes [161, 
168]. I stress these findings because of emerging evidence implicating pseudogenes and 
other non-coding RNAs as competing endogenous RNAs (ceRNAs) during develop-
a Other aliases include ‘Fortilin’, ‘P23’ in Homo sapiens and ‘P21’ in Mus musculus.
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ment and disease [169]. In this regard, transcribed tpt1 pseudogenes could potentially 
modulate the availability of miRNAs that regulate tpt1 mRNA translation and thus 
greatly shape its biological functions.
 In humans and rabbits, the tpt1 gene is transcribed into two virtually identi-
cal mRNAs, except for the length of their 3’UTRs. In Homo sapiens, the tpt1 mRNA 
isoforms are 843 and 1163 nucleotide long, and arise from the differential usage of 
two alternative polyadenylation signals [168]. In the same study, Thiele et al. went on 
to characterize qualitatively and quantitatively the distribution of both transcripts in a 
number of human tissues, including various regions of the brain. Although ubiquitously 
distributed, it was found that the expression of tpt1 mRNA variants differs considerably 
in quantity and proportion between tissues (and also in the different brain regions ana-
lysed), leading the authors to conclude that the tpt1 gene is under extensive transcrip-
tional regulation [168]. However, the biological significance behind the existence of the 
two tpt1 mRNA isoforms has remained unaddressed. 
Of particular note, the 5’UTR of tpt1 transcripts starts with a canonical 5’-ter-
minal oligopyrimidine (TOP) motif, a typical feature of transcripts selectively regulated 
at the translational level by mTORC1 [161, 170], a[171, 172]. Lastly, due to its complex 
secondary structure, the translation of tpt1 mRNA is suggested to be negatively regu-
lated by the double-stranded RNA-dependent (dsRNA) protein kinase R (Pkr) under 
serum starvation conditions [173].
C.2 Protein Structure
Not only has Tctp remained highly conserved throughout evolutionary history, but its 
primary sequence also lacks significant homology with any other known protein [16]. 
Brioudes et al. provide possibly the best evidence in support of its conservation: Dro-
sophila melanogaster Tctp can fully rescue Arabidopsis thaliana Tctp knockouts, and 
vice versa [174]. It is a relatively small, hydrophilic protein, composed of 172 amino 
acid residuesb and with a predicted molecular weight of approximately 19.5 kDa. Fur-
a This cis-regulatory motif is found in a subset of mRNAs regulated by mTORC1 that shifts to the trans-
lationally active polysome fraction when resting cells are induced to grow or proliferate. Invariably, it 
consists of a cytosine residue at the cap site, followed by an uninterrupted run of 4-15 pyrimidines. Ex-
cept for the initial cytosine, the sequence of the TOP motif varies significantly between different mRNAs 
of this class, even within the same species. The TOP motif has been traditionally described in mRNAs 
encoding for ribosomal proteins and other proteins associated with the translational apparatus.
b Tctp is a 172-amino acid protein in Homo sapiens, Pan troglodytes, Rattus norvegicus, Mus mus-
culus, Oryctolagus cuniculus (rabbit), Gallus gallus, Drosophila melanogaster, and Xenopus laevis; 
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thermore, no known organelle localization signal exists in its sequence a[175].
Tctp tertiary structure comprises three α-helices (H1, H2 and H3; the two long 
α-helices, H2 and H3, form a α-helical hairpin) and nine β-strands organized in two 
distorted β-sheets. The packing of structural elements gives rise to two hydrophobic 
cores within Tctp. Also of note, the portion of the protein encompassing residues 39-66 
is presumed disordered b[16, 17] (Figure 1.8). 
Initial structural analysis revealed similarities between the core Tctp fold and 
the mammalian suppressor of yeast Sec4 (Mss4) [16], which is suggested to function 
as a chaperone [176, 177], and methionine sulfoxide reductase gene B (MsrB) [178], 
a repair enzyme for proteins inactivated by methionine residue oxidation [179]. How-
ever, the biological significance of these findings is still elusive. More recently, the 
α--helical hairpin formed by helices H2 and H3 of human Tctp as been noted to share 
structural resemblances with the H5-H6 helices of Bax, a pro-apoptotic member of the 
Bcl-2 family of proteins (Figure 1.8). As detailed in a subsequent section, this study 
in Danio rerio, 171 amino acids; in Arabidopsis thaliana and Schizosaccharomyces pombe, 168 amino 
acids.
a Curiously, although it also lacks any known secretion signal in its primary sequence, Tctp can be se-
creted by cells.
b The three-dimensional structure of Schizosaccharomyces pombe Tctp was solved first by heteronuclear 
NMR spectroscopy; later, the crystal structure of human Tctp was solved at 2.0 Å resolution. Attesting 
the conservation of this protein throughout phylogeny, both groups reported the same ‘signature’ motifs, 
which I briefly describe here.
Figure 1.8 – The three-dimensional structure of Tctp. The crystal structure of Homo sapiens Tctp, 
shown here in two different orientations, contains three α-helices (H1, H2 and H3; coloured in red) 
and two distorted β-sheets (green and yellow). The desorded portion of the protein (residues 39-66) is 
not shown because of it not being visible in the electron density map. Although no relevant amino acid 
homology exists, the α-helical hairpin formed by helices H2 and H3 (boxed structural unit) has been ob-
served to possess similitudes with the H5-H6 helices of Bax [17]. Adapted from Susini et al. (2008) [17].
Structurally similar to the conformation 
adopted by the pair of helices H5-H6 in Bax
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went on to demonstrate that Tctp antagonizes Bax pro-apoptotic function by inhibiting 
its dimerization in the mitochondrial outer membrane (MOM) [17].
C.3 Biological Functions
Despite enjoying increasing attention from many areas in the field of Biology, which 
has translated in its association with a variety of physiological and pathological pro-
cesses, a clear and unified understanding regarding Tctp is yet to emerge. Still, the 
near-ubiquitous expression profile of Tctp, in combination with the fact that this protein 
has remained highly conserved throughout phylogenetic evolution, suggests that Tctp 
holds an important cellular role. A comprehensive systematization attempt would per-
haps include Tctp in three main functional categories: cell growth, cell survival, and 
immunity.
C.3.1 Cell Growth
Tctp expression has been intimately linked to growth across phylogeny and in multiple 
contexts [18, 19, 174, 180, 181]. The first in vivo clue linking Tctp to growth came from 
a large-scale screen in Caenorhabditis elegans that used RNA interference to target ap-
proximately 86% of the worm’s predicted genes, establishing that Tctp depletion elicit-
ed a slow-growth phenotype [18]. Later, in Drosophila melanogaster, Tctp knockdowns 
were shown to have reduced cell size, cell number and organ size. The authors of this 
study went on to demonstrate that Tctp displays guanine nucleotide exchange activity 
towards the Ras homolog enriched in brain (Rheb) GTPase, thus identifying Tctp as a 
positive modulator of mTOR [19], a master kinase behind cell growth [143], a[182]. Sim-
ilarly, tpt1-/- mouse embryos – which die in utero between E6.5 and E9.5 – show overall 
growth defects and a reduction in the number of cells populating the epibast [17, 164]. 
Curiously, overexpression of Tctp also elicits a slow-growth phenotype in mammalian 
cells [183], indicating that a tight regulation of Tctp expression levels is necessary in or-
der for cells to maintain growth homeostasis. Unlike in animals, Tctp does not regulate 
postmitotic growth in Arabidopsis thaliana; rather, plant Tctp appears to exclusively 
govern mitotic growth by impacting on the duration of the cell cycle [174]. During 
mitosis, Tctp specifically localizes to the mitotic spindle [184], and is phosphorylat-
a A role for Tctp has a guanine nucleotide dissociation inhibitor (GDI) has also been proposed by Cans et 
al.; in their study, the authors reported that Tctp stabilizes eEF1A in its GDP-bound form by impairing the 
GDP exchange reaction triggered by eEF1Bβ. Thus, not only has Tctp been proposed to modulate global 
mTOR signaling, but also to regulate the elongation step of protein translation. 
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ed by Polo-like kinase 1 [185]a; in particular, overexpression of a phosphorylation-in-
competent form of Tctp increases the frequency of phenotypes associated with mitotic 
catastrophe (e.g. multinucleation) [185]. Additionally, the laboratory of John Gurdon, 
recipient of the Nobel Prize in Medicine or Physiology in 2012, has demonstrated that 
Tctp activates the transcription of oct4 and nanog, early pluripotency genes, during nu-
clear reprogramming [186], a finding that might help explaining the abnormal number 
of epiblastic cells observed in tpt1-/- mouse embryos. 
C.3.2 Cell Survival
Loss of tpt1 expression in mice results in increased apoptosis during embryogenesis 
and early lethality [17, 164], supporting the notion that Tctp is a guardian of the integri-
ty of the cell. Indeed, Tctp shows protective effects against apoptosis in serum-deprived 
cells [187], and enhances chemoresistance in etoposide-, taxol-, or 5-fluorouracil treat-
ed cells [188, 189]. Although it lacks the characteristic Bcl-2 homology domains shared 
by the members of the Bcl-2 familyb [126, 127], Tctp has been shown to interact with 
the anti-apoptotic proteins myeloid cell leukemia 1 (Mcl1), Bcl-2-like protein 1 (Bcl-
XL), and Bcl-2-related protein A1 (A1, as known as Bfl1 in humans) [189-191]. In 
particular, the N-terminal region of Tctp was shown to be required for its association 
with Bcl-XL, and was recognized as fundamental for its anti-apoptotic activity [189]. 
Moreover, the data collected by Liu et al. suggests that Tctp modulates Mcl1 biological 
activity by promoting its stabilityc [190]. While it does not interact directly with Bcl-2 
associated X protein (Bax), Susini et al. reported that Tctp inhibits Bax dimerization in 
the mitochondrial outer membrane (MOM) [17]. According to the model put forward 
by the authors, Tctp is able to inhibit Bax-induced mitochondrial outer membrane per-
meabilization by associating with Mcl1 and Bcl-XL, thereby antagonizing this key step 
a Polo-like kinases regulate various mitotic (M)-phase-specific events, including centrosome maturation 
and mitotic spindle formation.
b The Bcl-2 protein family – which includes Mcl1 and Bcl-XL, known Tctp interactors with anti-apop-
totic functions, but also executioner pro-apoptotic effectors (e.g. Bcl-2 associated X protein, Bax; Bcl-2 
homologous antagonist/killer, Bak) and BH3 (Bcl-2 homology 3)-only initiators (e.g. Bcl-2-associated 
death promoter, Bad; P53 upregulated modulator of apoptosis, Puma) – plays a key role mediating mi-
tochondrial integrity by regulating the permeabilization of the mitochondrial outer membrane (MOM). 
Mechanistically, the pro-survival members of the Bcl-2 family (e.g Mcl1 and Bcl-XL) operate by seques-
tering initiator and executioner pro-apoptotic proteins (e.g. Bax), thus preventing the release of Cyto-
chrome c from the mitochondrial intermembrane space and subsequent activation of caspases; as such, 
the interactions between the members of this family are dictated by local equilibria that are dependent on 
their relative protein concentrations and binding affinities.
c Mcl1 half-life ranges between 30 to 40 minutes.
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of the apoptotic cascade [17]. More recently, Tctp has also been shown to interact with 
apoptotic peptidase-activating factor 1 (Apaf1) [192], a key component of the apopto-
some [193].
On a different note, a proteomic screen aimed at detecting differently expressed 
proteins upon exposure to a low-dosage of gamma rays – ionizing radiation is com-
monly used in investigations on the mechanisms involved in DNA damage responses 
– identified Tctp, among a plethora of other regulated proteins, as the most sensitive to 
this treatment, suggesting a potential relevant role for Tctp in DNA damage sensing and 
repair [163]. Notably, increased Tctp levels were detected in human cells as early as 30 
minutes after irradiation. Moreover, the authors of this study went on to demonstrate 
that Tctp upregulation upon exposure to ionizing radiation – which was particularly 
prominent in the nuclei of irradiated cells – was dependent on ataxia-telangiectasia 
mutated (Atm) kinase, and elicited protective effects against radiation-induced DNA 
damage, altogether suggesting that Tctp may promote genomic integrity in cells sub-
jected to DNA-damaging agents [163]. More recently Hong et al. demonstrated that, in 
Drosophila melanogaster, Tctp mutants display increased radiation sensitivity during 
development, as well as marked deficiencies in terms of chromosome stability [194].
C.3.3 Allergic Response of the Host
In addition to its numerous roles within the cell, extracellular Tctp displays histamine-re-
leasing activity and other cytokine-like functions [175]. Historically, the presence of 
histamine-releasing activity in the supernatants of cultured peripheral blood mononu-
clear cells prompted research efforts in the pursuit of the factors behind this activity, 
which culminated in 1995 with the identification of Tctp [162]. In particular, Tctp – or, 
as termed then by MacDonald et al., Histamine-releasing factor (Hrf) – was demon-
strated to enhance or prime the release of histamine from human basophils in an Immu-
noglobulin E (IgE)-dependent mechanism [162]. Apart from promoting the release of 
histamine, Tctp has later been associated with other cytokine-like actions, including the 
induction of Th2-type cytokines and chemoattractants [175], and the stimulation of B 
cell activation and function [180]. In addition, since the original report by MacDonald 
et al. [162], many studies have supported the notion that secreted Tctp/Hrf only devel-
ops cytokine-like functions following some kind of structural rearrangement triggered 
by the inflammatory extracellular environment that arises during an allergic response 
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[175]. It is now known that Tctp/Hrf is secreted as a monomer but is required to di-
merize via an intermolecular disulphide bond to gain its cytokine-like activity [195].
C.4 Signals Regulating Tctp Expression Levels
Several lines of study have established that Tctp cellular levels are regulated in response 
to extra- and intracellular signals, including growth signals and certain cytokines [159, 
163, 196, 197]. In fact, the naming of Tctp as a ‘translationally controlled’ protein re-
flects the original observations regarding the regulation of Tctp expression [198]: while 
the rate of Tctp protein synthesis was greatly enhanced in growing versus non-growing 
Ehrlich ascites tumour cells, such upregulation was neither associated with a concomi-
tant increase in tpt1 mRNA levels nor was it blocked by transcription inhibitors [159]a. 
In 1994, Bommer et al. demonstrated that Tctp protein synthesis is well correlated with 
the phosphorylation and consequent activation of the eukaryotic translation initiation 
factor 4E (eIF4E) under mitogenic stimulation [199], a result that found support in re-
cent genome-wide studies profiling mTOR-regulated mRNAs [171, 200]. 
In spite of these findings, it was later recognized that Tctp is also regulated at the 
transcriptional level [201-203]. Indeed, the expression of tpt1 gene is now known to be 
governed by a number of conditions and stresses, including during a vitamin D-induced 
cell death program in glioma cells [203], macrophage activation [204], in earthworms 
exposed to heavy metals in their habitat [202], ammonium starvation in yeast [205], 
or in response to increased intracellular calcium concentrations [206]. More recently, 
the tpt1 gene has been shown to be upregulated by androgens in the context of prostate 
cancer [25].
C.5 Tctp Expression in the Nervous System
Although the expression of tpt1 mRNA in many areas of the adult human brainb was 
reported in a study published in 2000 [168], little is known about its functions in neu-
ronal biology. The early notion that Tctp is mainly expressed in mitotically active tis-
sues, associated with its relative low expression level in the brain [161, 168], has per-
haps potentiated this almost complete disregard for the study of Tctp in the context of 
neurodevelopment and neurophysiology. However, recent evidence has challenged this 
a Its classification as a ‘tumour protein’ denotes the origin of the material from which the cDNA of the 
human tpt1 homolog was obtained: a mammary tumour.
b Including the amygdala, caudate nucleus, cerebellum, cerebral cortex, frontal lobe, occipital lobe, tem-
poral lobe, hippocampus, medulla oblongata, thalamus, and spinal cord.
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view, for many independent genome-wide profiling studies have identified tpt1 mRNA 
among the most enriched in the axonal compartment across diverse embryonic and 
adult neuronal populations, including embryonic retinal ganglion cells [12], neonatal 
sympathetic neurons [11], embryonic and adult sensory neurons [13], and cortical and 
hippocampal neurons derived from embryonic E18 rats and matured in culture [14], de-
noting of an important role in axons. Of note, Tctp protein levels were found downregu-
lated in the temporal cortex of Alzheimer’s disease patients, and in the temporal cortex, 
caudate nucleus and thalamus of individuals with Down syndrome [207]. Collectively, 
these reports suggest that Tctp expression in the nervous system remains important after 
development and that it may contribute to cellular homeostasis.
C.6 Tctp in Malignancy 
The association between Tctp and tumorigenesis dates back to its discovery in the early 
1980s [158, 208]. Tctp has since been found overexpressed in a multitude of cancer 
cell lines [20, 209, 210], though true recognition as a fundamental player in cancer 
pathogenesis came much later [23]. Pioneering investigations by Telerman and col-
leagues on the mechanisms behind tumour reversion identified tpt1 as the most differ-
ently expressed transcript between the malignant and reverted states, showing a steep 
down-regulation in reverted cells (248 reads in tumour cells versus 2 in revertants) 
[23], a[211]. Of note, in the same study, knockdown experiments targeting tpt1 mRNA 
increased by approximately 30% the reversion of malignant phenotypes [23]. More 
recently, the same group reported that Tctp represses P53 expression, a key regulator 
of apoptosis and tumour suppression, by promoting its degradation [24]. In this latter 
study, Tctp was found to exert its modulation on P53 by preventing the auto-ubiquitina-
tion of Mdm2b. In parallel, P53 was shown to directly repress tpt1 transcription, leading 
the authors to conclude that a reciprocal negative feedback loop exists between Tctp 
and P53 [24], c[167]. Moreover, in a cohort of 508 breast cancer patients, a high-Tctp 
a Although extremely rare, tumour reversion is the process by which some malignant cells overcome 
their cancerous programs and return to their initial ‘normal’ state.  
b The data reported by the authors suggest that Tctp competes with Numb, an inhibitor of P53 ubiq-
uitination, for binding to Mdm2-P53 complexes. Mdm2 is an E3 ubiquitin protein ligase and a major 
antagonist of P53, as it mediates the ubiquitination and proteosomal degradation of this protein. Thus, by 
preventing Mdm2 self-ubiquitination, Tctp effectively promotes its biological activity.
c As I have alluded to in a previous section, this finding has been questioned recently. Indeed, Chen et 
al. later reported that P53 upregulates Tctp transcription and identified a P53-responsive element in the 
promoter region of the Mus musculus tpt1 gene [167].
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expression profile, which was observed in a fraction of these cancers, correlated with 
indicative markers of aggressive disease (e.g. poor differentiation). The same study has 
also recognized Tctp expression as an independent prognostic factor in breast cancer 
patients [24]. In line with these findings, Tctp expression levels in glioma tumours were 
later found significantly elevated when compared to normal brain tissues [157]. In ad-
dition, a high-Tctp expression status was shown to correlate with clinicopathological 
markers of advanced disease, and Tctp expression established as an independent prog-
nosis factor in patients with these tumours. Overall, individuals with glioma and higher 
Tctp expression profiles were noted to have shorter survival times [157].
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D – Environmental Regulation of Cancer Cell Invasion
Motility and invasiveness are traits central to malignancy and growth cone migration 
alike. Indeed, for carcinoma cells to break away from the primary tumour, increased 
actin polymerization at the leading edge must necessarily accompany the acquisition of 
a neoplastic phenotype; and just like a navigating growth cone, cancer metastasization 
is highly modulated by the tumour environment. Notably, the four families traditionally 
described for their role as environmental guidance cues in axon pathfinding (ephrins, 
semaphorins, netrins and slits, and respective receptors) have emerged as important 
regulators of cancer progression, in particular during the phases of primary tumour 
growth and dissemination [43, 48, 51, 212], suggesting that similar signaling may op-
erate in both contexts. Hence, it is perhaps not surprising that frequent mutations were 
discovered in canonical axon guidance genes in tumours derived from pancreatic ductal 
adenocarcinoma patients [213], or that several independent genome-wide screens have 
found cancer-linked transcripts to be well-represented in axonal mRNA populations 
[11-13]. In effect, the merits of solidifying these links are fully embodied by recent, 
on-going and soon to start cancer clinical trials targeting ‘axon guidance’ molecules, 
including Semaphorin 4D [244], Neuropilin-1 [245], EphA2 [246], and EphB4 [247-
249].
 In this section, I consider the acquisition of an invasive phenotype in the frame-
work of cancer dissemination and attempt to find common ground between this process 
and the mechanisms of neural circuitry formation.
D.1 Epithelial-to-Mesenchymal Transition in Metastatic Invasion and Neuronal 
Development
During metastatic dissemination, individual or small groups of cells escape from the 
primary tumour, locally invading the surrounding extracellular matrix and stromal cell 
layers. The subsequent cell-biological events – intravasation into the microvasculature 
of the blood systems, extravasation from the bloodstream at distant sites, adaptation 
to a new microenvironment and, finally, launch of proliferative programs anew – al-
though also heavily dependent on microenvironmental cues, bear smaller mechanistic 
resemblance to growth cone migration and, thus, are conceptually less important for the 
present discussion.
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The discovery within tumours of cancer stem cells (CSTs)a with significantly 
enhanced tumour-initiating potential demonstrated that cancers are formed by a hetero-
geneous population of hierarchically organized cells [214]. This is a relevant idea to 
bring forth because many of the biological phenotypes associated with tumour malig-
nancy – motility, invasiveness, self-renewal and a heightened resistance to cell death – 
are now known to be derived from this subpopulation of cells. In fact, it is hypothesized 
that cancer stem cells are the driving force behind tumour dissemination. However, an 
important distinction – that between intrinsic and induced cancer stem cells – is deemed 
necessary for the purpose of this discussion: intrinsic cancer stem cells are assumed to 
be a constitutive part of primary tumours since the earliest stages of tumour develop-
ment; differently, the tumour microenvironment may induce non-cancer stem cells into 
a cancer stem cell-like state through an epithelial-to-mesenchymal transition program 
[215], which encompasses changes in adhesion, an overall loss of apico-basolateral 
polarity, as well as the acquisition of migratory and invasive attributes [216, 217]. 
Throughout organogenesis, a reciprocal and dynamic relationship develops 
between cells and their surroundings, which is necessary for the association of cells 
into functional multicellular tissues. Particularly, the extracellular matrix, in addition to 
working as a physical support frame of tissue architecture, also provides cells with di-
rect survival and differentiation factors. Hence, it is reasonable to expect that deregulat-
ed signals from the microenvironment to have the potential to destabilize tissue homeo-
stasis and induce derivative phenotypes, even in the absence of a genetic susceptible 
background [218]. This notion is actually overtly accepted in the field of oncology: it is 
well established, for example, that higher stromal densities potentiate the likelihood of 
developing breast cancer [219, 220]. Indeed, accumulating evidence shows that, during 
the early phases of tumour progression, the initially homeostasis-protecting stromal 
confines of the tumour may be converted to growth and metastasis-promoting as a 
consequence of the mobilization of a variety of bone marrow-derived cells, including 
fibroblasts, myofibroblasts, macrophages, neutrophils, mesenchymal stem cells, and 
lymphocytes [215, 221]. The recruitment of these cells, and the ensuing release of sig-
naling factors by them (e.g. Wnt, transforming growth factor-β and fibroblast growth 
factor), forms a reactive microenvironment that can trigger tumour cells to undergo an 
epithelial-to-mesenchymal transition (EMT) program and acquire a motile and invasive 
phenotype [215]. 
a Otherwise known as tumour-initiating cells or cancer-initiating cells.
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A comparable process has been shown to occur during the development of the 
neocortex. Here, once neural precursor cells become committed to a neuronal fate, 
they delaminate from the pseudostratified epithelium in the ventricular zone where they 
originate and migrate in the direction of the pia. Recently, an epithelial-to-mesenchy-
mal transition-related mechanism has been proposed to bring about the transforma-
tion of these neural precursor cells into migrating neurons [222]. In specific, Scratch 1 
and Scratch 2, important transcription factors of the Snail superfamily that govern the 
program of the epithelial-to-mesenchymal transition, were shown to be up-regulated 
downstream of proneural transcription factors (namely Neurogenin 1, Neurogenin 2, 
or Ascl1) and to effectively promote the departure of committed cells from the ventric-
ular zone [222]. Thus, the aforementioned study provides a relevant link between the 
earliest steps of neuronal migration and the acquisition of invasive properties by cancer 
cells. First, the epithelial sheet from where carcinoma cellsa evade can be equated to the 
neuroepithelium where neural progenitor cells originate in the ventricular zone (e.g. the 
two share cell-cell junctions and the same apicobasal polarity). Second, in both cases 
a mesenchymal phenotype is acquired, enabling the subsequent migratory phase. And 
third, because the Wnt pathway, mentioned above for its implications in the acquisition 
of cancer stem cell-like traits, is reported to induce the expression of Neurogenin 1 in 
neural precursor cells [223], one of the upstream proneural transcription factors known 
to regulate EMT-promoting Scratch proteins (Figure 1.9) [222].
Moreover, although not studied directly in the context of axon-dendrite polar-
ization, the signaling mechanisms behind the program of epithelial-to-mesenchymal 
transition have, likewise, been suggested to orchestrate the process of axon specifica-
tion [224]. In particular, this work provides in vivo evidence for a role in axon specifica-
tion of the signaling cascade triggered by transforming growth factor-β, one of the most 
potent known inducers of epithelial-to-mesenchymal transition [217].
In conclusion, while more studies are required, the events in early neuronal 
morphogenesis, like those shaping an induced cancer stem cell-like phenotype during 
tumorigenesis, may indeed share significant mechanistic similarities. Namely, in both 
contexts cells lose epithelial traits, including cell-cell junctions and overall polarity, 
and develop a motile and invasive phenotype. Also, Wnt and transforming growth fac-
tor-β-mediated signaling function upstream of all of these processesb[225], further sug-
a Tumours with an epithelial origin, denominated carcinomas, constitute approximately 80% of 
life-threating cancers.
b Wnt signaling is also a well-established driver of neuronal polarization.
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gesting that an co-opted program may exist.
D.2 Axon Guidance Molecules in Cancer Progression
A short incursion into the history of the ‘canonical’ axon guidance molecules reveals 
that their association to cancer dates back to their initial discovery. The epha1 gene, for 
example, was cloned from a carcinoma cell line in 1987 in a screen for novel tyrosine 
kinase receptors with oncogenic potential, and the first Ephrin ligand was as well de-
scribed by a group working in the context of cancer [51]. Likewise, the gene encoding 
for the prototypical Netrin-1 receptor Dcc was originally identified as a tumour sup-
pressor in advanced stages of colorectal carcinoma progression (hence its designation 
deleted in colorectal cancer) [48]. Only in the mid-1990s did their association to axon 
pathfinding begin to emerge [43, 101].
D.2.1 Netrin Signaling in Cancer
Key properties of tumour dissemination include not only the acquisition of a migratory 
phenotype, but also a heightened propensity to survive [215]. In this Netrin-1 signals 
play an instrumental role, because the Dcc/Unc5 family functions as ‘dependence re-
ceptors’, a specific class of receptors that may mediate cell-death programs depending 
on the absence of ligands [226]. Indeed, when netrins are present, Dcc/Unc5 receptors 
form dimeric or multimeric complexes and induce mitogen-activated protein kinase 
(Mapk)-, focal adhesion kinase (Fak)- and Akt (also known as protein kinase b)-depen-
dent signals; however, if disengaged, an apoptotic signal is triggered instead. 
Figure 1.9 – Hypothetical regulation of epithelial-to-mesenchymal transition-like programs at the 
onset of neuronal migration. The Wnt pathway is known to support the acquisition of a neuronal fate 
by neural precursor cells in part by promoting the expression of Neurogenin 1, a proneural transcription 
factor [223]. In turn, Neurogenin 1-regulated Scratch 1 and Scratch 2 have been show to regulate neuro-
nal migration mechanisms via an EMT-like program [222].
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The presence of Netrin-1 in the surrounding tissue can thus act as a regulatory 
death signal to tumour cells expressing these receptors, particularly when the number of 
cancer cells outweighs the availability of the ligand, or when metastatic cells dissemi-
nate into tissues where Netrin-1 expression is absent or only weakly present. 
It follows from the existence of dependence receptors that cancer cells must 
somehow override the ‘safeguard’ inhibitory influence on growth such constraints im-
pose [48]. To this end, three main strategies have been documented in human tumours: 
1) receptor downregulation or loss-of-function, as originally shown in colorectal can-
cers [227]; 2) upregulation of Netrin-1 expression, which has been found in a large 
number of breast cancers that develop secondary tumours [228]; 3) downregulation or 
loss of pro-apoptotic partners that participate in the dependence receptor-evoked death 
pathway [229].
 Analogously, in addition to being necessary for commissural axon attraction 
towards the ventral midline [101], Netrin-1 has been shown to inhibit the pro-apoptotic 
activity mediated by Dcc in developing axons, where it also functions as a dependence 
receptor [230].
D.2.2 Semaphorin Signaling in Cancer
Semaphorin research in the context of tumorigenesis has focused primarily on eluci-
dating the contribution of this family to the formation of tumour vasculature, where its 
various members can elicit anti- or pro-angiogenic effects. Given that the proliferation 
of cancer cells depend on adequate supplies of oxygen and nutrients [231], it comes as 
no surprise that the expression of semaphorins or their receptors has frequently been 
encountered deregulated in tumours. As a general rule, the levels of pro-angiogenic 
semaphorins are upregulated in tumour cells, whereas semaphorins that convey inhib-
itory signals to the vasculature are downregulated [212]. This notable versatility in 
semaphorin-mediated effects is partly due to the diversity of signaling receptors – in-
cluding the receptor tyrosine kinases vascular endothelial growth factor receptor type 2 
(Vegfr2), erythroblastic leukemia viral oncogene homologue 2 (Erbb2), and hepatocyte 
growth factor receptor (Hgfr) – that can associate with plexins and neuropilins upon 
semaphorin binding [212]. That is, semaphorin signaling in many instances is cell con-
text-dependent.
In turn, these considerations very much echo semaphorin-mediated mechanisms 
during brain development. For example, Semaphorin 3E/Plexin D1-mediated attractive 
or repulsive chemotropic responses are known to be dependent on the expression pro-
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file of Neuropilin-1 [232]. Even more remarkable is the finding linking the association 
of Vegfr2 with PlexinD1/Neuropilin-1 receptor complexes to the axon growth promot-
ing effects elicited by Semaphorin 3E in subicular neurons [233]. 
D.2.3 Eph/Ephrin Bidirectional Signaling in Cancer
The transmembrane Eph-Ephrin cell communication system relays two-way – bidi-
rectional – signals: upon ligand binding, the ‘forward’ signaling arm impinges in the 
Eph-expressing cell and is mainly mediated by the receptor’s kinase domain, whereas 
the ‘reverse’ arm acts on the Ephrin-expressing counterpart through associated Src fam-
ily kinases [51]. As the history of their discovery suggests, Eph receptors and ephrins 
are abundantly expressed in cancer cells as well as in the tumour microenvironment, 
and, in many cellular contexts, including cancer, Eph-Ephrin signals promote morpho-
logical and behavioural changes reminiscent of an epithelial phenotype by effectively 
enhancing cell-cell contacts and suppressing cell invasiveness [51, 234]. It stands to 
reason, then, why perturbations to this signaling system are prone to initiate malignant 
phenotypes.
Indeed, during cancer pathogenesis, Eph-Ephrin signaling has been implicated 
in many steps of the tumorigenic cascade, including tumour proliferation, angiogene-
sis and dissemination, and their expression, particularly that of Eph receptors, is often 
found deregulated at advanced cancer stages and is well correlated with tumour pro-
gression and patient survival. However, their actions are complex, even paradoxical 
at times, rendering attempts to provide generalizations of their effects rather inconse-
quent. That being said, it is often the case that the expression levels of Eph receptors and 
Ephrin ligands are regulated discordantly in the context of cancer and, in consequence, 
oncogenic cell-cell crosstalk develops between cancer cells and their environment [51]. 
Hence, as highlighted by their roles in neural circuit formation, a finely tuned regulation 
of the Eph system is crucial for the maintenance of tissue homeostasis.
D.2.4 Slit Signaling in Cancer
The strongest evidence implicating Slit-Robo signaling in cancer progression comes 
from comparative genomic studies using clinically homogenous tumour samples [213, 
235]. In both instances, in addition to modifications in well-established cancer-related 
genes, prevalent mutations and copy-number variations (CNVs) were reported for Slit 
and Robo genes in tumours derived from patients diagnosed with liver fluke-associat-
ed cholangiocarcinoma [235] and pancreatic ductal adenocarcinoma [213]. Particular-
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ly, low Robo2 and high Robo3 mRNA expression were independently correlated with 
poor patient prognosis in the latter study [213]a,b. These data, together with previous 
evidence from invasive cancers of the lung, breast, kidney and cervix, strongly suggest 
that deregulated Slit-Robo signaling may be a common tumorigenic feature of many 
human cancers [48, 236].
Slit2, a particularly well-studied ligand, has been shown to inhibit tumour cell 
migration in medulloblastoma and glioma models in vitro and in vivo [237, 238]. Al-
though the exact intricacies of its mode of action are yet to be fully elucidated, Slit-Ro-
bo signaling in physiological contexts is known to sustain the activation of glycogen 
synthase kinase 3β (Gsk3β) by inhibiting Akt; in turn, Gsk3β in its active form phos-
phorylates β-catenin, which results in its export from the nucleus and a consequent loss 
of its transcriptional activity. Concurrently, Gsk3β also promotes the degradation of 
Snail1 through the ubiquitin-proteasome pathwayc. These events have a double effect 
on E-cadherin, a key molecule involved in stabilizing cell-cell junctions: first, there is 
an accumulation of β-catenin at the plasma membrane, where it interacts and stabilizes 
E-cadherin; second, because Snail1 is a strong transcriptional repressor of E-cadher-
in expression, its degradation effectively augments E-cadherin cellular levels (Figure 
1.10). Hence, normal Slit-Robo signaling can prevent cell migration in part by potentiat-
ing cell-cell adhesive contactsd. By contrast, attenuated Slit-Robo signaling leads to the 
inactivation Gsk3β, which relieves the modulation it previously exerted on the nuclear 
pool of β-catenin. This impacts on the expression of E-cadherin and, simultaneously, 
limits the association between β-catenin and E-cadherin at the membrane, thus weak-
ening adhesive contacts between cells. In addition, the nuclear localization of β-catenin 
also promotes the canonical Wnt signaling arm, which, as discussed above, is a strong 
inducer of the epithelial-to-mesenchymal transition program [48, 213, 236, 239-241]. 
a Robo3 has been shown to negatively regulate Robo2 signaling in commissural axons; the upregulation 
of its transcripts in pancreatic cancers suggests that a similar mechanism may operate in this context, as 
hypothesized by the authors of the study.
b Incidentally, some genes encoding for semaphorins ligands and receptors were also found to harbor 
alterations in these tumours.
c The Snail transcription factors, as discussed above, are important regulators of the epithelial-to-mes-
enchymal transition program.
d Other significant mechanisms, such as the inhibition of the key actin cytoskeleton regulator Cdc42 
by Slit-Robo-specific GTPase-activating protein (srGAP), additionally contribute to the global effects 
observed downstream of homeostatic Slit-Robo signals, in this case by hindering cell motility.
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D.3 The ‘Seed and Soil’ Affinity Hypothesis
Finally, it seems fruitful to mention the seminal work of Stephen Paget, an English sur-
geon who published in 1889 what has come to be known as the ‘seed and soil’ hypothe-
sis, for it embodies an idea quite akin to that implied in Sperry’s chemoaffinity postulate. 
Paget noted, in the process of analysis of more than 900 autopsy records, that tumour 
metastasis contains an organ-specific, non-random character: “The evidence seems to 
me irresistible that in cancer of the breast the bones suffer in a special way (…) Some 
bones suffer more than others; the disease has its seats of election” [242]. From these 
observations, he equated that metastases depend on certain cancer cells – the ‘seeds’ – 
having a specific affinity for the environment of certain organs – the ‘soil’ – correctly 
concluding, with sound resemblance to modern day theories of neural circuit formation, 
that only when both ‘seed’ and ‘soil’ were compatible would metastasis form [216, 243]. 
Figure 1.10 – Modes of Slit/Robo signaling with impact on cell adhesion. P- phosphorylation event; 
Ub- denotes a UPS-mediated mechanism. See text for details.
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E – Focus of this Thesis
From the influence of the environment, to the modulation of cellular adhesive contacts, 
or the build up of protrusive actin dynamics necessary for motility, the initial challenges 
experienced by a metastatic cancer cell resemble in many ways the obstacles contin-
uously overcome by a navigating growth cone as it progresses through the complex 
embryonic environment. Moreover, the significant subcellular prevalence of transcripts 
encoding for cancer-associated proteins in diverse axonal populations, together with 
accumulating evidence implicating the deregulated expression of axon guidance mole-
cules in tumour pathogenesis, underline the striking cellular and molecular commonali-
ties that exist between both processes. Thus, it is reasonable to assume that by learning 
more about the properties of growth and migration during development, a better un-
derstanding of disease-associated cell invasion strategies can be attained; vice versa, 
it is likely that the knowledge gathered in the context of tumorigenesis can be partly 
transduced to the field of axon guidance.
Herein, motivated by the parallels between growth cone and metastatic migra-
tion, I studied a tumorigenic protein during the early development of neuronal circuitry. 
Using the Xenopus laevis retinotectal projection as an in vivo model system, and from 
a RNA-centric perspective, I examined the involvement of Tctp in axon pathfinding 
and dissected the cellular and molecular consequences of its deficiency in neurodevel-
opment. Given that the identification of tpt1 as a potential candidate of study stemmed 
from genome-wide profiling screens [11-14], I initially sought to confirm the presence 
of this mRNA species in the axonal compartment of retinal ganglion cells. The exper-
imental validation of this premise permitted me to form the basis for the objectives of 
my research: the characterization of how the expression of axonal Tctp is locally regu-
lated and, in parallel, the evaluation of its potential involvement in the process of axon 
guidance. The range of phenotypes detected in embryos depleted of Tctp eventually led 
me to pursue a third research aim, which focused on understanding the contribution of 
Tctp to axonal biology. In particular, I studied how mitochondrial function is affected 
in Tctp-depleted axons, and linked Tctp, through its interplay with the Bcl-2 protein 
family, to the survival machinery of the axon.
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Xenopus laevis Embryos
Xenopus laevis embryos were obtained by in vitro fertilization, raised in 0.1X Modified 
Barth’s Saline (0.88 mM NaCl, 0.01 mM KCl, 0.024 mM NaHCO3, 0.1 mM HEPES, 
8.2 μM MgSO4, 3.3 μM Ca(NO3)2, 4.1 μM CaCl2) at 14-22 ºC and staged according to 
Nieuwkoop and Faber [250]. All animal experiments were approved by the University 
of Cambridge Ethical Review Committee.
Retinal Cultures 
Unless otherwise noted, eye primordia were dissected from anesthetized stage 32 em-
bryos, rinsed and then plated on culture dishes pre-coated with poly-L-lysine (10 μg/
mL, Sigma) and laminin (10 μg/mL, Sigma). Cultures were incubated at 20 ºC in 60% 
L15 minimal medium (Life Technologies) for 24 hours before experimentation and/or 
fixation.
In Situ Hybridization (ISH) and Fluorescent In Situ Hybridization (FISH)
ISH on transverse cryosections of fixed embryos was performed as described previous-
ly [251]. Digoxigenin-labelled RNA probes were generated from linearized IMAGE 
clones (tpt1 IMAGE ID: 5542512); sequence-specific probes were derived from PCR 
amplicons with primers containing SP6 or T7 promoter sequences at 5’ end. Photomi-
crographs were taken with a Zeiss microscope equipped with a Micropublisher 5.0 RTV 
2. Experimental Procedures
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camera (Qimaging). For whole-mount ISH, stage 40 Xenopus laevis embryos were pro-
cessed as described elsewhere [252, 253] using the same probes as described above for 
the ISH on transverse cryosections methodology; processed embryos were imaged on 
an agarose bed using a Leica MZ FLIII inverted microscope equipped with a Micropub-
lisher 5.0 RTV camera. FISH probe design followed documented guidelines [254] and 
probes were 3’-labeled with DIG oligonucleotide tailing kit (Roche); FISH procedure 
on retinal growth cones was then carried out as described with minor variations [12].
Immunostaining of Retinal Sections
Anesthetized embryos were fixed in 4% paraformaldehyde (vol/vol) in phosphate buff-
ered saline (PBS) overnight at 4ºC, washed and incubated in 30% sucrose (wt/vol) in 
PBS for 2 hours at 4ºC before sectioning. Transverse 12 μm cryosections were processed 
using standard immunohistochemistry protocols (blocking solution: 10% heat-inacti-
vated goat serum, 1% bovine serum albumin, 0.5% Triton X-100 in 1X PBS). Anti-
bodies: rabbit anti-Tctp (1:500, kind gift from J. Kubiak); mouse anti-Calbindin D-28k 
(1:1000, Swant); rabbit anti-Calretinin (1:1000, Millipore); rabbit anti-GAD65/67 
(1:200, Abcam) mouse anti-Rhodopsin (1:200, Novus Biologicals), mouse anti-Opsin 
(1:1000, Sigma). Alexa Fluor 488 phalloidin (Life Technologies) was used at 1:40. Nu-
clei were labelled with 0.1 μg/mL DAPI (Life Technologies) at the last wash step before 
mounting. Alexa Fluor secondary antibodies (Life Technologies) were used throughout 
at 1:1000. Antigen retrieval with steaming 0.01 M sodium citrate (0.05% Tween 20, pH 
6.0) was carried out prior to staining for Tctp. Processed sections were visualized with 
a Nikon Eclipse 80i and photographed with a Hamamatsu ORCA-ER camera.
Laser-capture Microdissection and RNA Extraction
Per experiment, ~140 stage 33/34 eye explants were plated on PET (polyethylene tere-
phthalate) membrane slides (Leica Microsystems), pre-coated with poly-L-lysine (10 
μg/mL; Sigma) and laminin (10 μg/mL, Sigma), and cultured for 32-36 hours. As de-
scribed previously [12], retinal cultures were fixed (4% paraformaldehyde, 4% sucrose 
FISH antisense probe sequence in 5’-3’ orientation
TAGATATCCGAGAACATTTCGTCTTCAGTGATGCAGTCCTTGTAGATGA
ATCATCAATTGCACCTTCTTCTCTTTGGATTACCTTGCCTTCAACTTC
CCTTGATGTAATTCTTGTAAGAGTCCTTGGTGAAGCCTGTTTCCTGAA
GGGGTTCATTCTTTCTCCGGTGTAAAACTGATAGTTTTTGAAATTTCGAAG
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in 1X PBS) for 10 minutes, subsequently dehydrated through an ethanol series and 
air-dried before capture. To aid visualization, the membrane stain FM 1-43FX (Life 
Technologies) was added 20 minutes before fixation. Samples were processed using the 
Leica LMD6000 system. RNA was extracted immediately after with RNAqueous-Mi-
cro kit (Life Technologies) according to manufacturer’s instructions. Unlike Zivraj et 
al. [12], a linear amplification was not used prior to RACE, RT-PCR or RT-qPCR pro-
cedures. Control RT-PCR reactions were performed using OneStep RT-PCR kit (QIA-
GEN); the presence of microtubule-associated protein-2 (map2), histoneH4 (hist1h4a), 
and β-actin (actb) transcripts was evaluated before running the each RACE PCR or 
RT-qPCR experiment
5’ and 3’ Rapid Amplification of cDNA Ends (RACE PCR)
Eye and pure axonal extracts were processed with SMARTer RACE cDNA Ampli-
fication Kit (Clontech) according to manufacturer’s instructions. RACE PCR was 
performed using Advantage HF 2 PCR kit (Clontech). Following gel extraction, PCR 
products were TA-cloned and sequenced in both orientations.
Quantification of tpt1 mRNA Isoforms by RT-qPCR
Eye and axonal RNA extracts were prepared as detailed above. QIAGEN QuantiTect 
SYBR Green RT-PCR kit was used in combination with Roche LightCycler 480 Re-
al-Time PCR system. Manufacturer’s guidelines were followed thoroughly except for 
primer concentration – 0.4 µM instead of 0.5 µM was found optimal. Primer design 
intently kept amplicon size below 150 base pairs to ensure optimal amplification effi-
ciency. Due to the inexistence of introns in the 3’UTR of the tpt1 gene, it is impossible 
to design primers specific to the unique region of tpt1-L and spanning an exon-intron 
boundary, as an optimal primer set for RT-PCR would. Hence, when designing primers 
specific to the coding region of tpt1, exon-intron boundaries were, as well, intently 
avoided. To overcome potential pipetting errors during the initial reaction assembly, 
each reaction was run in quadruplicate. Reaction volume was 10 µL per well. Follow-
ing reaction assembly, plates were centrifuged at 1,500 x g for 2 minutes at 4ºC.  Stan-
dard curves for the calculation of amplification efficiency were run independently from 
the actual experiments [255]. Relative quantification data was obtained following the 
∆∆Ct method using Roche’s LightCycler 480 data analysis module. actb (beta-actin) 
mRNA was used as reference for data normalization. As an additional quality control 
for the axonal RNA preparations, and similarly to the controls performed in the axo-
nal RACE PCR experiments, the presence of microtubule-associated protein-2 (map2) 
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and histone H4 (hist1h4a) transcripts was evaluated by RT-PCR before running each 
RT-qPCR experiment (data not shown).
The real-time cycling reaction conditions, as per manufacturer’s guidelines, 
were as follows:
Reverse transcription   30 minutes, 50ºC
PCR Initial Activation Step  15 minutes, 95ºC
Polymerase Chain Reaction (45 cycles)
 Denaturation   15 seconds, 94ºC
 Annealing   30 seconds, 57ºC
 Extension   30 seconds, 72ºC
 Data acquisition  15 seconds, 72ºC
Melting Curve
 1 minute at 95ºC
 1 minute at 40ºC
 0.11ºC/second increments from 40ºC to 95ºC and continuous  
  fluorescence readings
MS2 In Vivo Biotin Tagged RNA Affinity Purification (MS2-BioTRAP): Cell Cul-
ture and Metabolic Stable Isotope Labelling for SILACa Mass Spectrometry 
Human Embryonic Kidney (HEK) two hundred and ninety-three stable cell lines ex-
pressing MS2-HB (293MS2-HB) were a gift from Marian Waterman (University of Cali-
fornia, Irvine) [256]. The methodology followed here and in subsequent steps drew pro-
fusely on the procedure described in Tsai et al. original technical report [256]. Briefly, 
to ensure complete isotope incorporation in the proteome, 293MS2-HB cells were grown 
for seven doublings in SILAC DMEM Media containing unlabelled arginine (12C and 
14N) and lysine (12C and 14N) amino acids (Dundee Cell Products) or in SILAC DMEM 
Media containing 13C and 15N labelled arginine and 13C and 15N labelled lysine (Dundee 
Cell Products) supplemented with 10 % (vol/vol) dialyzed foetal bovine serum (FBS, 
Pierce Biotechnology), 50 units/mL of penicillin + 50 µg/mL of streptomycin (Pen 
Strep, Life Technologies), and 3 µg/mL of puromycin (for cell selection, Life Technolo-
a SILAC: Stable Isotope Labeling by Amino Acids in Cell Culture.
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gies). For the purpose of assessing isotope incorporation, a one-dimension SDS-PAGE 
gel was run, Coomassie stained (Colloidal Blue Staining Kit, Life Technologies), and 
analysed at the Cambridge Centre for Proteomics (data not included).
MS2-BioTRAP: Cloning of pRL-Rluc-MS2-tpt1-3’UTR
Due to the necessary inclusion of non-related sequence elements in the final DNA prod-
uct if traditional cloning methods were to be applied (e.g. restriction sites), the syn-
thesis of the MS2 stem loop repeats upstream of the Homo sapiens tpt1 3’UTR was 
commissioned to a manufacturer of custom DNA products (GENEWIZ). 
 Ordered sequence:
 This custom-made MS2-tpt1-3’UTR insert (shipped ligated to a pUC57 plas-
mid) and the pRL-SV40 Renilla luciferase reporter plasmid (Promega) were digested 
with XbaI and NotI for 3 hours. Afterwards, New England Biolabs’ Antarctic Phos-
phatase catalysis of 5’ phosphate groups was used to prevent vector self-ligation. The 
digested vector was then run on an agarose gel and the band corresponding to the insert 
extracted with PureLink Quick Gel Extraction Kit (Life Technologies). Insert and vec-
tor were ligated overnight at 16ºC at a 6:1 ratio before transformation, and successful 
insertions were confirmed by DNA sequencing. The pRL-Rluc-MS2-Control construct 
was generated in a similar fashion; namely, the custom-made MS2-tpt1-3’UTR insert 
was used as the starting DNA material for a PCR reaction with the following primer 
pair: 5’-GCTAACTCTAGACATCGAAACATGAGGATCACCC-ATA-3’ and 5’-AT-
TCTAGCGGCCGCCTACAGTAATGCCGAGTACGGG-3’. Primer design included 
unique restriction sites (XbaI and NotI recognition sites in the forward and reserve 
primers, respectively) and six extra nucleotides upstream of the restriction site. Subse-
quent steps were executed in parallel to the pRL-Rluc-MS2-tpt1-3’UTR cloning proce-
dure.
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MS2-BioTRAP: Renilla Luciferase/Firefly Luciferase RT-qPCR and Dual Lucif-
erase Reporter Assay
On the day before transfection, 293MS2-HB cells [256] were trypsinized and plated in 
a 24-well plate.  Volumes were adjusted so that cells were ~80-90% confluent on the 
day of transfection.  For normalization proposes, cells were co-transfected with pRL-
Rluc-MS2-tpt1-3’UTR or pRL-Rluc-MS2-Control (experimental vectors) and Prome-
ga’s pGL3-Control Vector (which expresses Firefly luciferase) using Lipofectamine 
2000 (Life Technologies). Since both pRL and pGL3 plasmids contain the SV40 early 
enhancer/promoter, and to minimize possible trans effects between promoters on the 
co-transfected plasmids which could potentially affect reporter gene expression, a ratio 
of 10:1 between experimental and control plasmids, respectively, was used (1 µg:100 
ng).
Twenty-four hours post-transfection, RNA extracts were prepared using RNeasy 
Micro Kit (QIAGEN) following the instructions provided by the manufacturer. Of par-
ticular note, the cell lysate was passed five times through a blunt 20-gauge needle fitted 
to a syringe to ensure homogeneity before transferring the lysate to the spin column. 
Moreover, 2-mercaptoethanol at 1% (vol/vol) was added to Buffer RLT, and an on-col-
umn DNase digestion step was included in the protocol). For robustness, four biolog-
ical replicates per transfection condition were prepared. QIAGEN QuantiTect SYBR 
Green RT-PCR kit was used in combination with a Roche LightCycler 480 Real-Time 
PCR system. Manufacturer’s guidelines were followed thoroughly.
Alternatively, twenty-four hours post-transfection, the activities of both firefly 
and Renilla luciferases were measured sequentially using the Dual-Luciferase Reporter 
Assay (Promega) system according to manufacturer’s instructions on a TD-20/20 sin-
gle-tube luminometer (Turner Biosystems).
MS2-BioTRAP: Cell Transfection, Affinity Purification and Sample Preparation 
for Mass Spectrometry
Briefly, ‘light’ and ‘heavy’ 293MS2-HB cells cultured in five 150-mm plates to approxi-
mately 80-90% confluence were transfected with pRL-Rluc-MS2-tpt1-3’UTR or pRL-
Rluc-MS2-Control using Lipofectamine 2000 (Life Technologies). Forty-eight hours 
post-transfection, and before harvesting by scrapping, cells were washed with ice-cold 
PBSa and RNA-protein complexes cross-linked by ultra-violet illumination (energy 
a All steps, except otherwise expressly mentioned, were performed on ice or with ice-cold reagents.
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delivered: 400 mJ/cm2) on an ice tray using a Stratalinker 1800 (Stratagene). ‘Light’ 
and ‘heavy’ cell pellets were lysed using a denaturing lysis buffer (8M Urea, 300 mM 
NaCl, 50 mM NaH2PO4, 0.5% (vol/vol) Nonidet P-40, 1 mM phenylmethylsulfonyl 
fluoride (PMSF)a, and a protease inhibitor cocktail (Halt Protease Inhibitor Cocktail 
from Pierce Biotechnology, used at 1:100), sonicated at medium intensity settings three 
times for 15-second intervals, centrifuged at 14,000 x g for 15 minutes at 4ºC, and clari-
fied through 1.6 um GD/X Glass Microfiber filters (Whatman). Equal amounts of ‘light’ 
and ‘heavy’ lysates, determined by protein concentration, were then mixed, which was 
followed by the addition of previously-washed Dynal streptavidin M-280 magnetic 
beads (Life Technologies; approximately 1 µL of bead slurry per 20 µg of protein).
 After completing the affinity purification procedure, beads were equilibrated in 
ice-cold 25 mM NH4HCO3 aqueous solution (approximately thirty bed volume), resus-
pended in 250 µL of a trypsin solution (Promega’s Tryping Gold, Mass Spectrometry 
Grade; 10 ng/µL of acetic acid-reconstituted trypsin in 25 mM NH4HCO3 aqueous solu-
tion), and digested overnight at 37ºC with gentle agitation. Digested samples were taken 
on the following morning to the Cambridge Proteomics Centre for spectrometric analy-
sis. Differently from Tsai et al. methodology [256], the liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) run was prolonged for three hours instead of perform-
ing a strong-cation fractionation (SCX) step. In total, three independent mixed samples 
and submissions were completed. 
 Finally, the enrichment of RNA-binding proteins in the “tpt1 3’UTR” condition 
was judged based on SILAC ratios (the fraction of the heavy to light peptides); repro-
ducible identifications were then studied for correlation on the STRING (Search Tool 
for the Retrieval of Interacting Genes/Proteins) database. 
Translation-blocking Morpholino Antisense Oligonucleotides
Antisense tpt1-MO and control-MO were designed and supplied by GeneTools: 5’-AT-
CATGTTGGCGGCCTAAGTGTTGT-3’ and 5’-CCTCTTACCTCAGTTACAATTTATA-3’, re-
spectively. Fluorescein-tagged (3’end) morpholinos were used throughout, except 
when mitochondrion targeted GFP (mt-GFP) was to be subsequently electroporated.
Blastomere Microinjection
Embryos were injected as previously described [89]. Injections were preformed at the 
4-cell stage in one or both dorsal blastomeres as detailed in the main text. mRNA was 
a All reagents purchased from Sigma-Aldrich, unless otherwise stated.
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delivered at 90 pg/blastomere. tpt1-MO and control-MO were injected at 12 ng/blasto-
mere.
Retina-targeted Electroporation
Plasmid DNA electroporation was carried out on stage 28-30 embryos as described pre-
viously [90] using eight consecutive 18 V pulses of 50-millisecond duration, delivered 
at 1-second intervals. Membrane RFP (gap-RFP) and/or mitochondria targeted-GFP 
(mtGFP, gift from M. Coleman) were delivered at 1 mg/μL.
Netrin-1 Stimulation
After 24 hours incubation, explants were bathed in 600 ng/mL recombinant mouse Ne-
trin-1 (reconstituted in PBS containing 0.1% [wt/vol] bovine serum albumin) for 5 min-
utes and fixed in 2% (vol/vol) paraformaldehyde, 7.5% (wt/vol) sucrose; BSA (0.1%) 
was used as control. Cycloheximide (25 μM, Sigma) and rapamycin (10 nM, Sigma) 
were bath-applied to cultures 2 minutes prior to the addition of Netrin-1.
Ephrin-A1 Stimulation
As described elsewhere [257], to pre-aggregate proteins, recombinant mouse Ephrin-
A1-Fc (a recombinant chimera between mouse Ephrin-A1 and human IgG1 Fc region
a; 
R&D Systems) or human IgG1 Fc peptide (supplied by Jackson Immunoresearch Labs) 
was incubated with a goat antibody against the human Fc region (Jackson Immunore-
search Labs). Specifically, anti-human IgG, Fc fragment specific antibody (100 μL, 
diluted at 0.9 mg/mL) was incubated with Ephrin-A1-Fc (100 μL of 100 μg/mL stock) 
or 100 μL of IgG1 Fc peptide (100 μL, diluted at 100 μg/mL). After gentle agitation 
for 45 minutes at room temperature, protein aggregates were bath-applied to retinal 
cultures for 10 minutes (unless otherwise specified) at a 1:10 dilution (final concentra-
tion: 5 μg/mL) before fixation. Cultures were subsequently processed for quantitative 
immunofluorescence analysis.
Quantitative Immunofluorescence
Quantitative immunofluorescence was carried out largely as described [22]. Cells were 
fixed in 2% (vol/vol) paraformaldehyde, 7.5% (wt/vol) sucrose for 20 minutes, washed 
in PBS and permeabilized for 3 minutes with saponin (1 mg/mL in PBS). Standard 
immunocytochemistry protocols were followed henceforth (blocking solution: 5% 
a Fragment crystallizable (Fc) region.
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heat-inactivated goat serum in 1X PBS). Fluorescence intensity (mean pixel intensity 
per unit area) was measured in non-collapsed growth cones using Openlab or Volocity 
software (PerkinElmer). Measurements were taken using masks obtained by manually 
tracing growth cones in corresponding bright-field images. Background fluorescence 
was then subtracted from total growth cone fluorescence and data were normalized to 
the mean immunofluorescence intensity of the control group and expressed as percent-
age. A Nikon Eclipse TE2000-U inverted microscope was used for all image acquisi-
tions. Antibodies: rabbit anti-Tctp (1:500, gift from J. Kubiak); rabbit anti-pS235/236rpS6 
(1:500, Upstate); mouse anti-‘mono- and polyubiquitinylated conjugates’ (FK2 clone; 
1:500, Millipore); mouse anti-P53 (1:300, Abcam); rabbit anti-Active Caspase-3 (1:200, 
Abcam). Alexa Fluor secondary antibodies (Life Technologies) were used throughout 
at 1:1000.
Cloning and In Vitro Transcription of Kaede-S and Kaede-L
Generation of chimeric tpt1-Kaede constructs made use of TA-cloned RACE frag-
ments and an empty pKaede-S1 cloning vector (accession number: AB085641). 
The tpt1 5’UTR was amplified with the following primer pair: 5’-TCAGCAGAATTC-
CCTTTTCTCTCCCCACCCTCCG-3’ and 5’-TCGCGTGGATCCGTTGGCGGCCTAAGTGTTG-
TAATG-3’ (forward and reverse primer, respectively). Primer design included unique re-
striction sites in the 5’ end (EcoRI and BamHI sites in the forward and reserve primers, 
respectively). As the amplified fragment was shorter that 100bp, QIAGEN’s MinElute 
Reaction Cleanup Kit was used to purify the resulting DNA product. The pKaede-S1 
cloning vector and the tpt1 5’UTR insert were subsequently digested with EcoRI and 
BamHI for 3 hours. New England Biolabs’ Antarctic Phosphatase catalysis of 5’ phos-
phate groups was used to prevent vector self-ligation. The digested vector was then 
run on an agarose gel and gel extracted with PureLink Quick Gel Extraction Kit (Life 
Technologies). Insert and vector were ligated overnight at 16ºC at a 6:1 ratio before 
transformation. Successful cloning was confirmed by DNA sequencing.
The resulting tpt1 5’UTR–Kaede fusion construct was used in succeeding clon-
ing steps. Overall, the tpt1 3’UTRs cloning involved an equivalent strategy. The tpt1-S 
3’UTR was amplified with the following primer pair: 5’-CGCACTGCAGCATTCCGTTTG-
GTTCTTCCATCTT-3’ (forward primer) and 5’-GGGCCCATATGACAGTGGAGAATCATG-
GGCTTTAT-3’ (reverse primer). The tpt1-L 3’UTR was amplified with the following 
primer pair: 5’-CGCACTGCAGCATTCCGTTTGGTTCTTCCATCTT-3’ (forward primer) and 
5’-CGCGGCCATATGTTGTTTAATTCTGTCTTTATTCAGGATC-3’ (reverse primer). Here, the 
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forward primer design included a PstI restriction site (note that this primer was used in 
the amplification of both short and long 3’UTRs) and both reverse primers contained a 
NdeI site.
In the last step of the devised cloning strategy, a T3 phage polymerase promoter 
was added immediately upstream of the 5’UTR using the following primer combi-
nations: 5’-AATTAACCCTCACTAAAGGCCTTTTCTCTCCCCACCCTCCG-3’ and 5’-GGG-
CCCATATGACAGTGGAGAATCATGGGCTTTAT-3’ (forward and reverse primers, respec-
tively, for Kaede-S); 5’-AATTAACCCTCACTAAAGGCCTTTTCTCTCCCCACCCTCCG-3’ 
and 5’-CGCGGCCATATGTTGTTTAATTCTGTCTTTATTCAGGATC-3’ (forward and reverse 
primers, respectively, for the Kaede-L construct). Resulting products were run on an 
agarose gel and gel purified. Isolated products were then TA-cloned and positive inser-
tions identified by sequencing.
Capped Kaede mRNAs were synthesized from linearized plasmids using 
mMESSAGE mMACHINE T3 Transcription kit (Life Technologies); a poly(A) tail 
was subsequently added to DNase-treated reactions using Poly(A) Tailing Kit (Life 
Technologies). Before delivery, the resultant RNA was column-purified in accordance 
to manufacturer’s instructions (RNeasy Mini Kit, Qiagen).
Kaede Translation Reporters in Cultured Axons
Experiments with Kaede reporters were performed as described previously with 
minor alterations [5, 89]. Eye primordia were dissected from anesthetized stage 24 
Kaede-positive embryos and cultured for 14-18 hours before imaging. Culture dishes 
were pre-coated with poly-L-lysine (10 μg/mL, Sigma) and fibronectin (10 μg/mL, 
Sigma). RGC axons were manually severed from cell bodies using a mounted pin hold-
er. Before netrin-1 (600 ng/ml) or control stimulation (0.1% BSA), Kaede green was 
partially photoconverted with two 5-second pulse of 405-nm laser illumination. Images 
were acquired at 5-minute intervals using an UltraView VoX spinning disk confocal 
imaging system (PerkinElmer) on an Olympus IX81 microscope. For data analysis, 
growth cone outlines were traced in Volocity; fluorescence recovery was calculated 
from background-corrected intensity measurements by normalizing green fluorescence 
change (F – F0) as percentage change of fluorescence intensity (F – F0)/F0, where F0 is 
the fluorescence intensity at 0 minutes and F that of the subsequent time points.
DiI Labeling of Retinal Axons
As described [22], embryos were fixed overnight at 4 ºC in 4% paraformaldehyde in 
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PBS; after a quick wash in PBS, retinal ganglion cell axons were labelled by intraoc-
ular injection of the fluorescent carbocyanine DiI (DiIC18(3), Life Technologies). Dye 
crystals were dissolved in 100% ethanol at ~25 mg/μL and heated to 65 ºC for five 
minutes before use. Fourteen to twenty hours at 19-22 ºC were allowed for proper dif-
fusion before proceeding. Then, the contralateral (in respect to the dye-injected eye) 
brain hemisphere was dissected, mounted in 1X PBS and immediately visualized on 
a Nikon Eclipse TE2000-U inverted fluorescent microscope and photographed with a 
Hamamatsu ORCA-ER camera. Optic projection length was normalized to the distance 
between the optic chiasm and the posterior boundary of the tectum, two easily recog-
nizable morphological landmarks on bright-field/red-channel superimposed images; 
data were subsequently normalized to the mean projection length of the control group.
In Vivo Imaging of Axon Pathfinding
Live imaging of pathfinding retinal axons was performed as documented elsewhere 
[22]. tpt1-MO- or con-MO-injected embryos were electroporated with gap-RFP and/
or mt-GFP. Anesthetized embryos, selected on the basis of healthy appearance, were 
restrained before skin and dura were carefully removed above the contralateral optic 
tract. They were then transected below the heart and mounted in an imaging chamber 
consisting of two superimposed Gene Frame adhesive frames (Thermo) on oxygenat-
ed Permanox slides (Nunc). Images were acquired every 15 minutes for up to 2 hours 
using an UltraView VoX spinning disk confocal imaging system on an Olympus IX81 
microscope or, alternatively, a Nikon Eclipse 80i setup. Axon outgrowth was analysed 
with Volocity (PerkinElmer); axons were scored as ‘stalled’ if their outgrowth was ≤ 10 
μm over a 2-hour period.
In Vivo Imaging of Transected Axons
Gap-RFP was delivered by eye-targeted electroporation to wild-type stage 28 embryos, 
when the first retinal ganglion cell axons have just exited the eye, and axon extension 
kinetics were analysed 21-24 hours later (stage 37/38), when most axons are growing 
up the optic tract towards the optic tectum. Just before imaging, the optic nerve was 
manually transected, and con-MO or tpt1-MO was delivered subcellularly by targeted 
brain electroporation. Of note, transected retinal ganglion cell axons can continue to 
grow and navigate accurately in vivo for up to 3 hours, well within the 1-hour perior of 
this experiment. Differently from the protocol described above, images were acquired 
every 15 minutes for up to 1 hour using an a Nikon Eclipse 80i setup.
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Analysis of Photoreceptor Degeneration
Transverse retinal sections probed for opsin or rhodopsin and counterstained with DAPI 
were used, respectively, in cone and rod photoreceptor phenotypic analyses. Photore-
ceptor inner segment length was taken as the average of the distance between the DAPI 
signal in the outer nuclear layer (id est, photoreceptor cell bodies), and that of the 
outer segment markers, across a number of points (at least five) in the retinal hemi-cir-
cumference. Differently, the number of cells without an identifiable outer segment was 
normalized to the length of the outer nuclear layer to calculate the percentage of photo-
receptor neurons with degenerative phenotypes. Cone and rod analysis were conducted 
independently, and measurements were made using Volocity (PerkinElmer).
ATP Bioluminescence Assay
As documented [258], paired retinae from stage 37/38 embryos were dissected in 1x 
Modified Barth’s Saline with MS-222 (tricaine methanesulfonate, 0.04% wt/vol). ATP 
was measured with the ATP bioluminescence kit CLS II (Roche) according to manufac-
turer’s instructions on a Turner Designs luminometer, model TD-20/20. Single retinae 
were incubated in 50 μL of 1% HClO4 immediately after dissection for precisely 10 
minutes at room temperature before the reaction was stopped in 450 μL of boiling Tris 
buffer (100 mM Tris, 4 mM EDTA, pH 7.75), incubated for 2 minutes at 100ºC, and 
centrifuged at 1,000 x g for 1 minute. The supernant was then transferred to a fresh tube 
and kept on ice until bioluminescence measurement. In parallel, total protein quantifi-
cation was assayed on a Qubit 2.0 Fluorometer (Life Technologies) following manufac-
turer’s recommendations. Experimental ATP values were interpolated from a standard 
curve and normalized to total protein.
Mitochondrial Membrane Potential (ΔΨm) Measurement
Retinal cultures were incubated with 20 nM tetramethylrhodamine, methyl ester 
(TMRM) at 20ºC for 20 minutes and washed with culture medium before imaging on 
a Nikon Eclipse TE2000-U (to reduce phototoxicity, lamp fluorescence was limited to 
25% and a 0.9 neutral density filter was used). To account for the dependence of Fm on 
the plasma membrane potential (ΔΨp), ΔΨm was derived from the ratio of fluorescence 
intensity between mitochondria (Fm) and mitochondria-poor regions along the axon 
and in the growth cone (Fc) [259]. Fluorescence measurements were taken by manually 
tracing mitochondria using Volocity (PerkinElmer); the mitochondria-rich growth cone 
central domain was analysed as a single unit.
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Visualizing Mitochondrial Transport in Cultured Retinal Ganglion Cell Neurons
tpt1-MO- or con-MO-positive retinal explants were incubated with 25 nM MitoTracker 
Red, a mitochondrion-selective probe, at 20ºC for 20 minutes and, as above, washed 
with pre-warmed culture medium before imaging on a Nikon Eclipse TE2000-U (to 
reduce phototoxicity, lamp fluorescence was limited to 25% and a 0.9 neutral density 
filter was used). Time-lapse imaging was performed immediately after for 5 minutes 
applying a 5-second interval between each frame. During the analysis process, kymo-
graphs were derived for each time-lapse sequence using the KymographTracker module 
on the freely available Icy image analysis package (created by the Quantitative Image 
Analysis Unit at the Institute Pasteur). A mobile mitochondrion was only considered as 
such if its dislocation was ≥ 5 μm over the imaging period [260].
RT-qPCR of Nuclear-encoded Mitochondrial Genes and qPCR Analysis of Mito-
chondrial DNA Content
All real-time PCR runs were performed using a LightCycler 480 (software release 
1.5, Roche). Triplicate 10-μL reaction mixtures were prepared according to manu-
facturer’s instructions (QuantiTect SYBR Green RT-PCR or PCR kits, QIAGEN). 
RNA purification was performed using RNeasy Mini kit (QIAGEN) and included a 
DNase-treatment step; QIAamp DNA Micro kit (QIAGEN) was used for DNA puri-
fication. Per condition, 7-9 independent samples were collected on different days and 
each consisted of two retinae dissected from the same embryo (stage 37/38). RNA 
integrity was assessed on a 2100 Bioanalyzer (Agilent) using a Pico assay. For the 
quantification of nuclear-encoded mitochondrial genes, reference gene (ywhaz, rps13, 
hprt1 and tbp1)a normalization was performed using the geNorm module integrated in 
qbase+ (Biogazelle); the optimal normalization factor was calculated as the geomet-
ric mean of reference targets ywhaz and tbp1; all samples were measured in the same 
run for a given reference target and statistical analysis was carried out with qbase+. 
Real-time quantitative PCR mitochondrial DNA content quantification was accom-
plished with two different primer sets for genomic (glucagon and beta-2-microglob-
ulin) and mitochondrial (mitochondrially encoded tRNA-leucine and ATP synthase 6) 
loci; efficiency-corrected run analysis was performed within the LightCycler software. 
a Gene names: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (ywhaz), 
ribosomal protein S13 (rps13), hypoxanthine phosphoribosyltransferase 1 (hprt1), and TATA box bind-
ing protein (tbp1).
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The real-time cycling reaction conditions, as per manufacturer’s guidelines, 
were as follows:
Reverse transcriptiona  30 minutes, 50ºC
PCR Initial Activation Step  15 minutes, 95ºC
Polymerase Chain Reaction (45 cycles)
 Denaturation   15 seconds, 94ºC
 Annealing   30 seconds, 57ºC
 Extension   30 seconds, 72ºC
 Data acquisition  15 seconds, 72ºC
Melting Curve
 1 minutes at 95ºC
 1 minutes at 40ºC
 0.11ºC/second increments from 40ºC to 95ºC and continuous  
  fluorescence readings
Primary Rattus norvegicus Cortex Neuronal Culture and Immunocytochemistry 
Foetal neurons derived from cortices of F344 Rattus norvegicus E18.5 embryos were 
obtained commercially from Cyagen Biosciences (dispensed as cryopreserved primary 
cells), and plated on culture dishes pre-coated with poly-L-lysine (15 μg/mL, Sigma) 
and laminin (15 μg/mL, Sigma, incubated overnight at 4ºC). Neuronal cultures were 
grown at 37 ºC in a 5% CO2 humidified incubator in OriCell Neuron Growth Medium 
(Cyagen Biosciences) supplemented with L-alanyl-L-glutamine (Life Technologies) 
and B-27 (Life Technologies) for at least 72 hours before further manipulation. Growth 
medium was replaced every 36 hours. Immediately before fixation (pre-warmed 4% 
paraformaldehyde in 1X PBS), cells were washed twice in pre-warmed 1X PBS. Af-
ter washing the fixative with 1X PBS containing glycine at a 10 mM concentration, 
cells were permeabilized for 10 minutes with a 0.03% Triton X-100 solution (diluted 
in PBS). Standard immunocytochemistry protocols were followed henceforthb. Alexa 
a This step was omitted for qPCR runs.
b Blocking solution: 5% heat-inactivated goat serum in 1X PBS; primary antibodies: anti-Tctp (1:400, 
Santa Cruz Biotechnology), anti-Mcl1 (1:100, Santa Cruz Biotechnology), and anti-Bcl-XL (1:100, Santa 
Cruz Biotechnology), incubated overnight.
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Fluor secondary antibodies (Life Technologies) were used at 1:1000. Laser scanning 
confocal imaging was performed using an Olympus FV1000 microscope.
In situ Proximity Ligation Assay (PLA)
Duolink (Olink Biosciences, distributed by Sigma) in situ proximity ligation assays 
were performed on rat cortex neuronal cultures according to manufacturer’s recom-
mendations. Up until the primary antibodies incubation step, all manipulations were 
performed as detailed above for the immunocytochemistry procedure. The following 
primary antibody pairs were used: mouse anti-Tctp (1:400, Santa Cruz Biotechnolo-
gy) and rabbit anti-Mcl1 (1:100, Santa Cruz Biotechnology); mouse anti-Tctp (1:400, 
Santa Cruz Biotechnology) and rabbit anti-Bcl-XL (1:100, Santa Cruz Biotechnology). 
Additionally, a blocking/competition Tctp peptide (Santa Cruz Biotechnology), used 
at a five-fold excess relative to the anti-Tctp antibody, was included in preliminary 
experiments to evaluate the specificity of the technique. After overnight primary anti-
body incubation at 4ºC, all stages of the protocol – except for the washing steps – were 
performed at 37ºC in a humidity chamber using no more than 100 μL per culture dish. 
Of note, instead of the supplied probe diluent, mouse and rabbit PLA probes were dis-
pensed in blocking solution. All washes prior to the ligation step utilized PBS; the last 
wash steps initially included Texas Red-Phalloidin (Life Technologies, incubated for 15 
minutes at a 1:40 dilution). Cultures were mounted using a minimal volume of Duolink 
In Situ Mounting medium, which incorporates DAPI in its formulation, and imaged 
using an UltraView VoX spinning disk confocal imaging system on an Olympus IX81 
microscope.
Western Blot
Stage 35/36 eye and/or brain lysates were prepared in ice-cold RIPA buffer (150 mM 
NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) and 
resolved by SDS-PAGE. Both ‘semi-dry’ and ‘wet’ electroblotting methods were ap-
plied, depending on the size of the target to be analysed. Nitrocellulose membranes 
were blotted using the following primary antibodies: rabbit anti-Tctp (1:5000, gift from 
J. Kubiak); anti-4EBP1 and anti-pT37/464EBP1 (1:2000 and 1:1000, respectively, Cell 
Signaling); anti-rpS6 (1:500, Abcam) and anti-pS235/236S6 (1:4000, Upstate); anti-Akt 
(1:1000, Cell Signaling); anti-Pgc1α (1:500, Aviva Systems Biology). HRP-conju-
gated secondary antibodies (Abcam) were used in combination with a chemilumi-
nescence-based detection system (Amersham ECL, GE Healthcare). To evaluate the 
62
efficiency of tpt1 shRNA knockdown in HCT116 cell lines, a commercial anti-Tctp 
antibody from Santa Cruz Biotechnology was used (1:500).
 
Statistical Analysis
Each experiment was repeated at least three times, unless otherwise stated. Details 
of statistical analysis for each experiment are provided in figure legends. Data were 
analysed in Prism 5 (GraphPad), except Real-time PCR data. For all experiments, a 
statistical significance threshold of α = 0.05 was used.
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Table 1. List of PCR primer sequences
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A – Expression and Regulation of tpt1
A.1 tpt1 is an Abundant Axonal Transcript
I initially sought to validate that tpt1 transcripts localize to retinal axons and growth 
cones. In situ hybridization of retinal sections showed robust staining in the optic fiber 
layer (OFL) and in the optic nerve head (ONH), axon-only structures where retinal gan-
glion cell (RGC) axons collect to exit the eye, indicating that tpt1 mRNA is expressed 
in retinal axons in vivo (Figure 3.1A). Similarly, in cultured eye explants, I detected 
tpt1 mRNA signal in the growth cone of retinal ganglion cell axons (Figures 3.1D and 
3.1E). Next, I examined the expression of Tctp protein with a specific antibody against 
Xenopus laevis Tctp [261]; in concordance with tpt1 mRNA localization, Tctp protein 
was also detected in the OFL and ONH (Figure 3.2A). Immunostaining on cultured 
embryonic retinal ganglion cell axons and growth cones confirmed these observations 
(Figure 3.2B). Ample mRNA and protein signals were also found in the inner and 
outer plexiform layers (IPL and OPL, respectively), suggestive of localization in the 
dendrites of retinal ganglion cells and neurites of other retinal neurons (Figures 3.1A 
and 3.2A). Apart from the retinal neuropil, tpt1 expression was noticeable in the photo-
receptor layer, and in the ciliary marginal zone (CMZ), a well-characterized retinal neu-
rogenic niche (Figures 3.1A and 3.2A). Also of note, tpt1 mRNA signal was observed 
in the brain and, particularly, along the optic tract region, where retinal ganglion cell 
axons navigate en route to the optic tectum, their main synaptic target (Figure 3.1B). 
3. Results
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Figure 3.1 – tpt1 mRNA is expressed in retinal ganglion cell axons and growth cones. (A) In situ 
hybridization (ISH) detection of tpt1 mRNA on coronal sections of stage 43 retinas (GCL: ganglion cell 
layer; ONH: optic nerve head; IPL/OPL: inner/outer plexiform layer; arrowheads indicate the optic fiber 
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layer, OFL). (B and C) ISH detection of tpt1 and pax6 mRNAs on coronal sections of stage 43 embryos. 
The boxed areas, which focus on the lateral surface of the mesencephalon through where retinal axons 
pass en route to the optic tectum, are shown at a higher amplification in B’ and C’. Note the striking 
contrast between the distribution pattern of tpt1 and pax6 mRNAs, the latter encoding for a transcription 
factor abundantly expressed by retinal ganglion cells [9]. (D and E) ISH detection of tpt1 mRNA in ret-
inal ganglion cell axons of cultured eye explants (mean ± SEM; *** P < 0.0001, one-way ANOVA and 
Bonferroni). Scale bars: 50 μm in A, 25 μm in B and C, and 5 μm in D.
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Figure 3.2 – Tctp is expressed in retinal ganglion cell axons and growth cones. (A) Coronal section 
of stage 43 retina probed for Tctp (CMZ: ciliary marginal zone; PR: photoreceptor layer; arrowheads 
indicate the OFL). (E) Retinal ganglion cell growth cone stained for Tctp. Scale bars: 50 μm in A, and 5 
μm in B.
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The human tpt1 gene is transcribed into two distinct mRNA variants that differ 
only in the length of their 3’ untranslated regions (UTRs) [168]. Since most mRNA reg-
ulatory elements, including those that govern subcellular localization and translation, 
are situated within the untranslated regions [136], I next investigated whether tpt1 is 
regulated in an analogous manner in Xenopus laevis. Using rapid amplification of 5’ 
and 3’ cDNA ends (5’ and 3’ RACE), two 3’UTR variants of tpt1 were obtained from 
eye RNA extracts, comprising a short (tpt1-S, 210 bases) isoform and a longer (tpt1-L, 
607 bases) version, overlapping in its entirety the short form and possessing a unique 
segment at its 3’-end (Figure 3.3A). Similar to Homo sapiens, the exon encoding the 
3’UTR in Xenopus laevis contains two alternative polyadenylation signals, resulting 
in transcripts with 3’UTRs of different length but encoding for the same protein (Fig-
ure 3.3B). Concomitantly, a single 5’-end was identified, and, as described in Homo 
sapiens, its complete sequencing revealed the existence of a 5’-terminal oligopyrimi-
dine (TOP) motif previously not detected in Xenopus laevis (Figure 3.4). In addition, 
sequence alignment of representative vertebrate species uncovered a highly conserved 
motif (38 bases) within the 3’UTR of tpt1-S, with 79% absolute sequence conservation 
between Xenopus laevis and Homo sapiens, and up to 85% between Homo sapiens and 
Mus musculus (Figure 3.5). Collectively, these results show that Xenopus laevis tpt1, 
like its human counterpart [168], generates two different mRNA variants, and suggest 
that tpt1, in addition to encoding for a highly conserved protein [16], has remained ap-
preciably unchanged throughout vertebrate evolution. 
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Figure 3.3 – tpt1 gives rise to two different mRNA isoforms in Xenopus laevis. (A) 5’ (left) and 3’ 
(right) RACE amplifications of tpt1 mRNAs using retinal RNA extracts (FP, forward primer: RP; reverse 
primer; UP, universal primer; NUP, nested universal primer). (B) Organization of the tpt1 gene in Xeno-
pus laevis (cds, coding region; poly(A), polyadenylation).
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Figure 3.5 – Conserved sequence motif in tpt1 3’UTR. (A) tpt1 3’UTR multi-species sequence align-
ment using T-Coffee. Purple line demarks a particularly well-conserved segment within the 3’UTR of the 
six vertebrate species analysed. The boxed area denotes the location of the first polyadenylation signal 
(AATAAA).
CCTTTTCTCTCCCCACCCTCCGCCG
Canonical 5ʼ- TOP motif
Figure 3.4 – tpt1 is a 5’-TOP mRNA. First 25 nucleotides of the Xenopus laevis tpt1 5’UTR.
Differential processing at multiple polyadenylation sites is known to be physi-
ologically regulated in development or by pathological events such as cancer, and can 
affect the localization and translational properties of the mRNA [262]. For instance, 
the longer importinb1 transcript, equally arising from alternative polyadenylation, har-
bours a signal that enables axonal localization and is specifically required for efficient 
retrograde signaling in injured axons [153]. I thus explored whether a similar mecha-
nism governed tpt1 localization in retinal ganglion cell axons. To directly address this, 
I used laser-capture microdissection (LCM) to harvest axonal extracts [12], a procedure 
much simplified by retinal ganglion cells being the sole projecting neurons of the eye 
(Figure 3.6A). To determine whether this approach successfully collected a pure pool 
of axonal mRNAs, I tested for the presence of mRNAs encoding nuclear proteins, such 
as histone H4 (hist1h4a), and for transcripts described in dendrites but not in axons, 
such as microtubule-associated protein-2 (map2); vitally, no amplification products 
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were detected by RT-PCR (reverse transcription-PCR). By contrast, actb, which en-
codes for β-actin, a transcript previously identified in axons and growth cones [254], 
was readily amplified, confirming purity (Figure 3.6C). Notably, sequence reads from 
5’ and 3’ RACE reactions using retinal ganglion cell axonal extracts were identical to 
those obtained from whole eye preparations, implying that both isoforms localize in 
these axons (Figure 3.6B). 
Given the inherent qualitative outcome of RACE PCR, I next employed quan-
titative RT-PCR (RT-qPCR) to complement my analysis. Specifically, two sets of prim-
ers were designed: one directed to a segment of the tpt1 protein coding region, and 
a second pair targeting part of the unique region of tpt1-L, thus allowing for a direct 
quantification of this variant (Figure 3.7A). In whole eye extracts, an approximately 
constant 9:1 tpt1-S to tpt1-L ratio was obtained in all developmental stages examined. 
Differently, a striking ~16:1 tpt1-S to tpt1-L ratio was measured in axonal extracts, 
indicating that the tpt1-S variant is locally enriched in the axonal compartment (Figure 
3.7B). Moreover, a near 10-fold (ΔCqtpt1:actb = 3.1) enrichment over actb mRNA was 
detected in axons (Figure 3.7C), attesting tpt1 as a highly abundant transcript in axons. 
Therefore, unlike other instances where the longer mRNA variants are predominant in 
neuronal processes [11, 153, 263], these data suggest there is a significant prevalence 
of the shorter tpt1 transcript in the axonal compartment.
(bp)
1000
250
750
500
1500
2000
5ʼRACE
1000
750
500
1500
2000
3ʼRACEB
C
Axo
ns
Cell 
bodie
s
gDN
A
map2
Axo
ns
Cell 
bodie
s
gDN
A
Axo
ns 
-RT-RT
actb histoneH4
Cell
Bodi
es C
ell
Bodi
es 
Axo
ns 
Axo
ns
Cell 
bodie
s
gDN
A
1000
250
750
500
(bp)
A
Eye RGC Axons
Laser Capture
Collected
Material
UP +
tpt1 FP
UP +
tpt1 RP
Figure 3.6 – tpt1-S and tpt1-L localize in retinal ganglion cell axons. (A) Diagram of laser-capture 
microdissection procedure. (B) 5’ (left) 3’ (right) RACE amplifications of tpt1 mRNAs using laser-cap-
tured axonal extracts. (C) RT-PCR assessment of laser-captured material. –RT, RNA samples not reverse 
transcribed; –RGC, retinal ganglion cell.
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A.2 Netrin-1 Triggers a Translation-dependent Rise in Growth Cone Tctp
The axonal enrichment of tpt1 transcripts raises the question of whether Tctp protein 
is synthesized locally in embryonic growth cones. Moreover, previous studies have 
demonstrated that 5’-TOP-bearing mRNAs are selectively regulated at the translational 
level by the mTOR complex 1 (mTORC1) in a growth-dependent manner [171], rais-
ing the possibility that Tctp growth cone levels can be regulated by guidance cues that 
activate this signaling pathway. Since Netrin-1 can trigger protein synthesis locally in 
an mTORC1-dependent manner [144], I reasoned it might specifically regulate tpt1 
mRNA translation in growth cones.
 To test this, I initially performed 5-minute Netrin-1 stimulations in cultured eye 
explants, and used quantitative immunofluorescence (QIF) to examine growth cone 
Tctp levels. This approach revealed a ~20% increase in the average pixel intensity per 
unit area in Netrin-1-treated growth cones compared to controls (Figures 3.8A and 
3.8B). In parallel, both cycloheximide (CHX), an inhibitor of translation elongation, 
and rapamycin, an mTORC1 inhibitor, prevented the increase in Tctp signal when ap-
plied acutely before the Netrin-1 stimulus (Figures 3.8A and 3.8B). Collectively, these 
results suggest that Tctp growth cone levels are rapidly regulated by Netrin-1, and that 
this event is protein synthesis- and mTORC1-dependenta.
 Next, to test directly whether the tpt1 UTRs drive the synthesis of new protein 
in response to Netrin-1, I generated Kaede fusion constructs flanked by the 5’UTR and 
3’UTRs of tpt1 (henceforth termed Kaede-S and Kaede-L) (Figure 3.9A). Kaede pro-
tein is originally green but can be irreversibly converted to the red form by ultra-violet 
illumination, thereby allowing for the distinction of new and pre-existing protein [5]. 
a Note that the small size of Tctp likely facilitates the swift build-up of its local pool.
Figure 3.7 – tpt1-S is an abundant axonal transcript. (A) RT-qPCR experimental design. (B 
and C) Axonal and whole-eye content of tpt1 mRNAs analysed by RT-qPCR and normalized to 
actb expression. In (B), data are plotted as tpt1-S + tpt1-L and  to tpt1-L ratios (P = 0.0175, one-
way ANOVA), whereas in (C) the quantification cycle (Cq) difference relative to actb is shown.
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Unstimulated, vehicle-treated Kaede-S- or Kaede-L-positive growth cones showed no 
green fluorescence recovery over the 30-minute course of these experiments (Figure 
3.9B and data not shown). However, in Kaede-S-expressing neurons, Netrin-1 signifi-
cantly increased the reappearance of green signal within 10 minutes of stimulation. No-
tably, the Netrin-1-induced return of green fluorescence was blocked by cycloheximide 
added prior to photoconversion, denoting the synthesis of new protein (Figures 3.9B 
and 3.9C). Furthermore, as this elevation in Kaede-green occurred in axons discon-
nected from their cell bodies, I excluded soma-derived protein as a possible source of 
new protein. By contrast, even upon stimulation with Netrin-1, I detected no resurgence 
of green signal in neurons expressing Kaede-L (Figures 3.9B and 3.9D). Collectively, 
these data indicate that the 3’UTR of tpt1-S can direct the local translation of new pro-
Figure 3.8  – Protein synthesis-dependent rise in Tctp in Netrin-1-treated growth cones. (A and B) 
Retinal explants were stimulated with Netrin-1 for 5 minutes and stained for Tctp. Netrin-1 induced an 
increase in growth cone Tctp mean intensity signal relative to control, and this effect was prevented by 
rapamycin or cycloheximide pre-treatment (mean ± SEM; n = no. of growth cones  analysed; *** P < 
0.0001, Kruskal-Wallis test). Scale bars 5 μm. 
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tein in response to Netrin-1. Also, they imply that the tpt1-S isoform is the sole origin 
of the de novo synthesized Tctp protein observed upon Netrin-1 stimulation. These 
findings thus suggest that the longer 3’UTR harbours Netrin-1-insensitive regulatory 
motifs, while not excluding that different cues or cellular conditions may activate its 
translation. In fact, tpt1-L transcripts are predicted to possess many additional stem-
loop structures and miRNA-binding sites within the unique region of its 3’UTR (Fig-
ures 3.10A, 3.10B and 3.11), and may therefore associate as part of different ribonuc-
leoprotein particles (mRNPs). Notably, both in Xenopus laevis and Homo sapiens, the 
tpt1 5’-TOP motif shares complementarity and is predicted to associate with a stretch 
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Figure 3.9  – mRNA isoform-specific Tctp upregulation in Netrin-1-treated growth cones. (A) Sche-
matic Kaede constructs and experimental design. (B) Quantification of green fluorescence recovery over 
multiple time-lapse sequences (*** P < 0.0001, two-way ANOVA and Bonferroni). (C and D) Pre- and 
post-photoconversion images of severed axons expressing Kaede-S or Kaede-L. Fluorescence recovery 
in response to Netrin-1 was only observed in Kaede-S-expressing neurons, and this effect was prevented 
by cycloheximide pre-treatment. Scale bars: 5 μm.
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of nucleotides located in the unique region of the tpt1-L’s 3’UTR (Figure 3.12). Thus, 
it is possible that, in combination with other post-translational regulatory mechanisms, 
the steric hindrance that such conformation confers to the 5’-TOP motif serves as an 
additional regulatory layer, rendering this isoform insensitive to mTORC1-activating 
cues such as Netrin-1. In any case, it is important to stress that these in silico data lack 
any concrete experimental support.
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Figure 3.10 – tpt1 encodes highly structured mRNAs. (A) Xenopus laevis tpt1-S and tpt1-L second-
ary structure prediction using the online RNAfold server. The structures are colored by base-pairing 
probabilities, with pale-colors indicating low base-pairing probabilities. For unpaired regions, the color 
denotes the probability of being unpaired. The unique segment of the tpt1-L 3’UTR is highlighted in 
light blue. The location of the main RNA landmarks, such as start and stop codons, is also indicated.
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Poly(a) signal 1 Poly(a) signal 2
AAAAAA
5ʼUTR tpt1 cds tpt1-S 3ʼUTR tpt1-L unique 3ʼUTR
Homo sapiens
tpt1 transcripts:
b Free energy (kcal/mol) calculated by miRanda algorithm.
Selected miRNAs Targeting H.sapiens tpt1
mRNAs as Predicted by miRNA_targetsa Energyb
 miR:  3' cgucuucguaaAGGUGUGUg 5'
tpt1:  5' ucugcuugucaUCCACACAa 3'miR-147a -13.32
 miR:  3' ccgaggguUCUUGG-AGUGGACa 5'
tpt1:  5' auuauuuuGGAUCUAUCACCUGu 3'miR-125a-3p -17.96
 miR:  3' cgaCGGCAUAUAC--ACUACAGUg 5'
tpt1:  5' uaaGACAAAUGGGACUGAUGUCAu 3'miR-489 -12.24
 miR:  3' uuggAGAUUU---UCCUACGUGAAa 5'
tpt1:  5' guugUCUAAAAAUAAAAUGCAUUUa 3'miR-519b-3p -11.91
miR-519a-3p  miR:  3' ugugAGAUUU---UCCUACGUGAAa 5'tpt1:  5' guugUCUAAAAAUAAAAUGCAUUUa 3' -11.91
miR-519c-3p -14.27  miR:  3' uaggAGAUUU---UUCUACGUGAAa 5' tpt1:  5' guugUCUAAAAAUAAAAUGCAUUUa 3'
 miR:  3' cgccuUGAAUCGG--UGACACUu 5'
tpt1:  5' ucuucAUUUAUUUUGACUGUGAu 3'miR-27a/b -10.56
  miR:  3' uuUAUAGUGU--GUGUGAUUUAAc 5'
 tpt1:  5' uaAUG-CAUAUUUAAACUAAAUUg 3'miR-32-3p -15.16
 miR:  3' guucCGUCGUGA-CAUUUCUUCGa 5'
tpt1:  5' uccuGUAGUGUUCCUGGAGAAGCu 3'miR-103a-2-5p -18.21
 miR:  3' gaCUUGUGGUUUUCUUUAGUca 5'
tpt1:  5' ugGAAUAUAAAAAAGAAUCAaa 3'miR-29a-5p -11.44
 miR:  3' uccguAUCCUAC--UGUUUCCCUu 5'
tpt1:  5' gauuuUGAGuuGCAAUAAAGGGAa 3'miR-204-5p -13.46
 miR:  3' ucguuuuuacaCGAUCACGGUUu 5'
tpt1:  5' ccaugcucauaGC-AGUGCCAAc 3'miR-96-5p -13.75
 miR:  3' ccaUGUCAGUUGCCAGUCACCa 5'
tpt1:  5' aaaAGAGAC-UCAUUCAGUGG- 3'miR-181a-2-3p -11.48
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a miRNA_Targets online server uses both miRanda and RNAhybrid for miRNA predictions.
Validated
interactionc
c Lo, W.Y., Wang, H.J., Chiu, C.W., and Chen, S.F. (2012). miR-27b-regulated TCTP as a novel 
plasma biomarker for oral cancer: from quantitative proteomics to post-transcriptional study. 
Journal of proteomics 77, 154-166
Figure 3.11 – miRNAs predicted to bind tpt1-S and tpt1-L 3’UTRs. Selection of in silico-predicted 
miRNAs targeting Homo sapiens tpt1 mRNAs. The online ‘miRNA_targets’ portal (developed by Amit 
Kumar and Christophe Lefevre, Deakin University, Australia) used in this analysis employs the miRanda 
and RNAhybrid algorithms in its predictions.
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Figure 3.12 – Hypothetical mechanism for the differential regulation of tpt1 isoforms observed in 
Netrin-1-treated growth cones. The most stable conformation for Xenopus laevis and Homo sapiens 
tpt1-L mRNAs is predicted to permit the association between the 5’-TOP motif and a complementary 
segment exclusive to the tpt1-L 3’UTR. Note that the 5’-TOP-complementary segment is not identical 
in Xenopus laevis and Homo sapiens; likewise, the 5’-TOP motif in tpt1 transcripts is not conserved be-
tween the two species. This in silico structure prediction was generated using the online RNAfold server 
[264].
A.3 Profiling of tpt1 mRNA Interacting RNA-binding Proteins
Trans-acting RNA-binding factors, such as RNA-binding proteins and miRNAs, dictate 
the post-transcriptional fate of mRNAs in terms of their stability, transport, subcellular 
localization, and translational control [137]. Thus, the profiling and characterization of 
these factors assumes extraordinary relevance towards an integrated understanding of 
RNA expression and, in a broader sense, the biology of the cell. If effective prediction 
criteria used in computational screens for miRNA binding sites have greatly aided the 
discovery of valid miRNA targets [265], the number of well-defined RNA consensus 
sequences/motifs for RNA-binding proteins has remained minute. This is, in large part, 
due to the fact that the secondary structure of the RNA, and not only the linear sequence 
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of nucleotides, influences its association with protein trans-acting factors [266]. On the 
other hand, the dynamic nature of RNA-protein interactions has proven their compre-
hensive identification challenging at best. Furthermore, most methodologies employed 
in the study of RNA-binding proteins use a candidate approach, in that prior knowledge 
of a particular RNA-binding protein is required for its interactome to be investigated. 
Such limitations are, however, incompatible with an unbiased analysis of the interac-
tome of a specific mRNA.
 Given the inexistence of RNA-binding proteins known to associate with tpt1 
transcripts, I made use of a recently developed RNA-centric approach – MS2 In Vivo 
Biotin Tagged RNA Affinity Purification (MS2-BioTRAP) [256] – in order to elucidate 
the protein composition of tpt1 mRNP complexes. In this methodology, a chimeric 
gene encoding the RNA of interest (or part of it, such as the UTRs) tagged with tandem 
repeats of stem-loop motifs specifically recognized by the MS2 bacteriophage coat pro-
tein is co-expressed ‘in-vivo’ with a modified MS2 coat protein [267] a,b,c. This allows 
for the MS2 coat protein, along with the MS2-stem-loop tagged RNA that it binds to, 
as well as any associated RNA-binding protein, to be effectively and rapidly collected 
by affinity purification. In the last phase of the strategy, the purified RNA-protein com-
plexes are subjected to a SILAC-based quantitative proteomic analysis [268].
 I constructed a tpt1-derived target for the bacteriophage MS2 coat protein by 
cloning the Homo sapiens tpt1-S 3’UTR (208 base pairs) downstream of the coding 
sequence of the sea pansy (Renilla reniformis) luc (luciferase) gene. Four tandem MS2-
stem-loop repeats were inserted between the luciferase coding sequence and the tpt1 
3’UTR to tag the luc-tpt1 chimera for recognition. Of note, the finalized pRL-Rluc-
MS2-tpt1-3’UTR construct contained an intron (comprised of a 5’-donor splice site, a 
branch site, and a 3’-acceptor splice site) located downstream of a SV40 enhancer/pro-
moter region, as well as a SV40 polyadenylation signal, guaranteeing that the expressed 
Rluc-MS2-tpt1 pre-messenger RNA (pre-mRNA) experiences the major processing 
events undergone by mature endogenous transcripts. In parallel, a control construct was 
generated lacking the tpt1-S 3’UTR exon (pRL-Rluc-MS2-Control), but maintaining all 
the remaining regulatory landmarks (Figure 3.13).
a The engineered MS2 coat protein is tethered to a tag comprising two hexahistidine clusters and a signal 
sequence for in vivo biotinylation (MS2-His-biotin (HB).
b The bacteriophage MS2 coat protein is functional only as a dimer.
c Although HEK (human embryonic kidney)-293 cells were employed in these experiments – namely 
a stable cell line expressing the modified MS2 coat protein (HEK-293MS2-HB) gifted to me by Dr. Marian 
Waterman (University of California, Irvine) – the MS2-BioTRAP system can be adapted for use in any 
other cell line or even in an animal model.
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Figure 3.13 – Schematic representation of the Rluc-MS2-tpt1 and Rluc-MS2-Control transgenes.
 Critically, both constructs were evaluated for expression in the HEK-293MS2-HB cell 
line, as comparable Rluc-MS2-tpt1 and Rluc-MS2-Control mRNA levels were neces-
sary to ensure the final mass spectrometry quantification data held experimental valid-
ity. To this end, a RT-qPCR quantification protocol was devised using a co-transfected 
firefly (Photinus pyralis) luc reporter for gene expression normalization purposes. Data 
analysis showed that both mRNAs were expressed at equivalent levels (P = 0.9158, 
unpaired t-test) (Figure 3.14A). Alternatively, the enzymatic activities of the lucif-
erase proteins encoded by the Rluc-MS2-tpt1 and Rluc-MS2-Control constructs were 
measured, allowing for a quantitative gene expression assessment at the protein level. 
Relative to the expression of Rluc-MS2-Control, I quantified a decrease (circa 20%) 
in the ratio of Renilla to firefly luciferase activity in cells transfected with the Rluc-
MS2-tpt1 construct (Figure 3.14B). Taken together, these results demonstrate that the 
Rluc-MS2-tpt1 and Rluc-MS2-Control constructs achieve similar levels of mRNA ex-
pression, as would be expected of transgenes driven by the same promoter. Moreover, 
they show that the tpt1-S 3’UTR negatively modulates the expression of the Rluc-MS2-
tpt1 mRNA, meaning that this segment confers an extra regulatory layer to the chimeric 
Rluc transcript. Thus, these results suggest that the tpt1-S 3’UTR retains functionality 
when fused to the Rluc gene. In any case, it should be stressed that it is the equivalent 
expression level of the mRNAs, and not that of the proteins, the sole prerequisite of a 
valid experiment.
 After complete SILAC labelling, MS2-HB-associated UV cross-linked mRNP 
complexes were purified under fully denaturing conditions using streptavidin-coated 
beads (Figure 3.15). In doing so, only cross-linked RNA-protein associations, and not 
indirectly interacting factors, were retained, ensuring that a comprehensive, but rigor-
ous, RNA-protein interaction profile for tpt1 was obtained. In total, three trypsin-treat-
ed replicate samples were analysed by mass spectrometry at the Cambridge Centre for 
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Figure 3.15 – Overview of the MS2 In Vivo Biotin Tagged RNA Affinity Purification (MS2-Bio-
TRAP) strategy. See text and experimental prodecures for details.
Figure 3.14 – Rluc-MS2-tpt1 and Rluc-MS2-Control mRNAs are expressed at equivalent levels in 
HEK-293MS2-HB cells. (A) RT-qPCR analysis of Rluc-MS2-tpt1 and Rluc-MS2-Control mRNA ex-
pression. A firefly luc reporter (Fluc) was included in the transfection protocol to allow for comparisons 
between conditions (four biological replicates were prepared per condition; P = 0.9158, unpaired t-test). 
(B) Analysis of Rluc-MS2-tpt1 and Rluc-MS2-Control expression at the protein level using a dual lucif-
erase reporter assay. As in (A), MS2-tagged plasmids were co-transfected with a firefly luc reporter for 
normalization purposes. In (A), boxplot whiskers denote the 5-95 percentile; in (B), error bars specificy 
the standard error of the mean.
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Proteomics. The determination of protein abundance ratios in SILAC-labelled cell pop-
ulations is possible because peptides with the same amino acid sequence, but different 
isotopic composition, can be discriminated by mass spectrometry means due to their 
different masses. If a given RNA-binding protein associates equally with both tagged 
RNAs, then the ‘heavy’ to ‘light’ relative abundance ratio of its digested peptides is, in 
theory, 1; conversely, a protein that specifically interacts with one of the tagged RNA 
species will give rise to a relative abundance ratio different from 1. Here, ‘heavy’ to 
‘light’ relative abundance ratios greater-than 1.5, or less-than 0.66, were judged as spe-
cific associations, following published guidelines [268, 269]. 
Using these analysis parameters, ten known RNA-binding proteins were re-
producibly identified as enriched interactors of MS2-tagged tpt1-S transcripts: RALY 
heterogeneous nuclear ribonucleoprotein (raly), heterogeneous nuclear ribonucleopro-
tein K (hnrnpk), heterogeneous nuclear ribonucleoprotein L (hnrnpl), poly(rC) binding 
protein 1 (pcbp1), poly(rC) binding protein 2 (pcbp2), polypyrimidine tract binding 
protein 1 (ptbp1), far upstream element-binding protein 2/KH-type splicing regulatory 
protein (khsrp), DEAD (Asp-Glu-Ala-Asp) box helicase 17 (ddx17), heterogeneous nu-
clear ribonucleoprotein H3 (hnrnph3), and serine/arginine repetitive matrix 2 (srrm2) 
(Table 2). This dataset was then examined using the STRING (Search Tool for the Re-
trieval of Interacting Genes/Proteins) database, which catalogues known and predicted 
protein-protein interactions according to published experimental findings (including 
high-throughput screens), genomic context, and scientific texts [270, 271]. Notably, 
STRING analysis revealed the core of tpt1-S 3’UTR-enriched factors comprises a high-
ly interactive collection of proteins (Figure 3.16), suggesting that an important portion 
of the tpt1-S mRNP complex may indeed have been captured. 
Taken together, and although requiring validation through parallel, protein-cen-
tric approaches (e.g. RNA immunoprecipitation), this dataset represents the first snap-
shot of tpt1 mRNA trans-acting factors, and hence an important novel insight into the 
regulation of tpt1 transcripts.
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Table 2. RNA-binding protein composition of tpt1 mRNP complexes
RNA-binding Protein Biological Overview
hnRNP K
Acts as a docking platform to enable molecular interactions and, simultaneously, as a signal 
transduction hub. Contains three K homology (KH) domains, which can function in RNA or 
single-stranded DNA recognition, and shows particular affinity for C-rich motifs. hnRNP K 
is aberrantly expressed – both in terms of abundance and localization – in many human can-
cers, suggesting it plays a role in cancer progression [272], and, functionally, has been linked 
to apoptotic pathways [273]. hnRNP K has been identified in the proteome of growth cones 
[274]. In addition, it interacts directly or indirectly with tpt1 mRNA in cultured hippocampal 
neurons (Graciano Leal and Carlos Duarte, Center for Neuroscience and Cell Biology – Uni-
versity of Coimbra; personal communication).
Pcbp1 and Pcbp2
Together with hnRNP K, poly(C)-binding protein 1 and 2 (Pcbp1 and Pcbp2; also known 
as hnRNP E1 and hnRNP E2), are the best-characterized elements of a set of evolutionari-
ly related RNA-binding proteins with affinity for C-rich single stranded motifs. Pcbp1 and 
Pcbp2 share the triple KH domain configuration of hnRNP K, and are involved in mRNA 
stabilization and translational control processes [275]. Of particular note, Pcbp1 is known to 
inhibit post-transcriptionally the translation of phosphatase of regenerating liver 3 (PRL-3), 
a metastasis-associated protein [276]. Likewise, knockdown of Pcbp2 has been shown to in-
hibit glioma growth by hindering cell cycle progression and promoting Caspase-3-mediated 
cell death [277]. Pcbp1 is expressed in growth cones [274].
hnRNP L
hnRNP L is involved in many processes of mRNA metabolism, including translational regu-
lation [278], poly(A) site selection [279], and control of mRNA stability [280]. Contains four 
RNA recognition motif (RRM) domains, and has specificity for CA-rich elements (CAGE). A 
genome-wide study on hnRNP L binding preferences has revealed that it preferentially asso-
ciates with intronic and 3’ untranslated regions [281]. Significantly, the Homo sapiens tpt1-S 
mRNA contains a highly conserved 16-nt CA-rich region (CATCCACACAACACCA), sug-
gesting that hnRNP L can associate with tpt1 transcripts via this motif.
Raly
Raly is a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family, and 
may be involved in pre-mRNA splicing and in embryonic development. Contains a RNA 
recognition motif (RRM) [282].
Ptbp1
Best known for its involvement in pre-mRNA splicing, Ptbp1 has also been linked to cyto-
plasmic post-transcriptional processes, including mRNA localization, translational control, 
and mRNA stability. In mouse, knockout of Ptbp1 results in embryonic lethality, attesting 
the importance of this RNA-binding protein in development. During early neuronal devel-
opment, Ptbp1 represses the expression of postsynaptic density protein 95 (psd95), a critical 
scaffolding protein, by affecting the stability of its mRNA. In cancer biology, Ptbp1 has been 
shown to regulate apoptosis, cell migration, and growth factor responsiveness. Structurally, 
Ptbp1 is composed of four RNA recognition motif (RRM) domains [283].
Khsrp
Khsrp is a single-strand nucleic acid binding protein known to promote the decay of mR-
NAs containing adenylate-uridylate-rich elements (AU-rich elements; AREs) in their 3’UTR 
[284], such as tpt1 (Figure 3.17). Khsrp has been shown to destabilize the mRNA encoding 
for growth-associated protein (Gap)-43 – an axonally synthesized factor [285] – and, by 
doing so, to constrain axonal outgrowth [286]. Additionally, Khrsp regulates the maturation 
of a small group of miRNA precursors, and regulates cellular proliferation and differentiation 
[284]. In terms of structure, Khsrp contains four KH domains [287]. It is also known as Ksrp.
Ddx17
‘DEAD box’ Ddx17 is a RNA- and ATP-dependent helicase. DEAD box proteins contain a 
conserved aspartic acid (Asp or D)-glutamic acid (Glu or E)-alanine (Ala or A)-aspartic acid 
domain (Asp or D), and regulate pre-mRNA splicing and translation initiation processes, 
among others, by promoting the rearrangement of RNA secondary structures. Its cellular role 
appears to be context-dependent, as Ddx17 is reported to have both pro- and anti-proliferative 
functions in cancer cells [288].
hnRNP H3 Like other heterogeneous nuclear ribonucleoproteins, hnRNP H3 regulates the splicing pro-cess [289], and plays a role in the early heat shock-induced splicing arrest response [290].
Srrm2
Srrm2 participates in pre-mRNA splicing, although its exact function is yet to be determined. 
Work in Saccharomyces cerevisiae by Grainger et al. indicate that Srrm2 may play a role at 
the catalytic centre of the spliceosome [291]. Of particular note, Srrm2 dysregulation in terms 
of the expression of its mRNA isoforms are proposed to serve as a potential blood biomarker 
in Parkinson’s disease [292]. It is also known as SRm300.
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Figure 3.16 – STRING protein network of the ten RNA-binding proteins reproducibly identified 
as interacting with the tpt1-S 3’UTR. Lines between nodes denote the existence of a direct or indirect 
association. The support for a given association is specified by the thickness of its connecting line.
tpt1-L
5’UTR 3’UTRtpt1 coding sequence
tpt1-S 3’UTR
AUUUA WWAUUUAWW
Figure 3.17 – AU-rich elements (ARE) in tpt1 mRNA. AUUUA site position in tpt1-S: 703-707 and 
719-723; the two additional AUUUA sites in tpt1-L are located at 787-791 and 828-832. WWAUUUAWW 
site position: 826-834 (sequence: AUAUUUAAA). Analysis performed using the AREsite online re-
source (University of Vienna). W- A or U residue.  
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A.4 Growth Cone Tctp Levels Are Downregulated by Ephrin-A1 
Growth arrest under a variety of conditions results in the selective repression of 5’-TOP 
mRNAs, as judged by their shift into the subpolysomal fraction in quiescent cells [172]. 
A developing axon may be understood to experience an analogous effect upon reaching 
its synaptic target area, as numerous cues signal for it to halt its extension program and 
arborize; for example, Eph receptor tyrosine kinases and their ligands, the ephrins, with 
their graded distribution along the retinal and tectal anterior-posterior and dorso-ventral 
axes, constitute an effective and well-characterized mode of establishing the correct 
termination zone coordinates for retinal ganglion cell axons [119]. Of particular note, 
EphA receptor activation by Ephrin-A has been shown to depress mTORC1 activity 
and protein synthesis in retinal ganglion cell axons [257]. On the other hand, transcripts 
encoding for Tctp – as any 5’-TOP-bearing message – are part of a subset of mRNAs 
specifically regulated by mTORC1 [171], raising the question of whether Ephrin-A1 
controls the translation of tpt1 transcripts in navigating growth cones and, more gener-
ally, that of 5’-TOP mRNAs as a whole. 
Since EphAs have a high-temporal to low-nasal expression pattern in retinal 
ganglion cells [120], and hoping to corroborate and simultaneously gain novel insight 
into the signaling mechanism defined by Nie et al. [257], I initially asked if the aforesaid 
gradient regulated the inhibitory effects on mTORC1 signaling elicited by Ephrin-A1. 
To this end, explants from temporal and nasal retinal crescents of stage 32 Xenopus lae-
vis embryos were cultured for 24 hours, a duration that approximately equates in vitro 
to the arrival of retinal ganglion cell axons in the Ephrin-A-expressing optic tectum 
in vivo [12, 119]. Notably, following a 10-minute incubation protocol with Ephrin-A1 
(5 μg/mL), I observed using quantitative immunofluorescence a significant decrease 
(approximately 35%; P < 0.0001, one-way ANOVA and Tukey’s Multiple Comparison 
Test) in ribosomal protein S6 (rpS6) phosphorylation levels at Ser-235/236, a cardinal 
marker of mTORC1 activity [293], in retinal ganglion cell growth cones derived from 
temporal regions of the eye vesicle, but no detectable effects in nasally-originating 
growth cones (Figure 3.18). Overall, these findings validate and expand on the results 
of Nie and colleagues [257], as they suggest that the level of expression of EphAs re-
ceptors is a fundamental variable in the outcome of Ephrin-A1-induced inhibition of 
mTORC1.
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Having confirmed that EphrinA1-EphA (forward) signaling modulates the 
mTOR pathway in Xenopus laevis retinal ganglion cells, and employing the same stimu-
latory protocol as before, I next examined whether EphrinA1-EphA-mediated signaling 
also regulated the expression of Tctp in the growth cone. Notably, an inverse correlation 
between EphA activation and Tctp expression was also observed using quantitative 
immunofluorescence: Tctp protein levels in temporal growth cones showed a reduction 
of approximately 25% relative to temporal controls (P < 0.0001, one-way ANOVA 
and Tukey’s Multiple Comparison Test), accompanied by a smaller but nonetheless 
significant decline in growth cone Tctp levels in nasal counterparts (circa 10% versus 
nasal controls; P < 0.0001, one-way ANOVA and Tukey’s Multiple Comparison Test) 
(Figure 3.19). Collectively, these results indicate that, at least to some extent, the levels 
of Tctp reflect the activation of mTORC1 in Ephrin-A1-treated growth cones.
Although my research work eventually took a different direction, I opted for in-
cluding these preliminary results in my dissertation because they may offer new mech-
anistic insights into the formation of the retinotectal topographic map. Retinal gangli-
on cells processes originating from the temporal retina are high-EphA-expressing and 
project to the anterior-most, low-Ephrin-A1-expressing regions of the optic tectum. 
Conversely, nasally-derived, low-EphA-expressing retinal ganglion cells extend past 
the anterior optic tectum towards posterior (and high-Ephrin-A1 expressing) regions 
of the target field. Id est, nasal processes are unresponsive to low-Ephrin-A1-territories 
that temporal axons find restrictive, and project to the back of the optic tectum, where 
higher – and increasingly less permissive – Ephrin-A1 concentrations are found. It 
follows that low-EphA-expressing nasal retinal ganglion cell growth cones must have 
a higher threshold of response to Ephrin-A1, otherwise they would terminate preco-
ciously along the anterior-posterior axis. In other words, the relative progression of the 
primary axon’s growth cone is dependent on the level of EphA receptor expressed on 
each growth cone’s surface, precisely matched to a repellent Ephrin-A1 counter-gra-
dient [119] – it is this molecular duality that defines the anterior-posterior coordinates 
of each discrete termination zone. At the termination zone, changes in cytoskeleton 
dynamics leading to actin depolymerization and the collapse of the growth cone cause 
Figure 3.18 – Ephrin-A1 differently regulates mTOR activity in nasal and temporal retinal gangli-
on cell axons. Nasal and temporal stage 32 retinal explants grown in vitro for 24 hours were stimulated 
with Ephrin-A1-Fc applied at a concentration of 5 μg/mL, and stained with an antibody that specifically 
recognizes rpS6 when phosphorylated at Ser-235/236. Representative micrographs of control (clustered 
Fc)- and Ephrin-A1-treated retinal ganglion cell growth cones are shown (mean ± SEM; n = no. of 
growth cones analysed; *** P < 0.0001, one-way ANOVA). Scale bar: 5 μm.
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it to halt its extension and arborize. My findings suggest that the progressive inhibition 
of mTOR signaling promoted by increasing Ephrin-A1 local concentrations can play a 
role in the fine modulation of this response, so that it occurs for each given growth cone 
only when its termination zone is reached and not before (Figure 3.20). Curiously, a 
set of translationally controlled pro-invasion mRNAs – in their majority (98 out of 144) 
canonical 5’-TOP-bearing mRNAs, including Tctp – were shown recently to promote 
prostate cancer invasiveness downstream of aberrant mTOR signaling, a hallmark of 
advanced human prostate cancers [200]. If a similar rational is applicable to the con-
text of topographic map formation, then the differential attenuation in mTOR signaling 
elicited by Ephrin-A1 could be understood as a way of reducing the invasive potential 
of the growth cone only and only when it arrives at its termination zone.
Figure 3.19 – Growth cone Tctp expression is correlated with the level of mTOR activation. Nasal 
and temporal stage 32 retinal explants grown in vitro for 24 hours were stimulated with Ephrin-A1-Fc 
applied at a concentration of 5 μg/mL, and stained for Tctp. Representative micrographs of control (clus-
tered Fc)- and Ephrin-A1-treated retinal ganglion cell growth cones are shown (mean ± SEM; n = no. 
of growth cones analysed; *** P < 0.0001, one-way ANOVA and Tukey’s Multiple Comparison Test). 
Scale bar: 5 μm.
Tukey's Multiple Comparison Test
Nasal Fc vs Nasal Ephrin-A1
Nasal Fc vs Temporal Fc
Nasal Fc vs Temporal Ephrin-A1
Nasal Ephrin-A1 vs Temporal Fc
Nasal Ephrin-A1 vs Temporal Ephrin-A1
Temporal Fc vs Temporal Ephrin-A1
Mean Diff.a
10.65
-0.08356
23.65
-10.73
13.00
23.74
Significant? P < 0.05?
Yes
No
Yes
Yes
Yes
Yes
Summary
***
n.s.
***
***
***
***
95% CI of diffb
5.977 to 15.32
-4.964 to 4.797
19.02 to 28.28
-15.73 to -5.739
8.252 to 17.75
18.78 to 28.69
a Difference of the means. b Confidence interval on the difference between means.
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Figure 3.20 – Modulation of mTOR activity by Ephrin-A1-EphA signaling and its hypothetical 
contribution to retinotectal map formation. TN- temporal-nasal axis; AP- anterior-posterior axis. See 
text for details.
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B – Tctp Regulates Retinal Axon Pathfinding In Vivo 
 
B.1 Tctp is Required for Normal Axon Projections
Prompted by the abundant localization of tpt1 mRNA in the retinal ganglion cell axonal 
compartment at a time when the retinotectal projection is developing, I next assessed 
whether Tctp plays a role in retinal axon guidance. To inhibit tpt1 mRNA translation in 
vivo, I used an antisense morpholino oligonucleotide directed against the start site of 
tpt1 mRNA (tpt1-MO), which was delivered at the four-cell stage by injection into both 
dorsal blastomeres (Figure 3.21A). In doing so, I targeted both tpt1-S and tpt1-L tran-
scripts in the central nervous system, including the neural retina. Western blot analysis 
validated the efficient knockdown in Tctp levels (ca. 50% in brain and eye lysates; P = 
0.041, unpaired t-test) (Figure 3.21B). In addition, quantitative immunofluorescence 
analysis of cultured eye explants showed an expression knockdown of approximately 
40% in retinal ganglion cell growth cones (P < 0.0001, Mann-Whitney test), demon-
strating that the axonal pool of Tctp is targeted by this approach (Figure 3.21C). At the 
morpholino dosage used, Tctp knockdowns appear morphologically normal, with no 
overt delays in development, albeit showing in most individuals small decreases in eye 
size (10% on average) (Figure 3.22A-D). Of note, I titrated a morpholino dosage capa-
ble of achieving a level of expression knockdown comparable in magnitude to that of 
tpt1+/- mice, which are reported to be viable and fertile, unlike homozygous tpt1-/- pups 
[17, 164].
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Figure 3.21 – Morpholino-mediated Tctp knockdown in microinjected Xenopus laevis embryos. (A) 
Experimental outline. (B) CNS lysates of control (con)-MO and tpt1-MO injected embryos were run on 
a SDS-PAGE gel and knockdown efficiency verified by western blot. (C) Representative con-MO and 
tpt1-MO-positive growth cones stained for Tctp. Scale bar: 5 μm 
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 I first analysed retinal ganglion cell axon trajectories by lipophilic dye (DiI) 
labelling at stage 40 (~3 day-old embryos), when most axons have completed their 
stereotyped growth through the optic tract and reached the optic tectum [22]. Whereas 
control projections consistently coursed a normal trajectory and reached the target re-
gion by this stage (Figure 3.23B), most age-matched Tctp knockdowns exhibited sig-
nificantly shorter projections that failed almost entirely to enter the optic tectum (Fig-
ures 3.23C-E). In addition, instead of forming the compact axonal bundle typical of 
normal projections, retinal ganglion cell axons in Tctp knockdowns grew dispersed and 
entered inappropriate territories in the diencephalon and telencephalon, which resulted 
in comparatively wider projections (Figures 3.23C and 3.23F); indeed, the retinal pro-
jection in Tctp knockdowns was on average 20-25 μm wider along the mid-optic tract 
region compared to controls (Figure 3.23F). Remarkably, one day and a half later, at 
stage 45, when normal axons are undergoing arborization and synaptogenesis in the op-
tic tectum, the retinotectal projection in Tctp knockdowns still contained axons that had 
not completed their extension through the optic tract (Figures 3.23). Taken together, 
these data demonstrate that Tctp is necessary for the accurate and timely development 
of the retinotectal projection.
Figure 3.22 – Morphological evaluation of Tctp knockdowns. (A and B) Micrographs of stage 39 
con-MO- or tpt1-MO-injected embryos. Tctp knockdowns develop at comparable rates relative to control 
embryos and appear morphologically normal, albeit with smaller eyes. (C) Plot of eye size measurements 
(mean ± SEM; ** P < 0.0063, unpaired t-test). (D) Plot of body length (anteroposterior axis) measure-
ments (mean ± SEM; non significant, P < 0.8614, unpaired t-test). Scale bar: 110 μm.
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Figure 3.22 – Tctp knockdown perturbs axon development in vivo. (A) Schematic representation of 
the experiment. (B and C) DiI-labeled retinotectal projections in con-MO- or tpt1-MO-injected embryos. 
Dashed lines indicate the tectal boundary. (D) Quantification of retinotectal tract length (mean ± SEM; n 
= no. of brains analysed; ** P < 0.0014, Mann-Whitney test). The length of the longest axon was taken 
for each measurement; since the bulk of the retinotectal projection in Tctp knockdowns is appreciably 
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shorter, this analysis actually provides a conservative assessment of the phenotype. (E) Percentage of 
brains displaying axon extension defects (** P < 0.0016, Fisher’s exact test, performed on number of 
observations but plotted as percentage). (F) Quantification of mean optic tract width in controls and Tctp 
knockdowns. C2-5 denote hemi-circumferences centered on the optic chiasm and scaled according to a 
line connecting the optic chiasm and the posterior pole of the optic tectum. MOT- mid-optic tract.Scale 
bars: 100 μm.
Figure 3.23 – The optic tectum is not fully innervated by stage 45 in Tctp knockdowns. (A) Experi-
mental outline. (B and C) DiI-labeled retinotectal projections in con-MO- or tpt1-MO-injected stage 45 
embryos. In brains from Tctp morphant embryos, a subset of axons (arrowheads) has not reached the op-
tic tectum by stage 45; seven out of a total of eight embryos analysed were noted to have this phenotype. 
The boxed areas in (B) and (C) are shown at a higher magnification in panels (B’) and (C’). Dashed lines 
indicate the tectal boundary. (7 out of 8 embryos evinced this phenotype) Scale bar: 100 μm. 
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 Following on these results, and working in collaboration with Hovy Ho-Wai 
Wong, a fellow doctoral candidate supervised by Christine Holt, we next addressed di-
rectly whether Tctp regulates axon elongation in vivo. To this end, we made time-lapse 
movies of control and morphant axons using electroporation to deliver gap-RFP (a 
membrane-targeted RFP) specifically into the eye (Figure 3.24A). While DiI-fills of-
fered a static glimpse of the axon projection, time-lapse imaging allowed us to directly 
compare the kinetics of axon growth along the retinotectal pathway. Overall, Tctp-de-
pleted axons advanced through the optic tract at a significantly slower average rate than 
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control axons (ventral optic tract [VOT]: 16.5 μm/h versus 34.4 μm/h; dorsal optic tract 
[DOT]: 16.1 μm/h versus 27.8 μm/h) (Figures 3.24B-D). In addition, 40% of morphant 
axons (33 of 82 axons) stalled along the optic tract, a significantly higher proportion 
than that observed in control samples (5 of 84 axons) (Figure 3.24E). As previously, 
we observed that the growth of retinal ganglion cell axons in Tctp knockdowns was 
rather dispersed and erratic, which translated into significantly wider projections rela-
tive to controls (mean tract angular spread: 80º versus 30º, P < 0.0001, unpaired t-test). 
Also, degenerating axons, distinguished by their beaded morphology and retraction be-
haviour, were more frequent along the optic pathway in the tpt1-MO:gap-RFP dataset 
(10 out of 82 axons versus 2 out of 82 axons in controls, P = 0.0145, unpaired t-test), 
suggesting that Tctp could act by promoting axon maintenance and survival. Collec-
tively, these data demonstrate that Tctp is necessary for the accurate development of the 
retinotectal projection. Moreover, our results show that Tctp knockdown affects the rate 
of axon elongation, resulting in shorter projections that fail to reach the optic tectum at 
the precise developmental window.
B.2 Tctp Acts Cell-Autonomously
Tctp displays IgE-dependent histamine-releasing activity and other cytokine-like ex-
tracellular functions [162, 175]. It could therefore act non-cell-autonomously in the 
embryonic environment to promote axon development, as histamine is suggested to 
have a significant role during neural development [294]. To address this concern, I next 
investigated whether the axonal phenotype in Tctp-deficient embryos might have a ret-
inal ganglion cell-extrinsic basis.
At the four-cell stage, targeted microinjection into the two dorsal blastomeres 
delivers the morpholino to the prospective brain as well as the eye, meaning that mor-
phant retinal ganglion cell axons grow into morphant brain tissue. However, as the 
first cleavage in Xenopus laevis eggs separates the future left and right-hand halves of 
the embryo [295], I was able to generate tadpole chimeras by targeting only one of the 
Figure 3.24 – Tctp knockdown impairs axon extension in vivo. (A) Stage 28 embryos, con-MO- or 
tpt1-MO-injected, were electroporated with gap-RFP to label retinal axons and allowed to develop until 
stage 40. (B and C) Time-lapse series of gap-RFP-labeled control or Tctp-depleted retinotectal projec-
tions coursing through the optic tract. Dashed lines indicate the tectal boundary. (D) Quantification of 
axon outgrowth rates through the ventral optic tract (VOT) and dorsal optic tract (DOT) in controls and 
Tctp knockdowns (mean ± SEM; n = no. of axons analysed; VOT: P < 0.0001, unpaired t-test; DOT: P < 
0.0273, unpaired t-test). (E) Percentage of axons with stalling extension. (*** P < 0.0001, Fisher’s exact 
test, performed on frequencies but plotted as percentage). Scale bars: 25 μm. Experiment perfomed in 
collaboration with Hovy Ho-Wai Wong.
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Figure 3.25 – Validation of the experimental strategy devised to investigate cell-autonomy. (A) Ex-
periment outline, depicting unilateral blastomere microinjection of con-MO or tpt1-MO, and the two ex-
perimental paradigms used to investigate cell-autonomy. (B) Dorsal view of embryos microinjected uni-
laterally with con-MO or tpt1-MO. (C) Western blots of eye or brain lysates probed with Tctp antibody. 
Ipsilateral (‘Ipsi’) and contralateral (‘Ctra’) refer to the side of the embryo injected with morpholino. 
Eight independent lysates were prepared: con-MO-injected ipsilateral (‘Ipsi’) and contralateral (‘Ctra’) 
eyes or brain hemispheres, plus tpt1-MO-injected ipsilateral and contralateral eyes or brain hemispheres 
(mean ± SEM; no. of independent samples assayed = 2). Scale bars: 100 μm.
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dorsal blastomeres: morpholino-positive in one half of the central nervous system, and 
wild-type, morpholino-free, in the other (Figures 3.25A-C).
As before, I assessed retinotectal projections at stage 40 using DiI anterograde 
labelling. Importantly, con-MO-injected embryos consistently developed normal ret-
inotectal projections in both paradigms, verifying the suitability of the strategy (Figures 
3.26B and 3.26D). Whereas tpt1-MO-positive retinal axons navigating into the contra-
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lateral, tpt1-MO-free, hemisphere replicated the same range of phenotypes observed in 
global Tctp knockdowns (Figure 3.26C), tpt1-MO-negative retinal ganglion cell axons 
projecting into the opposite, tpt1-MO-positive, hemisphere showed none of the defects 
I had previously characterized (Figure 3.26E). Namely, in the former condition, most 
axons failed to reach the optic tectum, while, in the latter, tpt1-MO-negative axons de-
veloped unaffected by the morphant brain environment, qualitatively indistinguishable 
from controls (Figures 3.26F and 3.26G). Taken together, these findings indicate that 
the axon extension phenotype in Tctp knockdowns is not a consequence of extrinsic 
perturbations, but a cell-autonomous event.
B.3 Normal Axon Extension When Tctp Translation is Locally Inhibited
Having found that Tctp regulates axon growth, I next investigated the relative contri-
bution of axonally synthesized Tctp to this process. To address this directly, I measured 
the outgrowth dynamics of transected pathfinding axons in which tpt1 mRNA transla-
tion was subcellularly blocked (Figure 3.27A). In doing so, I specifically targeted the 
pool of newly synthesized axonal Tctp and, as transected retinal ganglion cell axons can 
continue to grow and navigate in vivo for up to 3 hours [3], simultaneously eliminated 
the effects of soma-derived protein.
In contrast to microinjected-Tctp knockdowns, the axonal delivery of tpt1-MO 
did not significantly affect the outgrowth dynamics of retinal ganglion cell axons along 
the optic tract during the 1-hour period of my analysis when compared to controls (ven-
tral optic tract (VOT): 50.5 ± 3.1 μm/h versus 47.8 ± 3.9 μm/h in controls; dorsal optic 
tract (DOT): 42.7 ± 4.5 μm/h versus 47.9 ± 4.7 μm/h in controls) (Figures 3.27B-D). In 
addition, a post hoc evaluation of axon trajectories did not identify guidance errors aris-
ing in either condition, even though a major guidance decision – the caudal turn in the 
mid-optic tract [22] – was made by many axons in the temporal window of the analysis.
Although these results corroborate previous reports excluding protein synthesis 
in distal axons as a pre-requisite for axon growth [296], it was impossible to confirm di-
Figure 3.26 – Axon extension defect in Tctp morphants is cell-autonomous. (A) Schematic represen-
tation of the experiment, depicting unilateral blastomere microinjection of con-MO or tpt1-MO, and the 
two experimental paradigms used to investigate cell-autonomy. (B-E) DiI-labeled retinotectal projection 
in unilaterally injected stage 40 embryos. Refer to the diagram in (A) for a graphical outline of each 
experimental paradigm. Dashed lines indicate the tectal boundary. (F) Quantification of retinotectal tract 
length (mean ± SEM; n = no. of brains analysed; *** P = 0.0004, Kruskal-Wallis and Dunn’s Multiple 
Comparison Test). (G) Percentage of brains displaying axon extension phenotypes (** P = 0.0011, Chi-
square test, performed on frequencies but plotted as percentage). Scale bars: 100 μm.
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Figure 3.27 – Local synthesis of Tctp is not required for axon extension in vivo. (A) Gap-RFP was delivered 
by eye-targeted electroporation to wild-type stage 28 embryos, when the first retinal ganglion cell axons have 
just exited the eye, and axon extension kinetics were analysed 21-24 h later (stage 37/38), when most axons are 
growing up the optic tract towards the optic tectum. Just before imaging, the optic nerve was manually transected, 
and con-MO or tpt1-MO was delivered subcellularly by targeted brain electroporation. Of note, transected retinal 
ganglion cell axons can continue to grow and navigate accurately in vivo for up to 3 hours, well within the 1-hour 
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rectly whether my experimental approach indeed blocked the axonal synthesis of Tctp. 
However, recognizing that 5’-TOP-bearing mRNAs such as tpt1 are specifically regu-
lated by mTORC1 [171], I asked whether the inhibition of this signaling complex could 
recapitulate the axon phenotype detected in Tctp knockdowns. mTORC1 inhibition, 
as assessed by the levels of rpS6 phosphorylation at Ser-235/236, is readily achieved 
in Xenopus laevis embryos reared in rapamycin-containing saline [297]. In line with 
the above results, rapamycin-treated individuals showed normal retinotectal projec-
tions in terms of tract length (Figure 3.28), albeit developing seemingly less dense 
retinotectal projections (not quantified). However, even this approach is not without 
limitations, as I later came to learn that rapamycin, an allosteric mTOR inhibitor, only 
blocks p70S6K1/2 activity [200], and tpt1 is reported to be regulated, at least partly, 
by the eIF4E-mediated signaling arm of mTOR [199]; therefore, it is possible that the 
syntehsis of new Tctp protein is not significantly affected in rapamycin-treated embryos 
a[143,293].
a rpS6 is phosphorylated downstream of  p70S6K1/2 activation. The p70S6K1/2/rpS6 and the eIF4E-
BP/eIF4E pathways are the two main effectors of mTOR signaling.
period of this experiment. (B and C) Time-lapse series of severed retinal ganglion cell axons coursing 
through the optic tract in embryos subcellularly electroporated with con- or tpt1-MO. (D) Quantification 
of axon outgrowth rates through the VOT and DOT in embryos subcellularly electroporated with con- or 
tpt1-MO (mean ± SEM; n = no. of axons analszed; VOT: P = 0.5956, unpaired t-test; DOT: P = 0.4381, 
unpaired t-test; 7-9 replicates were performed per condition; n.s., not significant, unpaired t-tests). Scale 
bars: 50 μm.
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Figure 3.28 – mTOR inhibition does not recapitulate the axon pathfinding defects detected in em-
bryos deficient for Tctp. (A and B) Representative DiI-labeled retinotectal projections from embry-
os raised in DMSO (vehicle)- or rapamycin-containing saline. The dashed lines represent the anterior 
boundary of the optic tectum. (C) Quantification of retinotectal tract length (mean ± SEM; n = no. of 
brains analysed; not significant, P = 0.5403, Mann-Whitney test). (D) Percentage of brains displaying 
axon extension phenotypes (not significant, P = 1.0000, Fisher’s exact test, performed on number of 
observations but plotted as percentage). Scale bars: 25 μm.
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Collectively, these results suggest that the fine regulation of axonal Tctp ex-
pression achieved by local translation mechanisms is not essential in the short-term to 
support the advance of retinal ganglion cell axons in the optic tract. Thus, as a whole, 
my results indicate that the axon phenotype detected in Tctp knockdowns arises not as 
consequence of a regionally delimited dysregulation, but rather from a chronic deple-
tion of Tctp, as would be expected of a protein with constitutive cellular functions. In 
any case, judging from the enrichment of its mRNA, Tctp is an abundant axonal protein 
and, owing to its appreciable half-life (t1/2 > 6 h) [190], may be able to maintain a suffi-
cient degree of activity when its translation is temporarily inhibited.
B.4 Tctp is Necessary for Photoreceptor Maintenance
I next explored whether the axon phenotype in Tctp knockdowns somehow recapitulated 
an underlying defect in eye development. Analysis of phalloidin and nuclei-stained reti-
nal sections showed the overall stratification of the retina to be unaffected in morphant 
embryos, although a relatively disordered neuropil was noted (Figure 3.29A). I sub-
stantiated these observations using antibody markers with validated cellular specificity, 
suggesting that the global cytoarchitecture of the retina is unaffected in tpt1-MO-inject-
ed embryos (Figures 3.29B and 3.29C).
 However, on closer inspection of the outer layer of the neural retina, striking 
morphological alterations were detected in the cellular domains comprising the inner 
and outer segments of photoreceptor neurons (PR) in Tctp-deficient individuals (Figure 
3.30A). These surprising findings, in addition to the abundant expression of Tctp in the 
photoreceptor layer of the retina, prompted me to evaluate more closely the effects of 
Tctp depletion in photoreceptor biology. Briefly, the apical outer segment is a structure 
densely packed with discs of folded membranes containing the light sensitive photopig-
ments (opsins), whereas the inner segment, which lies between the outer segment and 
the outer nuclear layer, is dedicated to sustaining the high energy and protein synthesis 
needs of the photoreceptor [298]. Using opsin markers and a nuclear stain, I first pin-
pointed the localization of Tctp to the mitochondria-rich inner segments of cone and 
rod photoreceptors in wild-type specimens (Figure 3.30A). Subsequent quantification 
of the photoreceptor inner segment (IS) average length in control and Tctp-depleted 
retinas revealed this structure to be significantly thinner in the latter condition (cone 
inner segment: 13.7 μm versus 16.1 μm in controls; rod inner segment: 11.8 μm ver-
sus 15.8 μm in controls), a defect often accompanied by the complete loss of the outer 
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segment in a significant proportion of cone and rod photoreceptors (Figures 3.30B-E). 
Collectively, these data indicate that while Tctp is not essential for the timely develop-
ment of the retina, it lends an unexpected contribution to photoreceptor maintenance. 
This is in itself an insightful observation, since previous studies have shown Tctp to be 
downregulated in conditions associated with mitochondrial defects such as Alzheimer’s 
disease and Down syndrome [128, 207, 336], and photoreceptor degeneration is fre-
quently characterized by bioenergetic decline [298]. Indeed, mitochondrial dysfunction 
is reported in a number of retinal diseases, including photoreceptor-specific age-related 
macular degeneration [298], as well as neurodegenerative disorders with prominent 
axonal phenotypes, such as retinal ganglion cell-specific dominant optic atrophy [130, 
131] and Leber’s hereditary optic neuropathy [299]. Hence, the phenotypes I have char-
acterized in Tctp-deficient retinal ganglion cell axons and photoreceptors, two cellular 
domains particularly vulnerable to mitochondrial compromise and where Tctp is abun-
dantly expressed, indicate that Tctp could work by promoting mitochondrial function. I 
therefore set out to examine the status of mitochondria in Tctp knockdowns
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Figure 3.29 – Global retinal architecture is preserved in Tctp morphant embryos. (A) Coronal sec-
tions of stage 43 control or Tctp-depleted retinas stained with phalloidin and DAPI. The boxed areas are 
shown at a higher magnification in the rightmost panels. (B and C) Coronal sections of stage 43 control or 
Tctp-depleted retinas stained for glutamate decarboxylase (GAD65/67) or calretinin, two cell-type-spe-
cific markers (GAD65/67 and Calretinin antisera detect GABAergic amacrine cells, and retinal ganglion 
cells/bipolar cells, respectively). Scale bars: 50 μm.
A
co
n-
M
O
tp
t1
-M
O
DAPI Phalloidin
Merge
co
n-
M
O
tp
t1
-M
O
DAPI GAD65/67
Calretinin
co
n-
M
O
tp
t1
-M
O
DAPI
B
C
107
IS
OS
PR
DAPI Tctp Rhodopsin
ONL
DAPI Tctp Opsin
B
A
IS
OS
ONL





	
	


	
	


	
	




con-MO tpt1-MO
Cone PRs Rod PRs
D






	














  

E
Cone PRs Rod PRs
con-MO tpt1-MO
DAPI Opsin DAPI Opsin
C
con-MO tpt1-MO
DAPI Rhodopsin DAPI Rhodopsin
Figure 3.30 – Tctp is necessary for photoreceptor maintenance. (A ) Photoreceptor (PR) layer in cor-
onal sections of stage 43 wild-type retinas probed for Tctp and Opsin or Rhodopsin (ONL: outer nuclear 
layer; IS:  PR inner segment; OS: PR inner segment). See also Figure 3.2A. (B and C) Photoreceptor 
layer in coronal sections of stage 43 control or Tctp-depleted retinas probed for opsin or rhodopsin 
and counterstained with DAPI. (D) Quantification of the average inner segment length in control and 
Tctp-depleted embryos (*** P < 0.0001, unpaired t-tests; boxplot whiskers denote 5-95 percentile). (E) 
Quantification of the proportion of photoreceptors showing complete outer segment loss in control and 
Tctp-depleted embryos (n = no. of PR layers analysed; *** P < 0.0001, unpaired t-test). Scale bars: 25 
μm.
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C – Mechanistic Insights Into the Role of 
Tctp in Neural Development
C.1 Tctp Knockdown Leads to Mitochondrial Compromise
I initially gained direct insight of the metabolic status of Tctp-depleted embryos by 
using a bioluminescence assay to determine total ATP concentration [258]. The energy 
content in Tctp-depleted retinas was found to be on average 30% lower relative to con-
trols (Figure 3.31), suggesting that the function of mitochondria, the cell’s powerhouses 
and key organelles behind axon survival [126], is affected in Tctp knockdowns. Follow-
ing on this result, I sought to measure the mitochondrial membrane potential (ΔΨm) in 
retinal explant cultures, a parameter related to a cell’s capacity to generate ATP by oxi-
dative phosphorylation and, for this reason, a cardinal indicator of mitochondrial func-
tion [300]. Notably, in Tctp knockdowns, I found a significantly lower accumulation of 
the cationic fluorescent probe tetramethylrhodamine methyl ester (TMRM) in the mito-
chondria-rich growth cone central domain (~20% in respect to control), denoting ΔΨm 
depolarization (Figures 3.32A and 3.32B). A significant decrease in the number of ax-
onal mitochondria was also noted in these experiments, which I confirmed in vitro with 
a mitochondrial stain (approximately 30% fewer mitochondria), and in vivo, working in 
collaboration with Hovy Ho-Wai Wong, by co-labelling retinal ganglion cell axons with 
mitochondrion-targeted GFP (mt-GFP) and gap-RFP (approximately 23% fewer mito-
chondria) (Figures 3.33A-C and 3.34). Consequently, these findings raised concerns 
about my assessment of mitochondrial depolarization in Tctp-depleted growth cones, as 
a decrease in axonal mitochondrial density would be expected to affect to some extent 
the accumulation of mitochondria at the growth cone central domain; however, analysis 
of individual mitochondria distributed throughout the axonal compartment showed a 
comparable ΔΨm reduction in Tctp knockdowns (Figure 3.32C), supporting my initial 
conclusions regarding mitochondrial function in these embryos. In spite of these re-
sults, mitochondrial morphology in Tctp-depleted axons, as assessed by measuring the 
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length of axonal mitochondria, was not overtly different from controls (Figure 3.33D). 
Taken together, these results show a significant reduction, both in vitro and in vivo, in 
axonal mitochondrial density in Tctp-depleted axons, as well as a decrease in axonal 
mitochondrial function and global energy levels, thus establishing a framework for 
understanding the axon outgrowth defects we have characterized in Tctp knockdowns.
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Figure 3.31 – Decreased energy levels in Tctp knockdowns. (A ) Relative ATP levels per retina nor-
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Figure 3.32 – Mitochondrial dysfunction in Tctp-depleted axons. (A) Representative con-MO and 
tpt1-MO-positive retinal ganglion cell growth cones loaded with TMRM. (B) Quantification of TMRM 
fluorescence intensity in the mitochondria-rich growth cone central domain (mean ± SEM; *** P = 
0.0002, Mann-Whitney test). (C) Quantification of TMRM fluorescence intensity in individual mito-
chondria along the axonal compartment (mean ± SEM; ** P < 0.0012, Mann-Whitney test). A ΔΨp-con-
trolled assessment of ΔΨm was derived from the ratio of fluorescence intensity between mitochondria 
(Fm) and mitochondria-poor regions (Fc) [259, 300]. Up to 10 replicate experiments were performed 
per condition, totaling 427 growth cones and 4918 individual mitochondria analysed. Scale bar: 5 μm.
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C.2 Normal Mitochondrial Biogenesis and Mass in Tctp Morphants
The generation of new mitochondria in neurons is thought to occur mainly in the neuronal 
soma, being distributed from there to the cell periphery [260]. Thus, I next addressed wheth-
er the decrease in mitochondrial density detected in Tctp-depleted retinal ganglion cell 
axons stemmed from a global impairment of mitochondrial biogenesis. First, I document-
ed normal mitochondria DNA copy numbers (id est, the ratio of mitochondrial to nuclear 
DNA), as evaluated by quantitative PCR (qPCR), in Tctp-depleted retinas (Figure 3.35A). 
Western blot analysis of Tctp-depleted tissues showed, in addition, unaltered levels of 
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Figure 3.33 – Decreased mitochondrial density in Tctp-depleted axons – in vitro analysis. (A-C) 
Kymographs of MitoTracker-labeled mitochondria in con-MO- or tpt1-MO-positive retinal ganglion cell 
axons and quantification of axonal mitochondrial density (mean ± SEM; n = no. of axons analysed; *** P 
< 0.0001, Mann-Whitney test). Note also the weaker mitochondrial loading in Tctp-depleted axons (like 
TMRM, MitoTracker dyes are lipophilic cationic compounds; thus, their accumulation inside mitochon-
dria is dependent on ΔΨm). (D) Quantification of mitochondrial length in cultured retinal ganglion cell 
axons. Scale bars: 5 μm. This in vitro dataset complements the embryo data presented in Figure 3.34.
112
Pgc1α (peroxisome proliferator-activated receptor gamma, coactivator 1 alpha), a master 
inducer of mitochondrial biogenesis and regulator of mitochondrial density in neurons 
[301] (Figures 3.35B). I obtained a similar result with a luciferase reporter assay where 
the promoter region of human pgc1a was cloned upstream of the luciferase gene cassette 
and transfected into tpt1 or control shRNA-infected HCT116 cells; here, measurements 
of reporter activity were not different between the two conditions, even though the de-
crease in Tctp expression was as high as 85% in these cells (Figures 3.36A-C). Further 
corroborating these findings, the mRNA expression levels of the nuclear-encoded mi-
tochondrial genes examined (idh3a, isocitrate dehydrogenase 3 (NAD+) alpha; cox5a, 
cytochrome c oxidase subunit Va; cysc, cytochrome c, somatic), were unchanged rela-
tive to control retinas (Figure 3.37A). Cytochrome c protein levels were also examined 
by western blot, confirming its normal expression in Tctp knockdowns (Figure 3.37B). 
Collectively, these data strongly indicate that mitochondrial biogenesis and mass are 
unaffected in Tctp knockdowns, and consequently imply that the decrease in mitochon-
drial density detected in Tctp-depleted axons results from a secondary perturbation. 
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Figure 3.34 – Decreased mitochondrial density in Tctp-depleted axons – in vivo analysis. (A) Sche-
matic representation of the experiment. (B) Micrographs of retinal ganglion cell axons co-labelled with 
mt-GFP and gap-RFP, plus quantification of axonal mitochondrial density  (n = no. of axons analyzed; 
*** P = 0.0002, unpaired t-test; boxplot: whiskers cover 5-95 percentile, ‘+’ denotes the mean value). 
Note that the boxed areas in the control and morphant backgrounds are shown at a higher magnification 
in the rightmost panels. Experiment perfomed in collaboration with Hovy Ho-Wai Wong.
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Figure 3.35 – Normal mitochondrial biogenesis in Tctp knockdowns. (A) The ratio of mitochondrial 
to nuclear DNA was determined by qPCR in control and Tctp-depleted retinas (mean ± 95% confidence 
interval; n = 7 paired retinas per condition; n.s., P = 0.23, Mann-Whitney test). (B) Protein samples 
prepared from con-MO- or tpt1-MO-injected embryos were run on a SDS-PAGE gel and Pgc1α was 
subjected to immunoblot analysis (n =3 independent samples; n.s., P = 0.8048, unpaired t-test).
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Figure 3.36 – Normal pgc1a expression in HCT116 cells deficient for Tctp. The rational for applying 
this seemingly indirect approach is not immediate. I knew a priori that basal P53 levels were elevated in 
tpt1+/- mice [24]. In turn, I later learned that the expression of pgc1a was repressed by the activation of P53 
in the context of telomere dysfunction [340]. Since the mitochondrial traits I had identified in Tctp mor-
phants were highly reminiscent of dysfunctional Pgc1α activity [301], I hypothesised that the activation of 
P53 in Tctp-deficient backgrounds could result in mitochondrial dysfunction due to its repression of pgc1a 
expression. Hence the strategy used here, for it allowed me to evaluate the expression of pgc1a at the tran-
scriptional level. (A-C) The promoter region of human pgc1a (2.8 kb) was cloned upstream of the lucifer-
ase gene cassette and stably transfected into tpt1 or control shRNA-infected HCT116 cells. Subsequently, 
lysates of tpt1 or control sh RNA-infected HCT116 cells were run on a SDS-PAGE gel and Tctp protein 
expression verified by western blot. Tctp expression knockdown was as high as 85% in these cells. Also 
shown is a plot of the average relative light units (RLU) measured in cells co-transfected with pgc1a-luc 
and a control plasmid (mean ± SEM; six biological replicates of tpt1-shRNA-infected cells were measured 
in triplicate in the two independent rounds of experiments conducted; *** P = 0.5544, one-way ANOVA). 
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Figure 3.37 – Normal mitochondrial mass in Tctp knockdowns. (A) RT-qPCR analysis of nucle-
ar-encoded metabolic genes in control and Tctp-depleted retinas (mean ± 95% confidence interval; n = 9 
retinas per condition, Mann-Whitney test). (B) Protein samples prepared from con-MO- or tpt1-MO-in-
jected embryos were run on a SDS-PAGE gel and Cytochrome c was subjected to immunoblot analysis 
(n =3 independent samples; n.s., P = 0.5989, unpaired t-test)..
C.3 Tctp Knockdown Affects Mitochondrial Transport Dynamics in Axons
Having excluded impaired mitochondrial biogenesis, and because mitochondrial dis-
tribution and transport are inherently interdependent, I next investigated whether Tctp 
deficiency affects mitochondrial dynamics in axons. I was particularly intrigued by 
reports linking mitochondrial dysfunction in axons – which is present in Tctp knock-
downs – to the transport of these organelles back to the cell body for recycling [302], a 
mechanism with a potential negative impact on axonal mitochondrial density. Analysis 
of time-lapse movies of labelled mitochondria showed a nonsignificant decrease in the 
number of motile mitochondria in Tctp-depleted axons (30.4% versus 37.2% in con-
trols, P = 0.3193), accompanied by a higher proportion of mitochondria moving in the 
retrograde direction (8.7% versus 1.9% in controls, P = 0.0358) and fewer mitochondria 
moving anterogradely (21.7% versus 35.2% in controls, P = 0.0353) (Figures 3.38A 
and 3.38B). This translated into a mean net movement in the anterograde direction of 
+4.4 μm versus +8.9 μm in controls – id est, considering the analysed population of mi-
tochondria as a whole, including stationary and retrogradely trafficked organelles, the 
overall displacement of mitochondria in Tctp-depleted axons was smaller than in con-
trol axons, albeit still in the anterograde direction (Figures 3.38A-D). Whereas a global 
characterization of mitochondrial transport dynamics had initially been sought, I next 
centred my analysis on the subset of axonal mitochondria undergoing fast transport, 
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which was a priori defined as encompassing those moving at average velocities of ≥ 0.3 
μm/s. Notably, in this dataset, the velocity of transport in the anterograde and retrograde 
directions were not significantly different between both groups (Figure 3.38D). Plus, 
using RT-qPCR, I found that the mRNA expression level of miro1 (mitochondrial Rho 
GTPase 1, also known as rhot1), a key regulator of mitochondrial transport, was un-
changed in Tctp knockdowns (Figure 3.38E). Taken together, these findings show that 
mitochondrial dynamics are appreciably altered in Tctp-depleted retinal ganglion cell 
axons, with more mitochondria being trafficked retrogradely and fewer anterogradely. 
Additionally, they suggest that the mitochondrial transport machinery itself is not com-
promised upon Tctp knockdown. In any case, it must be stressed that this analysis was 
based on 5-minute long time-lapse movies; hence, what at first could be understood as 
a relatively small perturbation on mitochondrial trafficking dynamics, has in effect the 
potential to orchestrate a prominent decrease in axonal mitochondrial density over the 
course of axon development.
C.4 Axonal Tctp Interacts with Pro-survival Mcl1 and Bcl-XL
How does mitochondrial dysfunction occur in Tctp-depleted axons? An attractive pos-
sibility stems from findings implicating Tctp as a positive modulator of mTOR signal-
ing [19], a master kinase that controls cell growth and mitochondrial function [303, 
304]. However, like reported by others [164, 305], I have not detected alterations in 
global mTORC1 activation in Tctp knockdown embryos, nor did treatment with bis-
peroxovanadium (bpV), a PI3K-Akt-mTOR signaling-promoting drug [297], amelio-
rate mitochondrial function in Tctp-depleted axons (Figures 3.39A-D). Furthermore, as 
was documented in a previous section, rapamycin-treated embryos do not recapitulate 
the axon phenotype detected in Tctp knockdowns (Figures 3.28A-D). Taken together, 
these findings strongly suggest that mTORC deregulation is unlikely to be at the core 
of the observed mitochondrial defects in Tctp knockdowns.
Figure 3.38 – Tctp knockdown affects mitochondrial transport dynamics in retinal ganglion cell 
axons. (A) Kymographs showing the motility of MitoTracker-labeled retinal ganglion cell axonal mi-
tochondria. (B) Summary of changes in axonal mitochondrial dynamics (Fisher’s exact test). (C) Quan-
tification of the relative mitochondrial motility and mean net movement in retinal ganglion cell axons 
(boxplot whiskers denote 5-95 percentile; right panel: mean ± SEM; * P < 0.0117, Mann-Whitney test). 
(D) Quantitative analysis of fast mitochondrial transport (mean ± SEM; P = 0.9468 (anterograde direc-
tion), P = 0.7308 (retrograde direction), Mann-Whitney tests). (E) RT-qPCR analysis of nuclear-encoded 
miro1 in control and Tctp-depleted retinas (mean ± 95% confidence interval; n = 9 retinas per condition, 
P = 1.00 Mann-Whitney test). Scale bar: 5 μm.
117
Figure 3.39 – Unaffected mTORC1 signaling in Tctp knockdown embryos. (A and B) CNS lysates of 
con-MO and tpt1-MO injected embryos were run on a SDS-PAGE gel and mTOR activation verified by 
western blot using antibodies that specifically recognize the mTORC1-mediated phosphorylation of rpS6 
and 4EBP1. (mean ± SEM; n.s., not significant, unpaired t-tests; n =3). (C) Representative retinal ganglion 
cell growth cones loaded with TMRM. Of particular note, Tctp knockdowns raised in bisperoxovanadium 
(BpV), a PI3K/Akt/mTOR signaling-promoting drug, show no recovery in terms of ΔΨm. (D) Quanti-
fication of TMRM fluorescence intensity in the mitochondria-rich growth cone central domain (mean ± 
SEM; n = no. of independent experiments; ‘tpt1-MO’ versus ‘tpt1-MO + BpV’: n.s. P = 0.4809, unpaired 
t-test). A ΔΨp-controlled assessment of ΔΨm was derived from the ratio of fluorescence intensity between 
mitochondria (Fm) and mitochondria-poor regions (Fc) [259, 300]. Each replicate included four retinal 
explants; a total of 72 control, 47 Tctp-depleted, and 119 Tctp-depleted and BpV-treated axons were ana-
lysed in the course of this experiment. Scale bar: 5 μm.
An alternative hypothesis builds on reports documenting the interplay between 
Tctp and the B cell lymphoma-2 (Bcl-2) family of proteins, which comprises key cellu-
lar mediators of mitochondrial integrity [306]. Indeed, although it lacks the characteris-
tic Bcl-2 homology domains shared by the members of this family, Tctp has been shown 
to interact with the anti-apoptotic oncoproteins myeloid cell leukaemia 1 (Mcl1) and 
Bcl-2-like protein 1 (Bcl-XL) [189-191], and to interfere with Bcl-2 associated X protein 
(Bax) homodimerization in the mitochondrial outer membrane [17]. In addition, despite 
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Tctp being a cytosolic protein and lacking a membrane-binding region, its expression is 
documented as part of the mitochondrial proteome [307, 308], and Tctp has in fact been 
shown to anchor in the mitochondrial membrane [17], where much of the interplay 
between the Bcl-2 family members takes places [127]. Curiously, embryonic sensory 
neurons depleted of Bcl-2, the prototypic member of this family, have reduced axon 
growth rates [309], and the Bcl-2 family is associated in many instances with photore-
ceptor disease [310-312]. Hence, the phenotypes I have characterized in Tctp-deficient 
axons and photoreceptors, together with its close links to the Bcl-2 family, prompted 
me to explore Tctp’s potential interactions in neuronal cells.
First, I investigated if Mcl1 is expressed in vivo by retinal ganglion cells using 
an antibody raised against the Xenopus laevis protein [313]. Similarly to Tctp, Mcl1 
was expressed throughout the neural retina and particularly in the inner plexiform layer 
(IPL), the outer plexiform layer (OPL) and the inner segment of photoreceptors (Fig-
ures 3.40A and 3.40D). Mcl1 was also detected in the ganglion cell layer (GCL), the 
optic fiber layer (OFL) and the optic nerve head (ONH), indicating that Mcl1 localizes 
to retinal ganglion cell axons in vivo (Figure 3.40B). Supporting these results, immu-
nofluorescence studies on cultured eye explants confirmed Mcl1 expression in retinal 
ganglion cell axons and growth cones (Figure 3.40C). Regrettably, the lack of a spe-
cific antibody against Bcl-XL precluded the analysis of its expression in the embryonic 
Xenopus laevis retina, but in rat this protein is reported to specifically localize to the 
Figure 3.40 – Mcl1 is expressed in retinal ganglion cell axons and growth cones. (A and B) Coronal 
section of stage 43 wild-type retina probed for Mcl1. In (B), Mcl1 can be seen localizing in the optic fiber 
layer and optic nerve head (ONH). Arrowheads indicate the optic fiber layer. (C) Growth cone stained for 
Mcl1. (D) Photoreceptor (PR) layer of a stage 43 wild-type retina probed for Mcl1 and Rhodopsin. Scale 
bars: 50 μm in (A), 25 μm in (B), 5 μm in (C), and 10 μm in (D).
119
ganglion cell layer, the inner plexiform layer, the outer plexiform layer, and the inner 
segment of photoreceptors [314]. In line with these data, both Mcl1 and Bcl-XL were 
detected in axons and dendrites of cultured Rattus norvegicus cortical neurons, con-
firming that, like Tctp, these proteins are present in neurites (Figures 3.41A-C).
PhalloidinTctp
Mcl1 PhalloidinB
A
C PhalloidinBcl-XL
120
I then tested whether Tctp physically interacts in axons with Mcl1 and Bcl-XL 
using a proximity ligation assay (PLA)a [315]. I resorted to rat cortical neurons in these 
studies due to my inability to locate matching sets of Xenopus laevis-specific primary 
antibodies raised in different hosts, a central requirement of this methodology. Tctp-
Mcl1 PLA dots, id est, pairs of Tctp and Mcl1 epitopes, were abundantly detected in the 
cell body, but also along the axon, dendrites and growth cone central domain of rat cor-
tical neurons (E18.5 + 3 DIV) (Figure 3.42A). I obtained an even more profuse signal 
in cultures aged in vitro for 14 days, suggesting these interactions are not transient phe-
nomena (Figure 3.42B). Similarly, pairs of Tctp and Bcl-XL epitopes were also detected 
in these cells, mimicking the distribution of Tctp-Mcl1 interaction events, but occurring 
much less extensively at E18.5 + 3 DIV and to a comparable degree at E18.5 + 14 DIV 
(Figure 3.44).
a A PLA reaction generates a positive signal only when the two target epitopes are in close vicinity, 
the theoretical maximum working distance between two proteins of interest being 30-40 nm. Thus, this 
method allows protein-protein interactions to be analysed in situ.
Figure 3.41 – Mcl1 and Bcl-XL are expressed in the neurites of Rattus norvegicus cortical neurons. 
(A-C) Cultured rat cortical neurons (E18.5 + 3DIV) stained for Tctp, Mcl1 or Bcl-XL, and counterstained 
with Phalloidin. Scale bars: 25 μm.
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Figure 3.43 – The critical lysine residue for Mcl1 to interact with Tctp is conserved from Homo sa-
piens to Xenopus laevis. (A) Amino acid sequence alignment of vertebrate Mcl-1. The key lysine residue 
for Tctp:Mcl-1 interaction, as defined by Liu et al. [190], is shown in green. The Bcl-2 homology (BH)-1 
domain is indicated in yellow. Asterisks indicate fully conserved residues; colons and periods denote 
residues with strongly similar and weakly similar properties, respectively.
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Figure 3.44 – Axonal Tctp interacts with pro-survival Bcl-XL. (A) PLA signal derived for Tctp and 
Bcl-XL interactions in cultured rat cortical neurons (E18.5 + 14 DIV) counterstained with Phalloidin. 
Scale bar: 10 μm.
Figure 3.42 – Axonal Tctp interacts with pro-survival Mcl1. (A) PLA signal for Tctp and Mcl1 in cul-
tured rat cortical neurons (E18.5 + 3 DIV) counterstained with DAPI and Phalloidin. Note that the boxed 
area is shown at a higher magnification in the bottom panels. (B) PLA signal for Tctp and Mcl1 in cul-
tured rat cortical neurons (E18.5 + 14 DIV) counterstained with DAPI and Phalloidin. Scale bars: 10 μm.
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Mechanistically, the pro-survival members of the Bcl-2 family (e.g. Mcl1 
and Bcl-XL) operate by sequestering initiator and executioner pro-apoptotic proteins 
(e.g. Bax), thus preventing the release of Cytochrome c from the mitochondrial in-
termembrane space and subsequent activation of caspases; as such, the interactions 
between the members of this family are dictated by local equilibria that are depen-
dent on their relative protein concentrations and binding affinities [126, 127]. Of 
particular note, Tctp stabilizes and enhances Mcl1 biological activity [190], and pro-
motes P53 degradation [24, 316], which itself neutralizes the pro-survival actions 
of Bcl-XL and Bcl-2 at the mitochondria [317]. Therefore, I reasoned that Tctp-de-
pleted axons might develop a detrimental balance between the pro- and anti-apop-
totic arms of the Bcl-2 family. While Xenopus laevis retinal ganglion cell axons and 
growth cones depleted of Tctp did not manifest altered levels of Mcl1 (data not 
shown), I found using quantitative immunofluorescence that P53 expression levels 
were significantly upregulated in this subcellular domain (Figure 3.45), corroborat-
ing the findings by Telerman and colleagues in various organs of tpt1+/- mice [24]. 
In line with this evidence, I measured a 50% increase in active Caspase-3 mean signal 
relative to controls (FIgure 3.46). Collectively, these data validate previous biochem-
ical reports and add a hitherto unexplored subcellular dimension to them, revealing 
that Tctp-Mcl1 and Tctp-Bcl-XL interactions occur in the cell body and processes of 
neuronal cells. In addition, while caspases mediate normal physiologic processes in 
neurons [193], including growth cone chemotropic responses [318], the levels of P53 
and cleaved Caspase-3 indicate that mitochondrial dysfunction in Tctp-depleted axons 
can arise as a result of unbalanced, and therefore detrimental, pro-apoptotic signaling.
Figure 3.45 – Expression of P53 in growth cones is upregulated in Tctp morphants. (A) Represen-
tative con-MO and tpt1-MO-positive retinal ganglion cell growth cones stained for P53, and respective 
quantification (mean ± SEM; n = no. of growth cones analysed; *** P = 0.0002, unpaired t-test). Scale 
bar: 5 μm.
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Figure 3.46 – Increased Caspase-3 activation in the growth cones of Tctp-depleted embryos. (A) 
Representative con-MO and tpt1-MO-positive retinal ganglion cell growth cones probed with an anti-
body that specifically recognizes the cleaved form of Caspase-3, and respective quantification (mean ± 
SEM; n = no. of growth cones analysed; *** P = 0.0002, unpaired t-test). Scale bar: 5 μm.
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4. Discussion
Neurons are highly compartmentalized cells with great energy demands. Given their 
elongated morphology and unique metabolic requirements, mitochondrial operation 
needs to be appropriately regulated in these cells to sustain neuronal processes. This 
assumes particular relevance at distal axon terminals, which require the localized pres-
ence of mitochondria to support axon growth, maintenance, and synaptic transmission 
[260]. Significantly, the results herein identify axonally enriched Tctp as a cell-autono-
mous checkpoint for the normal development of the retinotectal projection by promot-
ing axon survival. In particular, my findings show that Tctp-deficient retinal ganglion 
cell neurons have impaired axon outgrowth rates in vivo, and that mitochondrial ho-
meostasis is compromised in this subcellular domain. 
4.1 Tctp and Cellular Homeostasis
Tctp expression has been linked to cell growth in multiple contexts, including during 
bone development and in cancer [19, 25, 174, 180, 181, 194]. Still, perhaps the stron-
gest molecular clue corroborating its involvement in growth programs comes from 
the identification of a 5’-terminal oligopyrimidine (TOP) motif in vertebrate tpt1 tran-
scripts [319, and my own observations], a hallmark of a subset of mRNAs specifically 
regulated by mTORC1 that shift to the translationally active polysome fraction when 
resting cells are induced to grow or proliferate [171, 320]. Although archetypal exam-
ples of TOP mRNAs include those encoding ribosomal proteins and elongation factors 
– effectively the build-up of the translational apparatus is needed to accommodate the 
increased demand for protein synthesis during growth programs [172] – the findings 
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herein presented suggest that Tctp may function in axons as an indirect growth ‘en-
abler’ rather than a de facto growth ‘promoter’, by participating in the maintenance of a 
permissive cellular environment for axonal growth. Indeed, following on previous bio-
chemical reports [189-191], I show that Tctp interacts in axons with key pro-survival 
members of the Bcl-2 family, and that P53, which itself neutralizes the actions of Bcl-2 
and Bcl-XL [317], is upregulated in Tctp-deficient axons. Moreover, Tctp is reported to 
protect cells from oxidative stress [167], a detrimental by-product of growth programs 
when not adequately counteracted. Consistent with these considerations, one day after 
reaching the optic tectum, when most retinal ganglion cells have effectively stopped 
extending their axons and synaptogenesis is under way, tpt1 mRNA and its encod-
ed protein are still present in the axonal compartment. Furthermore, tpt1 is expressed 
throughout the adult central nervous system [168] and, in particular, still ranks among 
the most enriched transcripts in adult sensory axons [13], indicating that Tctp remains 
important after the development of the nervous system, as indeed would be expected of 
a protein that contributes to cellular homeostasis.
4.2 On the Axonal Expression and Regulation of tpt1
In concordance with genome-wide transcriptomic evidence by several independent re-
search groups [11-14], my data show that tpt1 is expressed abundantly in the axonal 
compartment of retinal ganglion cells. Indeed, my results indicate that tpt1 transcripts 
are nearly 10-times more prevalent in axons than actb, widely regarded as the standard 
axon-enriched message [4, 5, 254]. Moreover, differently from other known axon-tar-
geted mRNAs, tpt1 transcripts containing the shorter 3’UTR variant (tpt1-S) were here 
documented to be the predominant form expressed in retinal ganglion cell axons. This 
is a surprising finding in the field of neuronal mRNA localization, considering that lon-
ger 3’UTRs have been known to harbour unique cis-regulatory elements that allow for 
the distal trafficking of transcripts [136, 262]. Prominent examples of this paradigm in-
clude importinb1 and impa1 in axons [11, 153], in addition to bdnf and camk2a in den-
drites [262, 263]a. At first glance, the most parsimonious explanation for this result is 
that the longer tpt1 mRNA variant (tpt1-L) contains a soma-restricting element of some 
sort. However, careful examination of the data presented in Figure 3.7C of the Results 
Section argues against this possibility, since the expression level of tpt1-L transcripts in 
a Gene names: karyopherin (importin) beta 1 (importinb1), inositol(myo)-1(or 4)-monophosphatase 1 
(impa1), brain-derived neurotrophic factor (bdnf), and calcium/calmodulin-dependent protein kinase 
(CaM kinase) II alpha (camk2a).
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the axonal compartment appears to be almost on a par with that of actb (ΔCqtpt1-L:actb 
≈ -1, meaning that, for every tpt1-L message populating the axon, there are two encod-
ing for β-actin). That is, on these terms, tpt1-L cannot be ruled as a weakly expressed 
isoform in axons; instead, this result suggests that the tpt1-L mRNA variant is actively 
trafficked into axons. In any case, it is noteworthy that shorter 3’UTRs are associated 
with more efficient translation kinetics [337], a feature that can partly justify why an 
‘uncomplicated’ transcript encoding for a protein with constitutive axonal functions 
such as Tctp might actually be favoured in a ‘housekeeping’ context. Still, the clearest 
hint to the overall cellular significance of tpt1-S is perhaps found in the genomes of 
Mus musculus and Rattus norvegicus: to the best of my knowledge, these species, un-
like Xenopus laevis, Oryctolagus cuniculus (rabbit) [168], and Homo sapiens [168], do 
not express tpt1 mRNA variants bearing longer 3’UTRs. This enigmatic evolutionary 
history inherently implies that the core of Tctp ‘signature’ functions is regulated solely 
through tpt1-S. Conversely, the reappearance of longer tpt1 mRNA variants in Oryc-
tolagus cuniculus and Homo sapeins with relatively little homology to Xenopus laevis 
tpt1-L suggests that newer biological functions may have been acquired by Tctp later in 
vertebrate evolution (Figure 4.1).
4.3 Axonal Tctp and Local Translation
Several lines of study have established that Tctp cellular levels are regulated in response 
to extra- and intracellular signals, including growth signals and certain cytokines [159, 
163, 196, 197], though the biological significance of this modulation remains unknown. 
Comparably, I observed protein synthesis-dependent increases in growth cone Tctp ex-
pression levels after acute treatment with Netrin-1, an mTORC1-inducing chemotropic 
guidance cue encountered by navigating and target-arrived retinal ganglion cell axons 
[144, 321], suggesting that the local translation of Tctp is subcellularly regulated during 
development.
It is well documented that caspases can be physiologically activated during mul-
tiple aspects of normal neuronal development and operation without signaling for the 
destruction of the entire cell [193]. Indeed, the localized activation of caspases, as seen 
in long-term depression (LTD) [322] or downstream of Slit1a-Robo2 signaling to con-
trol axonal arborization [323], might be understood as a form of subcellular apoptosis, 
with cellular and functional alterations that are limited in time and space [193]. Nota-
bly, the activation of Caspase-3 in retinal ganglion cell growth cones is also required for 
the chemotropic guidance responses induced by Netrin-1 [318]. Upstream of caspases, 
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Figure 4.1 – Poor sequence conservation between Xenopus laevis and Homo sapiens tpt1-L. The tpt1 
3’UTR in Xenopus laevis and Homo sapiens (A), or in Oryctolagus cuniculus (rabbit) and Homo sapiens 
(B), were aligned using the T-Coffee web resource. Note that upstream of the first polyadenylation signal 
(id est, the segment encompassing tpt1-S) both Xenopus laevis and Oryctolagus cuniculus show appre-
ciable sequence homology relative to Homo sapiens, suggesting that tpt1-S is under the same regulatory 
constrains in these species. By contrast, the level of sequence conservation relative to Homo sapiens 
drops significantly in Xenopus laevis downstream of this motif (that is, in the unique region of the tpt1-L 
3’UTR), but remains nearly unchanged between Oryctolagus cuniculus and Homo sapiens. Hence, this 
in silico dataset indicates that tpt1-L and the pool of Tctp protein in encodes for may have acquired over 
the course of vertebrate evolution additional regulatory domains and new biological functions, respec-
tively. The boxed areas denote the location of the first polyadenylation signal (AATAAA).
pro-apoptotic Bcl-2-associated agonist of cell death (Bad) and Bcl-2 antagonist/killer 
(Bak) are also necessary for LTD induction, implicating the Bcl-2 family in this neuro-
physiologic paradigm [324]. Hence, it follows as necessary that local mechanisms be 
in place to control the physiologic activation of apoptotic cascades and neutralize these 
destructive programs [193].
Critically, Bax is reported to act upstream of the caspase pathway in the context 
of trophic deprivation-induced axonal degeneration [341], while both Mcl1 and Bcl-
XL, pro-survival Tctp interactors, have been shown to block Bax- and Bak-mediated 
apoptotic programs [193]. Thus, due to its association with members of the apoptotic 
machinery, Tctp is potentially apt to influence the regulation of axonal caspase cas-
cades. Indeed, the spatiotemporal precision conferred to newly synthesized Tctp mol-
ecules may influence, through the stabilization and enhancement of Mcl1 biological 
activity [190], or the inhibition of Bax dimerization on a local scale [17], the confined 
modulatory response required to limit the effects of the regional activation of caspases. 
In line with these considerations, ribosome immunopurification data recently obtained 
in the Holt laboratory indicate that pro-apoptotic Bax is locally translated in target-ar-
rived retinal ganglion cell axons in vivo (Hosung Jung, Toshiaki Shigeoka, and Chris-
tine Holt, unpublished observations). Furthermore, it is noteworthy that neurotrophin 
stimulation of nerve terminals promotes de novo synthesis of another pro-survival fac-
tor, Bcl-2-like protein 2 (Bcl-w), which was shown to prevent axonal degeneration by 
counteracting caspase activation subcellularly [133]. Like Tctp a[17], Bcl-w is known 
to associate with Bax and inhibit Bax-induced mitochondrial outer membrane permea-
bilization [325]. Whether Tctp, Bcl-w and Bax are locally and synchronously regulated 
during axon development is, therefore, an enticing direction of investigation.
a As mentioned in the Introduction Section, Susini et al. reported that Tctp indirectly inhibits Bax di-
merization and consequent Bax-induced mitochondrial outer membrane permeabilization. The authors 
suggest that it may do so by recruiting Mcl1 and Bcl-XL to the mitochondrial membrane [17].
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4.4 Mitochondrial Density in Tctp-deficient Axons
The axonal transport of cargos, be it organelles, synaptic vesicles or RNA granules, 
requires a constant provision of ATP to power the activity of dynein and kinesin motors 
[135]. However, unlike vesicular fast axonal transport, which is reliant on the glycolyt-
ic pathway for its energetic needs [338], the trafficking of mitochondria is dependent 
on the ATP produced by oxidative phosphorylation [338, 339]. Thus, considering the 
disruption of mitochondrial membrane potential observed in Tctp-depleted axons, a 
parameter correlated with the capacity of mitochondria to generate ATP by oxidative 
phosphorylation, and that embryos depleted of Tctp actually have a lower ATP content 
than age-matched controlsa, the defective accumulation of mitochondria at the neuronal 
periphery was perhaps, in hindsight, a predictable outcome of my analysis. In turn, it 
has been reported that dysfunctional mitochondria in neurons are transported back to the 
cell body for repair and/or degradation [260, 302]b, and, more recently, that mitophagy 
of damaged mitochondria can take place locally in axons [327]. Thus, the mechanisms 
identified by these studies have the potential to exacerbate any mitochondrial distri-
bution defect already existing in Tctp-depleted neurons. While the subcellular com-
ponent of mitophagy was not addressed herein, the increased numbers of retrogradely 
transported mitochondria in Tctp-depleted axons suggests that the mechanism eluci-
dated by Miller and Sheetz contributes towards the overall mitochondrial phenotype 
in Tctp-deficient axons [302]. Indeed, the subcellular insult to mitochondria in these 
axons – whether exclusively a consequence of the imbalance in pro- and anti-apoptotic 
signaling, or arising in concert with an complementarily acting pathway – may in effect 
potentiate a secondary perturbation on mitochondrial dynamics, with more organelles 
being shuttled back to the cell body for repair. These ideas are thoroughly supported by 
my findings on normal mitochondrial biogenesis and mass in Tctp knockdowns, as they 
imply that the reduced mitochondrial density detected in Tctp-depleted axons does not 
stem from an inability of the neuron to generate mitochondria. Furthermore, given that 
a Note that the data collected on the total ATP content of Tctp knockdowns does not discriminate be-
tween a decline in glycolysis or oxidative phosphorylation. Still, given that postmitotic retinal cells in 
Xenopus laevis are known to be more dependent on oxidative phosphorylation than on glycolysis for its 
energetic needs [258], and considering the overwhelmingly superior output in terms of energy produc-
tion of the former process, it stands to reason that the decline in total ATP levels results, at least to some 
extent, from an impairment in mitochondrial ATP production.
b Miller and Sheetz demonstrated that the direction of transport of individual mitochondrion in axons 
is correlated with the mitochondrial membrane potential (ΔΨm). In particular, approximately 9 out of 10 
mitochondria with a high ΔΨm were observed to progress in the anterograde direction (that is, towards 
the growth cone), whereas circa 8 out of 10 mitochondria with low ΔΨm moved retrogradely towards the 
neuronal cell body [302].
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fast mitochondrial transport is unaltered in Tctp-deficient axons, it is equally unlikely 
that defects at the level of the transport machinery account per se for the decreased 
mitochondrial density observed. Likewise, the comparable proportion of stationary mi-
tochondria in control and morphant axons indicates that adequate mitochondrial dock-
ing mechanisms are still in operation, whereas the normal length of these organelles in 
Tctp-deficient axons rejects deregulated mitochondrial fusion and/or fission as the basis 
for the decrease in axonal mitochondrial numbers. Hence, this body of work collec-
tively points to the conclusion that the axonal mitochondrial loss seen in Tctp-deficient 
retinal ganglion cell axons arises from an impairment in mitochondrial function.
4.5 Tctp and Mitochondrial Function
How does axonal Tctp promote mitochondrial function? Although Tctp is a multifunc-
tional protein, which potentially could have limited the interpretation of any finding, 
the range of phenotypes detected in Tctp knockdowns – compromised axon outgrowth 
rates arising in a cell-autonomous fashion, photoreceptor degeneration, and mitochon-
drial dysfunction – ultimately permitted to narrow down the list of possible candidates. 
Pro-survival members of the Bcl-2 protein family, such as Mcl1 and Bcl-XL, work pri-
marily by sequestering and neutralizing Bcl-2-related pro-apoptotic factors (e.g. Bax), 
which, if left uncontrolled, negatively impact on the integrity of mitochondria [127]. A 
fitting analogy would be a molecular tug of war contest, with pro- and anti-apoptotic 
Bcl-2-related factors on opposite sides of a rope, playing for mitochondrial homeo-
stasis. According to the model put forward by Susini et al. [17], Tctp’s pro-survival 
activity results from it blocking Bax dimerization, a key mitochondrial outer mem-
brane permeabilization (MOMP)-inducing event, by binding and reconfiguring Mcl1 
and Bcl-XL in such a way that their inhibitory actions on Bax are effectively promoted. 
In this regard, Tctp is proposed to act as a cell survival enhancer. It is thus reasonable 
to assume that in axons chronically depleted of Tctp, part of the insult to mitochon-
dria likely occurs due to a shift in the equilibrium between the pro- and anti-apoptotic 
arms of the Bcl-2 family. Indeed, the increased levels of cleaved Caspase-3 detected in 
Tctp-depleted axons serve as a key insight into the local over-activation of pro-apoptot-
ic signaling. Crucially, though, considering that apoptosis is, in essence, a ‘yes’ or ‘no’ 
process [328], my observations also indicate that a full-scale cell death program does 
not occur in Tctp-deficient retinal ganglion cells – at least during the developmental 
stages analysed. Instead, the cellular insult produced in these neurons seems to impair 
mitochondrial integrity to a degree that repair responses are still deemed appropriate 
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by the cell.
Tctp may also promote mitochondrial integrity and axon survival indirectly 
through the negative regulation it exerts on P53 expression [24, 316, and corroborated 
by my own observations in Tctp-depleted axons]. In fact, P53 activation may influence 
axon development programs in a number of ways, since it can act both as a nuclear 
transcription factor and as a modulator of apoptosis in the cytoplasm [329, 330]. Of 
particular note, cytoplasmic P53 is known to translocate to the mitochondria under a 
range of cellular stresses [329], where it associates with and offsets Bcl-2 and Bcl-XL 
pro-survival actions [317]. Similarly, cytoplasmic P53 has also been shown to inter-
act with pro-apoptotic Bcl-2 homologous antagonist/killer (Bak) at the mitochondri-
al membranea, liberating it from the inhibitory effects constitutively exerted by Mcl1 
[331]. Thus, as a whole, mitochondrially-translocated P53 can potentially exacerbate 
any pre-existing unbalance between pro- and anti-apoptotic signalling in Tctp-depleted 
neurons ensuing from Tctp’s direct involvement in this pathway.
Based on the evidence discussed above, I propose that in Tctp-deficient ax-
ons a detrimental shift in the balance between the pro- and anti-apoptotic arms of the 
Bcl-2 family is produced and mitochondrial integrity is consequently compromised. 
Ultimately, this translates into mitochondrial dysfunction and an energy state that is 
insufficient to sustain the continuous expansion and rearrangement of a growing axon 
(Figure 4.2). In other words, Tctp impacts on axon development by having an effect on 
the homeostatic mechanisms of the neuron.
4.6 The Tumour Suppressor P53 in Neurite Outgrowth
Above, for the sake of a coherent argument, I presented a rather one-sided view on how 
the activation of P53 can affect axon development. In fact, P53 biological activities are 
much more diversified, and the cellular significance of its upregulation in Tctp-depleted 
axons difficult to interpret. Two related reasons justify this initial oversimplification on 
my part: P53 mode of action is context-specific and is impacted by various post-transla-
tional modifications. Broadly speaking, P53 can be understood as having transcription-
al and non-transcriptional functions [329]. Working as a transcription factor, P53 pro-
motes the expression of an extensive list of genes involved in apoptosis (including bax, 
a Like Bax, Bak can induce the permeabilization of the mitochondrial outer membrane.
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Figure 4.2 – A role for Tctp in neural circuitry formation - graphical overview. 
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as well as puma and pmaip1/noxa, which encode for BH3-only Bcl-2 proteinsa), cell 
senescence, cell cycle progression, and metabolism, among others [329]. Furthermore, 
it is now well established that P53 specifically modulates the cytoskeletal response 
associated with neurite outgrowth elicited by neurotrophin- and cue-mediated signal-
ing [342]. It does so by integrating these signals at the nuclear level, where it binds to 
the promoter region and activates the expression of a number of cytoskeleton-relat-
ed genes, including coronin1b (which encodes for an actin-binding protein), gap43 
and prkg1 [342]b. Also of note, emerging evidence suggests that various classical axon 
guidance genes are similarly under the control of P53 in the context of tumorigenesis 
[343]. Cytoplasmic P53, on the other hand, in addition to associating with the mito-
chondrial outer membrane under a number of apoptosis-inducing conditions, where it 
counteracts the actions of Bcl-2 family pro-survival proteins [317], is also reported to 
inhibit autophagy and mitophagy [329, 344, 345], which, in the context of Tctp deple-
tion, could accentuate the decline in mitochondrial integrity over the course of devel-
opment. Moreover, although less well characterized, a direct, transcription-independent 
role for P53 in the regulation of the growth cone cytoskeleton has been recently defined 
[342]. Of particular importance, P53 antagonizes growth cone Rho-associated protein 
kinase (Rock) activity [346], and participates in Semaphorin 3A-induced growth cone 
collapse responses [347].
 Given P53 often opposing roles, how can its many and spatially heterogeneous 
cellular effects be brought about? In general terms, the transcriptional versus non-tran-
scriptional functions of P53 are determined, as already alluded to, by a plethora of 
post-translational modifications at several domains (e.g. ubiquitination, neddylation, 
sumoylation phosphorylation, and acetylation) that shape the balance of its nuclear and 
cytoplasmic pools, and its association with other proteins [329]. For example, unlike 
the mitochondrial translocation of P53, which is initially regulated by monoubiquitina-
tionc and carboxy-terminal phosphorylation events, P53 neurite outgrowth-promoting 
a Gene names: p53 upregulated modulator of apoptosis (puma), also known as bcl-2-binding compo-
nent 3 (bbc3), and phorbol-12-myristate-13-acetate-induced protein 1 (pmaip1), which encodes for a 
protein commonly known as Noxa.
b Gene name: protein kinase, cGMP-dependent, type 1 (pkrg1).
c Note that P53 is apoptotically active in its non-ubiquitinated form – once at the mitochondria it gets 
deubiquitinated by herpesvirus-associated ubiquitin-specific protease (Hausp).
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transcriptional activity appears to be mainly modulated by acetylation [329, 342]. Dif-
ferently, P53-mediated inhibition of Rock at the growth cone is controlled by the phos-
phorylation of a serine residue in its N-terminus [346]. That is, as would be expected of 
a protein whose effects influence cells at so many different levels, P53 modus operandi 
is governed by an intricate network of regulatory signals, and, therefore, the outcome of 
its upregulation cannot be subjected to a one-dimensional evaluation. For this reason, 
it seems fruitless to elaborate much further on the possible transcription-dependent ef-
fects evoked by P53, as I have only characterized its expression in the growth cone of 
retinal ganglion cells. If anything, considering its negative impact on pgc1a transcrip-
tion in the context of telomere dysfunction [340], and the apparently unaffected pgc1a 
expression levels in Tctp knockdown embryos and cells, one can perhaps infer that 
P53 activation in Tctp-depleted backgrounds might have a predominantly cytoplasmic 
component. Still, providing that is indeed the case, establishing the actual consequenc-
es of its upregulation in the axonal compartment of Tctp-deficient neurons will require 
additional experimental work to distinguish between its cytoskeletal and mitochondrial 
effects.
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Whereas during my studies I have focused exclusively on examining the role of Tctp in 
the context of axon pathfinding, future work should aim at elucidating its implications 
in the adult nervous system. Indeed, the finding that tpt1 is still one the most abundant 
transcripts in adult sensory axons [13], together with reports of deregulated Tctp protein 
expression in Down syndrome and Alzheimer’s disease [128, 207, 336], two conditions 
associated with mitochondrial dysfunction, prompt speculation on whether Tctp may 
hold an important lifelong axonal function. However, given that Tctp contributes to the 
formation of neural circuits, temporal control over its knockdown will be a key aspect 
of any successful approach aimed at elucidating this question. New tools to meet such 
requisites in vivo are at tantalizing distance, since two different Mus musculus lines 
containing floxed tpt1 alleles have already been established [17, 164]; id est, Tctp in-
activation in a precisely limited temporal window could be achieved by crossing these 
animals with an inducible Cre recombinase strain. Considering that proper mitochon-
drial operation is an imperative of synaptic homeostasis [260], such strategy would, for 
example, allow one to study Tctp in the context of synaptic plasticity independently of 
underlying defects in neural circuitry formation.
It would also be important to investigate Tctp’s axon and cell body roles sep-
arately. Indeed, judging from the immunofluorescence studies I conducted, Tctp is 
abundantly expressed not only throughout neuronal processes, but also in the soma of 
these cells, suggesting that its contribution to neuronal homeostasis may have a com-
partment-specific component. These considerations assume particular relevance given 
5. Future Perspectives
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the many functions that have been ascribed to Tctp over the past 20 years of scrutiny. 
This is, I believe, an important limitation of my doctoral work, as I have not been able 
to directly differentiate between global and axon-specific effects in the context of Tctp 
knockdown. Cumbersome genetics in Xenopus laevis – this frog species has an allo-
tetraploid genome [91] – justifies this obstacle in large part, as effective genome-ed-
iting tools did not exist until very recentlya[332, 333]. By contrast, well-established 
gene knockdown methods like morpholinos target the different cellular pools of a giv-
en mRNA indiscriminately, precluding this type of analysis in vivo. A potential future 
strategy around these drawbacks could, for example, exploit the control exerted by the 
untranslated regions – and, in particular, that of the 3’UTR [136] – on the subcellular 
distribution of a transcript. To limit the axonal accumulation of tpt1 transcripts, a Xeno-
pus laevis or Mus musculus line could be engineered to have the tpt1 3’UTR substituted 
for that of a soma-restricted transcript, such as tubb (β-tubulin) [263, 334], or actg1 
(γ-actin) [254] – id est, tpt1-tubb or tpt1-actg1 chimeras in place of the endogenous tpt1 
gene. Alternatively, the exon encoding for the 3’UTRs could be removed altogether 
from the tpt1 gene. Still, supposing the proposed strains are viable, this approach would 
only partly succeed in reducing the expression of tpt1 in axons, as de novo synthesis 
of Tctp protein would cease to occur locally, but axonal transport of cell body-derived 
protein – if it happens – would remain uncompromised. In any case, given the local 
enrichement of this mRNA species, it stands to reason to expect this type of approach 
to yield a better in vivo understanding of the axon-specific functions of Tctp (or, indeed, 
any other protein encoded by a subcellularly-targeted transcript).
At a molecular level, further research is also needed to characterize the regulato-
ry duality of tpt1 mRNA isoforms observed in growth cones exposed to Netrin-1b. This 
was, in fact, what led me to pursue the profiling of tpt1 mRNPs in the first place. Had 
it not been for time constraints, the MS2-BioTRAP strategy applied simultaneously to 
the analysis of tpt1-S and tpt1-L mRNPs would likely have permitted the identification 
of some of the trans-acting factors behind the differential regulation exhibited by the 
two tpt1 variants. In parallel, additional experiments using the tpt1-Kaede translation 
reporters in different stimulatory contexts (e.g. Semaphorin 3A or Slit 2, which, like 
Netrin-1, signal through the mTOR pathway, but induce repulsive turning responses in 
growth cones [115, 144]; as another option, a protocol with axon survival-promoting 
a This paradigm has changed with the recent advent of CRISPR-Cas and TALEN technology.
b Although much less abundant in axons than tpt1-S, the expression of tpt1-L in retinal ganglion cell 
axons is almost on a par with that of actb mRNA, suggesting it plays an important subcellular function. 
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neurotrophins could be tried [133]), may achieve additional understanding regarding 
the modes of regulation behind tpt1 expression. Overall, the questions posed by the 
differential regulation of tpt1 isoforms echo on the necessity to globally elucidate the 
mechanisms regulating mRNA-specific translation programs in axonal processes pop-
ulated by thousands of transcripts.
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Concluding Remarks
Many mitochondrial dysfunctions lead to neurodegenerative conditions with prominent 
axonal phenotypes [129-131], suggesting that axons may be particularly vulnerable 
to mitochondrial compromise. A developing axon is all the more dependent on ade-
quate mitochondrial operation, as it requires a continuous provision of energy and Ca2+ 
buffering for its expansion in the embryonic brain. The corollary to these ideas is that 
neurons must operate, as well as preserve, a tightly regulated mitochondrial network to 
sustain an axon’s growth potential.
Many parallels can be drawn between the normal processes of migratory growth 
cones during axon development and the disease mechanisms of cancer cell invasion. 
Here, motivated by the abundance of its mRNA in diverse axonal populations, I pio-
neered the study of tumorigenic Tctp in the context of neural connectivity. Given the 
importance of maintaining an operational mitochondrial network to axon development 
and overall neuronal function, it is perhaps not surprising that all axonal populations 
analysed to date at the transcriptome level contain a large proportion of nuclear-encod-
ed mitochondria-related mRNAs [2]. In fact, it has been estimated that up to 25% of 
all locally synthesized proteins are transported to the mitochondria [335]. Hence, my 
efforts to characterize Tctp in the context of axon development typify the significant 
biological investment put into supporting these organelles subcellularly. 
In summary, the data collected over the course of my doctoral work indicate that 
Tctp regulates axon development by impacting on the homeostatic mechanisms of the 
neuron. My findings thus suggest a novel and fundamental role for Tctp in vertebrate 
neural circuitry formation.
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List of Abbreviations 
5’-TOP   5’-terminal oligopyrimidine motif
ΔΨm   mitochondrial membrane potential
ΔΨp   plasma membrane potential      
A   adenine
Å    angstrom
Alpha (α)  level of significance
ANOVA  analysis of variance
Apaf1   apoptotic peptidase-activating factor 1 a
ARNm   ácido ribonucleico mensageiro
Bax   Bcl-associated X protein
Bcl-2   B-cell lymphoma 2
Bcl-XL   Bcl-2-like protein 1
Bdnf   brain-derived neurotrophic factor
Bmp   bone morphogenic protein
C   cytosine
cAMP   cyclic adenosine monophosphate
Cdc42   cell division control protein 42
ceRNA   competing endogenous RNA
CHX   cycloheximide
CMZ   ciliary marginal zone
CNS   central nervous system
CNV   copy number variation
Cq   (in qPCR) quantification cycle
ΔCqX:actb  quantification cycle difference of X relative to actb
CRE   cAMP response element
Cspg    chondroitin sulfate proteoglycan
CST   cancer stem cell
DAPI   4’,6-diamidino-2-phenylindole
Dcc   deleted in colorectal carcinoma
DIG   digoxigenin
DiI   1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate
DMSO   dimethyl sulfoxide
DNA   deoxyribonucleic acid
DOT   dorsal optic tract
dsRNA   double-stranded RNA-dependent
ECM   extracellular matrix
e.g.    exempli gratia
F-actin    filamentous-actin
Fc   fragment crystallizable
Fgf    fibroblast growth factor
FISH   fluorescence in situ hybridization
G   guanine
a Note that, although gene/protein names and symbols in Xenopus are based on the nomenclature of 
their human counterparts, protein symbols are first letter capital only.
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Gap-43   growth associated protein-43
GC   growth cone
GDI    guanine nucleotide dissociation inhibitor
GDP   guanosine diphosphate
GFP   green fluorescent protein
GPI   glycosylphosphatidylinositol
GTP   guanosine triphosphate
Gsk3β   glycogen synthase kinase 3β
h   hour
HEK 293  human embryonic kidney two hundred and ninety-three cells
HEKMS2-HB  HEK 293 cells expressing a modified MS2 coat protein tethered   
   to a His-biotin (HB) tag 
IgE   immunoglobulin E
IgG   immunoglobulin G
ISH   in situ hybridization
IPL   inner plexiform layer
kDa   kilodalton
LCM   laser-capture microdissection
LGN    lateral geniculate nucleus
LTD   long-term depression
M-phase  mitotic phase
Mag    myelin-associated glycoprotein
MBS   Modified Barth’s Saline
Mcl1   myeloid cell leukemia 1
Mdm2   MDM2 proto-oncogene, E3 ubiquitin protein ligase
min   minute
miRNA   microRNA
MO   morpholino antisense oligomer
MOM   mitochondrial outer membrane
MOMP   mitochondrial outer membrane permeabilization
mRNA   messenger ribonucleic acid
mRNP   messenger ribonucleoprotein
MS-222  Tricaine methanesulfonate
MS2-BioTRAP  MS2 in vivo biotin tagged RNA affinity purification
MsrB    methionine sulfoxide reductase gene B
Mss4   mammalian suppressor of yeast
mtDNA   mitochondrial DNA
mTOR   mechanistic/mammalian target of rapamycin
mTORC1  mammalian TOR complex 1
MOT   mid-optic tract
Ngf   nerve growth factor
no.   number
NP-40   nonyl phenoxypolyethoxylethanol
Nt   neurotrophin
OFL   optic fiber layer
ONH   optic nerve head
OPL   outer plexiform layer
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PBS   phosphate buffer saline
PCR   polymerase chain reaction
Pkr   protein kinase R
PLA   in situ proximity ligation assay
Poly(A)  polyadenylation
PR   photoreceptor
QIF   quantitative immunofluorescence
qPCR   quantitative real-time polymerase chain reaction
RACE   rapid amplification of cDNA ends
RBP   RNA-binding protein
RGC   retinal ganglion cell
Rheb   Ras homolog enriched in brain
RhoA   Ras homolog gene family, member A
RIPA buffer  radioimmunoprecipitation assay buffer
RFP   red fluorescent protein
RNA   ribonucleic acid
RT-PCR  reverse transcriptase-polymerase chain reaction
s   second
SAGE   sequential analysis of gene expression
SDS   sodium dodecyl sulfate
SDS-PAGE  sodium dodecyl sulfate-polyacrylamide gel electrophoresis
SEM   standard error of the mean
Shh    sonic hedgehog
shRNA   small hairpin RNA
SILAC   stable isotope labeling by amino acids in cell culture
srGAP   Slit-Robo-specific GTPase-activating protein
STRING  Search Tool for the Retrieval of Interacting Genes/Proteins
T   thymine
TAF   trans-acting factor
Tctp   translationally controlled tumor protein (protein)
TMRM   tetramethylrhodamine methyl ester
tpt1   tumor protein, translationally-controlled 1 (gene)
tpt1-L   long 3’UTR variant of the tpt1 mRNA
tpt1-S   short 3’UTR version of the tpt1 mRNA
U   uracil
UPS   ubiquitin proteasome system
UTR   untranslated region
V   volt
Vamp2    vesicle-associated membrane protein 2
Vegf   vascular endothelial growth factor
VOT   ventral optic tract
Zbp1   zipcode-binding protein 1
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